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Abstract
Dendritic cells (DC) are important modulators of the immune response 
with the ability to present antigen to naïve T cells. DC can be generated in vitro 
from blood monocytes (MoDC), which represent an appropriate model to study 
DC biology. In addition, they are important targets for many viruses and this 
interaction is crucial for the establishment of an anti-viral immunity. Equine 
arteritis virus (EAV) and Equine encephalosis virus (EEV) cause infectious 
diseases in equids. Little is known of the effect both viruses have on host 
immune cells, particularly DC. An optimized system was established to generate 
equine MoDC (eqMoDC) in vitro. Purified recombinant equine cytokines (GM-CSF 
and IL-4) were used for the differentiation of Mo to immature MoDC (iMoDC) and 
a cocktail of stimuli was used for DC maturation. The phenotype of DC, studied 
using flow cytometry and microarray analysis, and functional assays, such as 
endocytosis/phagocytosis, mixed leukocyte reactions, antigen presentation and 
cross presentation, were applied to characterise immature and mature MoDC 
(mMoDC). To study the interaction with EAV and EEV, MoDC were infected with 
strains of different genotypes and pathogenicity and virus replication was 
determined through titration and real-time quantitative PCR (qPCR). Both viruses 
were able to infect Mo and MoDC but showed differences in their replication 
pattern. EAV demonstrated a productive replication leading to lysis of cells 
whereas EEV displayed a possible restricted or restricted-persistent replication. 
Mature MoDC were the most susceptible to these viruses, unlike iMoDC which 
were the least susceptible cells thereby preserving their phenotypic and 
functional characteristics. The replication of EAV resulted in an apoptosis 
mediated cell death, which inevitably inhibited the differentiation and function of 
DC. On the other hand, EEV drove the differentiation of Mo. Both viruses 
inhibited the ability of mMoDC to activate T cells, which is a mechanism used to 
evade host anti-viral immunity.
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Chapter 1. General Introduction
The equine industry in the United Kingdom (UK) has a combined 
economic impact of £7 billion a year, over half of which is derived from 
horseracing (British Horse Industry Confederation, 2006). The potential financial 
and social impacts associated with a serious viral disease outbreak and the 
implemented control measures would cause irreparable damage to racing, the 
horse industry in the UK and throughout the world. Horses are second only to 
people in volume of global airline travel (Ferraro et al., 2006). The increase in 
the demand for movement of horses for sale, competition or breeding is 
influenced by the increased economic importance of the equine industry. The 
international movement of horses can be adversely affected by the emergence 
and/or re-emergence of viral diseases in horses. A disease arising from a single 
individual now has the potential of being spread to horses at distant locations. 
Other factors contributing to the emergence/re-emergence of equine viral 
diseases include the evolution of virulent strains from weaker strains and 
ecological changes such as climate change. The latter has had an inevitable 
impact on the spread and distribution of arthropod-transmitted diseases (Sellon 
et al., 2007).
The contagious Equine viral arteritis (EVA), is a disease of great concern 
following the recently reported outbreaks in Ireland and Argentina in May 2010 
and in the UK in August 2010 (Newton and Cruz, 2010). Most recently, there has 
been confirmation of EVA in a stallion in the UK in October 2012 (Department for 
Environment, Food and Rural Affairs, 2012). Another disease of great concern is 
Equine encephalosis (EE), following the reported outbreak in Israel from October 
2008 through January 2009 and the potential introduction of this virus into 
Europe (Aharonson-Raz et al., 2011). The causative agents of EVA and EE are 
Equine arteritis virus (EAV) and Equine encephalosis virus (EEV), respectively. 
These viruses adversely impact the equine industry and cause detrimental 
effects to the health and welfare of horses. Therefore, it is important to better
23
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understand how EAV and EEV interact with their host immune cells and cause 
disease.
Dendritic cells (DC) are crucial to host immunity because as antigen 
presenting cells (APC), they are the only cells that can initiate a primary 
adaptive immune response (Steinman, 1991; Hart, 1997; Banchereau and 
Steinman, 1998; Bell et al., 1999). No studies to date have investigated the 
effects of these viruses on equine DC phenotype and most importantly function. 
In order to explore this, an equine system must be used as EAV and EEV are not 
zoonotic. Therefore, the best possible model of equine DC should be employed. 
The monocyte-derived dendritic cell (MoDC) system is a good in vitro model 
since it has been shown to represent inflammatory tissue resident DC and can 
replicate all important DC functions (Cheong et al., 2010). Furthermore, an 
equine MoDC (eqMoDC) system, although not optimal, has already been shown 
to express DC markers (Mauel et al., 2006) and can be used to study equine DC 
biology. DC are exploited by many viruses as a route of entry for infection, 
therefore understanding the impact of EAV and EEV on DC function can give 
insight into viral evasion strategies.
24
Chapter 1. General Introduction
1.1. Equine arteritis virus
EAV is a member of the family Arteriviridae (order Nidovirales). Its virion 
is enveloped and spherical (Figure 1.1), with a diameter of 50-70nm and an 
icosahedral core that contains a 12.7 kilobase (kb) single-stranded, positive 
sense RNA genome (Snijder and Meulenberg, 1998; Snijder and Meulenberg, 
2001; Del Piero, 2000). The virus was first isolated in 1953 from lung tissue 
foetuses aborted during an outbreak in Bucyrus, Ohio (Doll et al., 1957a; Doll et 
al., 1957b) and became the prototype arterivirus.
Other members of this family include Lactate dehydrogenase-elevating 
virus (LDV), Simian haemorrhagic fever virus (SHFV) and Porcine reproductive 
and respiratory syndrome virus (PRRSV) (Snijder and Meulenberg, 1998). In  
vitro, EAV can replicate in a variety of cell lines such as hamster kidney cells 
(BHK21), rabbit kidney cells (RK-13), African green monkey kidney cells (Vero) 
and equine dermal cells (Ederm), but naturally its host range is narrowly 
restricted to equids (Glaser et al., 1996; Snijder and Meulenberg, 1998; Dea et 
al., 2000). Its susceptibility to cells lines of various origins may indicate the 
ability of this virus to use different mechanisms of entry such as membrane 
fusion, viral penetration and possibly several receptors. I t  may also indicate that 
the receptors on the viral envelope undergo conformational changes to fit the 
receptors on the membrane of various species.
Based on serological surveys and outbreaks, EAV is known to be present in 
many horse populations in North and South America, Europe, Australia, Africa, 
and Asia except Japan and Iceland (Timoney and McCollum, 1993). However, 
due to the absence of reliable surveillance data the status of EVA in many 
countries is unknown. The increase in the number of reported outbreaks of EVA 
in Europe and North America may be due to the continued increase in 
international trade of horses and semen. I t  may also reflect enhanced diagnostic
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capabilities and increase awareness of the disease among horse owners, 
breeders and veterinarians (Timoney, 2000; Holyoak et al., 2008).
envelope
viral
proteins
Figure 1.1. Structure of the EAV virion. Electron micrograph (EM) of 
extracellular EAV (US Bucyrus reference strain) grown on RK-13. The virion is 
enveloped, spherical and 65 nm in diameter. Image captured by D. Wescott, 
2007 at the Animal Health and Veterinary Laboratories Agency (AHVLA).
1.1.1. Clinical signs, transm ission and trea tm en t
Clinical signs of infection vary widely in horses and seem to depend on the 
strain, age, physical condition of the animal and maybe the route of infection 
(Timoney and McCollum, 1987; Timoney and McCollum, 1993). Natural 
infections often occur asymptomatically, as was shown in epidemiological studies 
(Vaala et al., 1992), but affected animals can also develop moderate to severe 
symptoms (Castillo-Olivares et al., 2003). These include influenza-like 
respiratory disease in adult horses, abortion of pregnant mares, interstitial 
pneumonia in young foals and persistent infection of stallions (Timoney and 
McCollum, 1993; Glaser et al., 1996). Other clinical signs include conjunctivitis 
with periorbital oedema, nasal discharge, oedema of distal limbs and 
fever/pyrexia up to 41°C, associated with depression, lasting for two to nine 
days. Importantly, stallions may become persistently infected carriers as the 
virus replicates in accessory glands. In mares EAV infection seems not to affect
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fertility, but stallions may exhibit temporary fertility problems as a result of 
generalised infection with fever (Neu et al., 1992).
EAV is transmitted horizontally via the respiratory route through direct 
contact with infectious aerosolized nasopharyngeal secretions from acutely 
infected horses or other secretions such as faeces, urine, vaginal fluids and 
foetal/placental/amniotic materials (aborted by mares due to EAV infection) 
(Timoney and McCollum, 1993; Hedges et al., 1999). Respiratory spread 
contributes to infectious transmission in some outbreaks. Transmission also 
occurs venereally by natural or artifical breeding of mares to persistently 
infected carrier stallions. Hence, infected stallions play an important role in the 
epidemiology of the infection. The most common ways infection spreads long 
distances and across international borders are by shedding stallions and chilled 
semen. This is supported by the recent outbreaks in Argentina, Ireland and the 
UK. The importation of shedding stallions or their semen poses the biggest risk 
of EAV infection in the UK (Newton and Cruz, 2010).
EVA can be confused on clinical grounds with many non-infectious and 
infectious, respiratory and systemic diseases of equids which includes Equine 
encephalosis. Equine herpesvirus 1 and 4 infections. Equine influenza, African 
horsesickness and Getah virus infection. Treatment of EVA cases is symptomatic 
with emphasis on controlling the amount of oedema and fever, especially in 
affected stallions (Timoney and McCollum, 1993). There should also be adequate 
rest for breeding stallions and horses in training. Older foals acutely infected 
with EAV can be administered with prophylactic antibiotics to combat possible 
secondary bacterial infection. There has been emphasis on eliminating the carrier 
state in the stallion by continued development of safe and effective therapeutic 
means (Timoney, 2000). Two vaccines have been developed against EVA, an 
inactivated adjuvanted virus product and a modified live virus product (Timoney 
and McCollum, 1993; Timoney, 2000). Since 1985 extensive use of the latter
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vaccine has confirmed its safety and immunogenicity for stallions and non­
pregnant mares.
1.1.2. Genome organization and replication
A fairly consistent genome organization has been described for all 
arteriviruses. The EAV genome includes nine known functional open reading 
frames (ORF) (Figure 1.2; Snijder et al., 1999). The polycistronic positive single 
stranded RNA has three-quarters of the 12.7 kb genome occupied by the two 
large replicases, ORFla and ORFlb, which are ideal targets for the detection of 
early replication by real-time quantitative PCR (qPCR). ORFla and ORFlb encode 
two replicase polyproteins (pp la  and pplab) which are post-translationally 
processed by three ORFla encoded proteinases (non-structural proteins - NSPl, 
2 and 4) to produce a set of 13 NSP and seven ORF (2a, 2b and 3-7) (Snijder 
and Meulenberg, 1998; Ziebuhr et al., 2000; van Aken et al., 2006). These 
seven additional genes, encoding structural proteins of the virus (Molenkamp et 
al., 2000), reside in the 3'-terminal quarter of the genome and include four 
minor envelope proteins (E, GP2, GP3 and GP4 encoded by ORF 2a, 2b, 3 and 4, 
respectively), two major envelope proteins (GP5 and M encoded by ORF 5 and 6 ) 
and the conserved nucleocaspid protein (N encoded by 0RF7) (Snijder and 
Spaan, 2006). I t  was shown that all minor and major structural proteins are 
required for the production of infectious progeny virus (Molenkamp et al., 2000) 
and are involved in the ability of this virus to infect immune cells such as CD14^ 
monocytes (Mo) and CD3^ T lymphocytes (Go et al., 2010).
Arterivirus genomic RNA reproduction is a combined process of genome 
replication and mRNA transcription. For EAV, the replication cycle starts with the 
expression of the relpicase gene from the incoming genome. Replicase ORFla 
and lb  are both expressed from the genomic mRNA. Translation of ORFlb 
requires a ribosomal frameshift just before ORFla translation is terminated 
(Figure 1.2; den Boon et al., 1991). The structural proteins of EAV are not
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expressed from the genomic RNA but from a 3'-coterminal nested set of 
subgenomic messenger RNA (mRNA), which contains the genomic leader 
sequence at their 5' end (Figure 1.2; Meulenberg et al., 1993; de Vries et al., 
1997; Snijder and Meulenberg, 1998).
EAV, like all arteriviruses, are assembled by budding of preformed 
nucleocapsids into the lumen of the smooth endoplasmic reticulum (ER)/Golgi 
region and are released by exocytosis (Pol and Wagenaar, 1992). The release of 
virus particles is around 10  hours after infection, determined from one-step 
growth experiments (Kim et al., 1993). In cell culture, the maximum titres 
obtained for EAV exceeded 10^ TCID50 (50% Tissue Culture Infective Dose)/ml 
with the infection being cytopathic (Snijder and Meulenberg, 1998). 
Characterization of EAV cytopathic effect (CPE) on cell lines includes rounding of 
the cells and detachment from the culture plate surface which allows virus 
titration by endpoint dilution or plaque assays (van Nieuwstadt et al., 1996; 
Snijder and Meulenberg, 1998).
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Figure 1.2. Overview of EAV genome organization and replication cycle.
The two replicases, ORF la  and lb  which encode non-structural proteins, are 
followed by four genes, ORF 2-5, that encode glycoproteins. ORF 6 and ORF 7 
genes encode membrane and nucleocapsid proteins, respectively. The seven 
viral mRNAs with white and grey boxes indicate the translated and translationally 
silent reading frames, respectively. This figure has been adapted from Snijder 
and Meulenberg, 1998.
1.1.3. Phylogenetic groups o f Equine a rte ritis  virus
Currently, there are three widely accepted phylogenetic groups of EAV 
based on the glycoprotein GP5 gene (Mittelholzer et al., 2006). These genetic 
groups are EAV-1 (viruses isolated almost exclusively in Europe), EAV-2 (viruses 
isolated mainly in the American region) and EAV-3 (viruses isolated in both 
Europe and America) (Figure 1.3). American EAV-3 viruses were found in the 
context of an outbreak caused by a stallion imported from Europe, but were 
isolated in America and named as such. Hence, it was cautioned that EAV strains 
should not be categorised by geographic location but on genetic properties 
(Mittelholzer et al., 2006). Recently, phylogenetic analysis has been performed 
on the 0RF5 nucleotide sequence of EAV isolates associated with the 2006-2007
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outbreak In America (Zhang et a!., 2010). This study confirmed the classification 
of the European and American genetic groups, but has proposed that the 
European group Is further divided Into two subgroups. This highlights the need 
for further phylogenetic studies on EAV Isolates, which was not Investigated In 
this project.
EAV-1
(European group)
EAV-2 
(American group)
/  EAV-3 
(European and 
American)
118
84
73
Figure 1.3. Phylogenetic representation of 120 EAV sequences from  
different countries. There are three main genetic groups, assigned EAV-1, 
EAV-2 and EAV-3. This phylogenetic tree was derived by comparing 518 
nucleotide fragments of the large glycoprotein GPS gene. The length of the 
branches reflects the phylogenetic distances. The numbers represent the 
percentage of branch pattern predictions. This figure has been adapted from 
Mittelholzer et al., 2006.
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1.1.4. S tra ins o f  Equine a rte ritis  virus investigated
Three strains were selected based on the genetic groups to which they 
belong and their pathogenicity, reflected In the clinical signs caused by the 
Isolates. The US (United States) Bucyrus reference strain belongs to the 
American genetic group and two variants of this reference strain, the US Bucyrus 
velogenic and attenuated, were Investigated. The third strain belongs to the 
European group and Is known as the UKl strain.
The US Bucyrus velogenic variant was one passage from the original 
Bucyrus Isolate (Doll et al., 1957a) prior to arrival at AHVLA. This strain has 
been shown to cause severe disease In experimentally Inoculated horses 
(McCollum and Timoney, 1999). The US Bucyrus attenuated strain Is less 
virulent and was prepared from the first passage stock of the velogenic Bucyrus 
virus by sequential serial passages: 20 times In African green monkey kidney 
cells (Vero), 3 times In baby hamster kidney cells (BHK-21) and 6 times again In 
Vero (Westcott et al., 2002). In challenge studies conducted with ponies, the 
attenuated variant showed no visibly observable Illness. The level and duration 
of nasal virus shedding was very low for challenged ponies which had neither 
detectable viraemla nor rectal virus shedding (Wescott et al., 2002). The 
European UKl strain was Isolated from semen of an Infected stallion Imported 
from Poland In 1993. This stallion was responsible for the EAV outbreak In the 
UK In 1993. It  Is considered to be of low pathogenicity based on the acute 
clinical signs observed from horses (Wood et al., 1995).
1.1.5. Equine a rte ritis  virus and host im m un ity
Infection of horses, naturally or experimentally, with different EAV strains 
results In long lasting Immunity against Infection (McCollum, 1970; McCollum, 
1986). The humoral Immune response to EAV Is characterised by the 
development of virus-speclfic neutralizing antibodies which Is believed to play an
32
Chapter 1. General Introduction
Important role In virus clearance (Timoney and McCollum, 1993; Balasurlya et 
al., 1999; Balasurlya et al., 2002). The serologic response of horses to the 
Individual structural proteins of EAV has been well characterised (MacLachlan et 
al., 1998; Hedges et al., 1998; Wagner et ai., 2003) but little Is known about the 
cell-mediated Immunity to EAV due to the lack of tools for evaluating these 
Immune responses. Understanding the role cell-mediated responses play In 
clearance of virus Infection would help to Identify If these cellular responses can 
be stimulated by vaccination.
Different strains of EAV vary significantly In their pathogenicity and In the 
severity of clinical disease they Induce (Balasurlya et al., 1999; McCollum et al., 
1999; Balasurlya et al., 2002; Balasurlya et al., 2007). After respiratory Infection 
of horses, the virus replicates In macrophages (MO) and endothelial cells In the 
lung. EAV's tropism for MO Is primarily determined by complex Interactions 
among the glycoproteins (GP2/3/4/5 and M envelope proteins) of the virus (Go 
et al., 2010). In vitro studies have shown that EAV Infects both equine 
pulmonary alveolar MO (PAMs) and blood-derived equine MO (BMO), but 
reproductive replication occurred only In BMO (Moore et al., 2003). Infection of 
both types of macrophages resulted In their activation with Increased 
transcription of pro-inflammatory cytokine genes such as Interleukin (IL )- lp , IL- 
6, IL-8 and a substantial Increase of tumor necrosis factor-alpha (TNF-a). Also, 
comparisons of different EAV strains, which Included a pathogenic and an 
attenuated strain. Induced different quantities of pro-inflammatory cytokines 
which reflected the virulence of the different strains. These cytokines may play 
critical roles In determining the outcome of Infection (Balasurlya and MacLachlan, 
2004).
It has been shown that the cytotoxicity Induced by EAV stimulated 
peripheral blood mononuclear cells (PBMC) was virus specific and mediated by 
CD8^ T (thymus-derived) cells (Castlllo-Ollvares et al., 2003). Recently,
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comparisons were made regarding the tropism of different EAV strains to Mo and 
T cells. The virulent Bucyrus strain Infects CD14^ Mo and CD3^ T cells (mostly 
CD4^ T cells), whereas the modified live virus vaccine strain showed reduced 
ability to Infect CD14^ Mo and has lost Its capability to Infect CD3^ T 
lymphocytes (Go et al., 2010). EAV's tropism for CD14^ Mo was attributed to the 
Interactions between the envelope proteins GP2/3/4/5 and M. Infection of CD3^ 
T cells was also attributed to the same envelope proteins except GP3. The 
Interactions between envelope proteins affect the binding of EAV to the different 
receptors on CD14^ Mo and CD3^ T cells (Go et al., 2010).
1.2. Equine encephalosis virus
EEV Is a member of the genus orblvlrus within the family Reoviridae. It 
was first Isolated In South Africa In 1967 from blood and tissue samples of an 
Infected horse (Wohlfender, 2009). Orblvlruses contain 10 double-stranded RNA 
(dsRNA) genome segments that are encapsldated by a double-layered 
Icosahedral shell (van NIekerk et al., 2003). The genome encodes at least seven 
structural and four non-structural proteins.
1.2.1. E tio logy and epidem io logy
EEV Is an Insect-borne virus transmitted by a variety of Culicoides 
subspecies. Seven serotypes (Howell et al., 2002) Infect equids of southern 
Africa, Including Kenya, Botswana and South Africa (Barnard, 1997). There Is no 
Information on the genetic and phenotypic stability of strains, and variations In 
pathogenicity are not recognised. The geographical distribution of strains Is 
possibly related to the distribution of the Culicoides subspecies (van NIekerk et 
al., 2003). The NS3 protein can significantly Influence vector competence and 
may therefore play a role In transmission of the virus In the vector and hence 
dissemination, which Impacts the epidemiology of this specific orblvlrus disease 
(van NIekerk et al., 2003).
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1.2.2. C linical find ings and replication
EEV appears to Infect all equids, but clinical signs are only seen In horses 
(Wohlfender, 2009). These signs consist of fever, mild jaundice, elevated heart 
and respiratory rates, congested mucosae, oedema of the neck, legs, eyelids and 
lips (Allison et al., 2009; Wohlfender, 2009; MacLachlan and Guthrie, 2010). 
Less common but more serious signs can Include respiratory distress with blood- 
tinged nasal discharge, chronic heart failure and abortion of pregnant mares. 
Mortality Is generally less than 5% of Infected animals (Wohlfender, 2009). No 
vaccine Is available for EEV and no recognised measures of treatment, control 
and prevention exist.
The replication cycle of orblvlruses has not been extensively studied. The 
basic features of cytoplasmic replication, transcription processes and the 
conservative mode of genome replication may be similar for all orlblvlruses 
(Knipe and Howley, 2007), Including Bluetongue virus (BTV), African horse 
sickness virus (AHSV) and Epizootic hemorrhagic disease virus (EHDV). The 
smallest orblvlrus genome segment, SIO, encodes two small non-structural 
proteins, NS3 and NS3A, which control the release of viral particles from Infected 
cells, possibly Influencing the natural dispersion of this virus (van NIekerk et al.,
2003). The NS3 protein may also be Involved In virus virulence (O'Hara et al., 
1998). Orblvlruses have the ability to multiply In the arthropod as well as In the 
vertebrate hosts. Interestingly, although orblvlruses are known to cause a cell- 
associated viraemla, nothing Is known about the cells In which EEV replicates.
1.2.3. S tra in o f  Equine encephalosis virus investigated
During 2008-2009 there was an outbreak of a febrile horse disease. 
Equine encephalosis, caused by EEV In Israel. This was the first description of 
EEV In Israel, which has long been enzootic In the Southern African region
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(Mildenberg et al., 2009). The strain used in this study was Isolated from a blood 
sample obtained from this outbreak (Figure 1.4).
-  EEV
Figure 1.4. Electron Micrograph of EEV. EM of ultra thin sections of African 
green monkey kidney cells (Vero) Infected with the Israel strain one day post 
Infection. Image captured by D. Wescott, 2007 at the AHVLA.
Phylogenetic analysis of EEV's segment 10 (NS3 gene) showed that the 
Israeli Isolates clustered with other EEV Isolates but as a distinct group with no 
close relation to the other orblvlruses. Three distinct clusters were recognised 
within the EEV group, of which one cluster was the Israeli Isolates (Figure 1.5; 
Aharonson-Raz et al., 2011). There Is potentially, as Is the case with AHSV and 
BTV, an extensive genetic heterogeneity of EEV field strains which may Influence 
the biological behaviour and virulence of Individual strains (Burrage and 
Laegreld, 1994; Bonneau and MacLachlan, 2004). The virulence of the Israeli 
strain Investigated In this study was unknown, but given that It Induced 
significant clinical signs, as described In section 1.2.2, the pathogenicity may be 
moderate.
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Figure 1.5. Phylogeny based on segment 10 (NS3 gene) of EEV isolated 
from horses of the Israel outbreak. Construction of the phylogenetic tree 
Involved using the neighbour joining method and bootstrapping with 100 
replicates. The genetic distances between sequences are represented by the 
branch lengths. The three EEV clusters are marked cluster A (green), cluster B 
(blue) and cluster C (orange; Israeli Isolates). Other orblvlruses were Included 
for reference. Permission to reproduce this figure has been granted by Dr. Eyal 
Klement (Aharonson-Raz et al., 2011).
1.2.4. Equine encephalosis virus and host im m un ity
The tissue and cell tropism of EEV Is unknown, but studies have been 
conducted with other orblvlruses such as AHSV and the prototype BTV. Since 
these viruses share similarities It Is possible that they may share similar tropism.
Target tissues across all serotypes of AHSV are the heart, lungs and 
spleen, and the main target cells for virus replication are the microvascular 
endothelial cells. Mo and MO (Brown et al., 1994; Wohlsein et al., 1997; 
Wohlsein et al., 1998; Clift and Penrith, 2010). AHSV infects and replicates In 
resident pulmonary Intravascular macrophages (PIMs), which are populations of
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mature phagocytes and resemble the structure and function of mature MO 
(Carrasco et al., 1999). Resident PIMs are found In species such as ruminants, 
pigs, horses and cats and can be Induced In species such as humans and rats, 
which normally lack them (Chltko-Mckown et al., 1991; Atwal et al., 1992; Brian 
et al., 1999; Molina and Brian, 2007; Schneberger et al., 2011). PIMs and PAMs 
are the sites of microbial uptake In the lungs but the degree of Immunological 
activity may differ between these two populations. In cats PAMs have been 
shown to exhibit a slower rate of in vivo phagocytosis and faster particle 
clearance than PIMs (Molina and Brian, 2007). In pigs PIMs are less phagocytic 
but more efficient at lysing Ingested microbes (Chltko-Mckown et al., 1991). It 
has been reported that resident PIMs In horses produce pro-inflammatory 
cytokines while recruited PIMs In rats produce antl-lnflammatory cytokines (Gill 
et al., 2005; Parbhakar et al., 2005). I t  Is possible that resident and 
recrulted/lnduced PIMs may represent the M l (pro-inflammatory) and M2 (anti­
inflammatory) M0.
BTV Is the causative agent of Bluetongue (BT) which Is characterised by 
vascular Injury with hemorrhage, tissue Infarction, widespread oedema and 
lesions, consistent with severe Infection. In ruminants the virus first Interacts 
with Inflammatory cells. Including DC. Further replication occurs In the local 
lymph node after which dissemination occurs to secondary replication sites such 
as lung, lymph node and spleen (Barratt-Boyes et al., 1992; Barratt-Boyes and 
MacLachlan, 1995; Hematl et al., 2009). Studies have established BTV tropism 
for bovine Mo, T lymphocytes and erythrocytes with virus replication In 
lymphocytes being limited to cells undergoing blastogenesis (multiplication of 
agranulocytic leukocytes). The long term viraemla associated with BTV Infection 
of cattle may be the result of Infected lymphocytes having low viability, as was 
demonstrated In in vitro cultures (Stott et al., 1990). Replication of BTV In 
bovine Mo and lymphocytes revealed the formation of viral Inclusion bodies and
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virus-speclfic tubules, but the virus was unable to replicate In erythrocytes as 
Infection did not progress beyond adsorption (Brewer and MacLachlan, 1994). 
The virus also replicates In mononuclear phagocytes, DC and endothelial cells, 
therefore the response of these cells to Infection Is critical to the disease 
pathogenesis (DeMaula et al., 2002; McLaughlin et al., 2003; Hematl et al., 
2009). Infection of endothelial cells lining the small vessels may be responsible 
for thrombosis (formation of blood clots Inside blood vessels) and subsequent 
Infarction that produce oral ulcers and myonecrosis (localised death of muscle 
cell fibres) (MacLachlan et al., 2008; MacLachlan et al., 2009). In vitro BTV 
Infections of cultured bovine pulmonary artery endothelial cells (boPAEC) and 
monocyte-derived macrophages (boMoMO) produced cytokines, such as IL-1, IL- 
6 and IL-8, and adhesion molecules, such as E-selectIn and ICAM-1, which may 
contribute to vascular Injury In BTV-Infected ruminants (Drew et al., 2010). This 
theory Is also supported by a previous study which showed Increased expression 
of Inflammatory cytokines, such as IL-12, IL - ip  and IL-6, In sheep DC In lymph 
draining from the site of Infection (Hematl et al., 2009).
1.3. Dendritic cells
DC function as specialized APC with the unique capacity to stimulate naïve 
T cells (Stelnman, 1991; Banchereau and Stelnman, 1998) and are the most 
potent Initiators of an Immune response against foreign antigen (Banchereau 
and Stelnman, 1998). Activation of DC represents an Important step In 
lymphocyte stimulation which drives an adaptive Immune response. DC, which 
form part of the Innate Immune system, possess receptors that recognize 
molecular patterns expressed by pathogens and subsequently stimulate 
phagocytosis and maturation of Immature DC (IDC). DC are activated by 
signalling through these receptors, which enables stimulation of naïve T cells.
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1.3.1. M yeloid dendritic  cells and im m un ity
White blood cells or leukocytes are derived from pi uri potent 
hematopoietic stem cells (HSC) In the bone marrow. These piurIpotent cells 
divide to produce the lymphoid and myeloid progenitor stem cells. The lymphoid 
progenitor (LP) gives rise T (thymus-derived) and B (bone marrow-derived) 
lymphocytes. The myeloid progenitor (MR) gives rise to cells such as 
granulocytes, Mo, M0, plasmacytold DC (PDC) and myeloid DC (MDC), which 
Include conventional dendritic cells (cDC) and MoDC (Gelssmann et al., 2010). It 
Is debatable as to whether natural killer (NK) cells are derived from lymphoid or 
myeloid progenitors. Myeloid cells perform diverse functions In the Immune 
response and have the ability to differentiate Into subsets of more mature and 
specialized cells (Gabrilovich et al., 2012). The focus of this thesis will be on 
MoDC as well as Mo.
Immunity Is the capacity of the host biological defenses to prevent 
Infection or disease. I t  Involves both Innate (non-specific) and adaptive (specific) 
components. Innate Immunity Is the natural resistance of a host and defends 
against a broad rage of pathogens Irrespective of the antigen specificity. These 
antigens can be engulfed by phagocytic cells such as Mo and their differentiated 
progeny, which Include MO and DC (Dale et al., 2008). On the other hand, 
adaptive Immunity Is the ability of antlgen-speclfic lymphocytes to respond to 
antigen and confers lifelong protective Immunity to reinfection with the same 
pathogen. Adaptive Immunity Is subdivided Into naturally acquired Immunity, 
developed through Infection, or artificially acquired Immunity, developed through 
vaccination (Janeway et al., 2005).
DC are central to the generation of efficient adaptive antlgen-speclfic 
Immune responses or Immunological tolerance. These responses Involve antigen 
uptake In peripheral tissues and presentation via major histocompatibility 
complex (MHC) class I and II  molecules to T cells In lymphoid organs (Fearon
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and Locksley, 1996; Peter et al., 1996). Antigen presentation In DC Involves 
different components such as antigen uptake. Intracellular transport and 
degradation, and the trafficking of MHC molecules, which are all different In DC 
compared to other APC namely MO and B cells (Guermonprez et al., 2002). 
Thus, DC are the most potent APC In the primary Immune responses. They are 
the only APC capable of activating naïve T cells, thus Initiating adaptive Immune 
responses and the Induction of tolerance, as mentioned above (Peter et al., 
1996; GIrolomonI and RIccardl-Castagnoll, 1997; Guermonprez et al., 2002). DC 
are the focus of extensive study and are being Investigated for their use In a 
variety of Immunotherapeutic strategies such as adjuvants for vaccines, as 
means to Induce Immunity against cancer, and for their use as a model to study 
the effect of pathogens on host Immunity.
DC are one of the cell populations most likely to have the earliest contact 
with viruses during Infection due to their presence within the skin, blood and 
mucosal surfaces (Klagge and Schnelder-Schaulles, 1999). This Interaction Is 
critical for the establishment of an anti-viral Immunity, which can be prohibited If 
the virus Interferes with antigen presentation, either by Inhibiting DC or by 
escaping Into a dormant state. Hence, DC are an Ideal target for Immune evasion 
by viruses. All examples presented exclude the majority of the literature and 
retroviruses.
Many studies have used the MoDC in vitro system as a model to 
Investigate host-vlrus Interactions. Human MoDC have been shown to be targets 
for viruses, such as the paramyxovirus Respiratory syncytial virus (RSV) and the 
herpesvirus Herpes simplex virus type I (HSV-1), which had varied effects on DC 
such as the Induction of maturation. Impaired CD4^ T cell activation 
characterized by low T cell proliferation and selective downmodulatlon of 
costlmulatory molecules (Kruse et al., 2000a; MIkloska et al., 2001; de Graaff et 
al., 2005). Several viruses such as Measles virus (Fugler-Vlvler et al., 1997;
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Grosjean et al., 1997), Vaccinia virus (Engelmayer et a!., 1999; DriHlen et al., 
2000) and Dengue virus (Wu et al., 2000) Interfere with DC function.
In the veterinary community, there Is Increasing use of species specific in 
vitro MoDC to Investigate the Impact of viruses on their host. Infection of porcine 
MoDC with the arterivirus PRRSV Inhibited the antigen presentation ability of 
MoDC, downregulated the expression of surface molecules and Induced minimal 
T helpher 1 (Th-1) cytokines (Wang et al., 2007). There Is very little Information 
available on the Impact of orblvlruses with MoDC, but It has been shown that 
ovine cDC are primary targets of BTV (Hematl et al., 2009). There Is currently no 
literature describing the use of the eqMoDC system as a model for virus 
Interaction studies.
1.3.2. D endritic  cell heterogeneity
A common DC precursor (CDP) was Identified In mice as the precursor of 
pre-classlcal cDC (pre-cDC) and plasmacytold DC (PDC), which circulate In the 
blood and enter secondary lymphoid tissues (Figure 1.6). Pre-cDC In lymphoid 
and non-lymphold tissues give rise to the organ-specific CDSa"  ^ cDC (specific to 
mouse spleen - Schnorrer et al., 2006) and to CD103^ lamina propria (IpDC), 
respectively (Merad et al., 2002; Gelssmann et al., 2010). I t  Is clear that DC are 
heterogenous and the different subtypes display varying differentiation lineages, 
phenotypic traits and effector functions.
Conventional DC are highly migratory cells that can move from tissues to 
the T and B cell zones of lymphoid organs. They are generally short lived and 
regulate T cell responses both In the steady state and during Infection (Waskow 
et al., 2008; Liu et al., 2009). Conventional DC can be divided Into a number of 
subsets according to their localisation. MDC are a typical cDC subtype and can be 
differentiated in vitro In the presence of granulocyte macrophage-colony 
stimulating factor (GM-CSF) (Mo et al., 2011).
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Figure 1.6. DC differentiation in mice. Hematopoietic stem cells (HSC) In the 
bone marrow produce both myeloid progenitors (MP) and lymphoid progenitors 
(LP). Monocytes, MO and DC precursors (MDP) are derived from the MP. The 
MDP give rise to Mo and common DC precursors (CDP). CDP give rise to pre- 
classical-conventional DC (pre-cDC), which give rise to CD8a^ and CD8a' cDC in 
lymphoid tissues and CD103^ lamina propria (IpDC) in non-lymphoid tissues. 
CDP also generate plasmacytold DC (PDC) which enter lymphoid tissues after 
blood circulation. Ly6C‘ Mo may contribute to alveolar MO under homeostatic 
conditions and Ly6C+ Mo give rise to inflammatory MO and TNF and INOS 
(inducible nitric oxide synthase) producing MoDC (TipDC). The dashed arrows 
highlight the uncertainty of LP to significantly contribute to PDC and cDC. This 
figure has been adapted from Gelssmann et al., 2010.
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PDC are relatively long lived and are capable of producing high amounts 
of interferon (IFN)-a in response to viral infections. They were once named 
natural type 1 interferon producing cells (NIPC) or plasmacytold T cells (Perussia 
et al., 1985; Fitzgerald-Bocarsly et al., 1988; Celia et al., 1999b; Siegal et al., 
1999; Vanberviiet et al., 2003). The concept of PDC arising from a specific 
lymphoid lineage has been challenged by studies in mice which showed a 
common DC precursor can develop into PDC and cDC, as mentioned above 
(Traver et al., 2000; Merad et al., 2002; Gelssmann et al., 2010). PDC express a 
different spectrum of toll-like receptors (TLR), therefore favour a different 
repertoire of microbial compounds compared to MDC (Banchereau et al., 2000). 
Human PDC express TLR 1, 6, 7, 9 and 10 whereas human MDC express TLR 1, 
2, 3, 4, 6,7, and 8. The marker CD303/BDCA-2 (blood DC antigen-2), a type II 
c-type lectin, in combination with CD123, the interleukin-3 (IL-3) receptor, and 
C D ll,  an integrin, expressed on PDC can be used to discriminate human PDC 
from MDC (Dzionek et al., 2000; Jongbloed et al., 2010). Hence, human PDC 
and MDC are phenotypically characterised as CD303^CDllc'CD123^ and CD303" 
CDllc^CD123', respectively (Figure 1.7a). Other features of PDC include 
poor ability to phagocytose latex-beads and endocytose Fluorescein 
isothiocyanate (FlTC)-dextran (Grouard et al., 1997) and the ability to prime 
naïve T cell responses toward either T h l or Th2 effector responses, depending 
on the stimulation (Celia et al., 2000; Rissoan et al., 1999). Human blood PDC 
and C D llc^ MDC exhibited similar abilities to expand specific cytotoxic T- 
lymphocyte (CTL) and CD4^ T h l cells upon activation with influenza virus 
(Fonteneau et al., 2003). This highlights that PDC may play a role in the 
adaptive immune response against viruses, but the biology of these cells and 
their interaction with viruses is not featured in this thesis.
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Figure 1.7. Nomenclature of blood dendritic cells, (a ) Human blood DC are 
divided Into two main subtypes, PDC and MDC, based on the presence or 
absence C D llc . MDC are further divided Into three subsets, CDlc"", CD141'" and 
CD16 (FcyRIII receptor)"", (b ) Mouse blood DC are also divided Into two main 
subtypes, PDC and MDC, based on the expression of C D llb , CD45RA and 
CLEC9A. MDC form two distinct subsets, CDllc"" CDllb"" CD45RA' (similar to 
CD8a DC) and CLEC9A+ (similar to CD8a+ DC). Mouse CDlIc+CDllb+CD45RA" 
blood MDC are homologous to human CDlc"" blood MDC and the CLEC9A"" mouse 
blood MDC are homologous to the human CD141"" blood MDC. This figure is a 
summary of the following literature: Dzionek et al., 2000, Traver et al., 2000, 
Merad et al., 2002, O'Keeffe et al., 2003, Robbins et al., 2008, Gelssmann et al., 
2010, Jongbloed et al., 2010 and Ziegler-Heitbrock et al., 2010.
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Subsets of MDC in human such as CDlc^ (glycoproteins expressed on 
human APC) DC and CD141'" (blood DC antigen-3/BDCA-3) DC represent 
different stages from a common precursor (Merad et al., 2002). CD141'" DC are 
better than CDlc"" DC at inducing T h l responses and cross-presenting antigen, 
which is the ability to take up, process and present exogenous antigen via MHC I 
to CDS'" cytotoxic T cells (Jongbloed et al., 2010). The unique expression profiles 
of CDlc"" DC and CD141"" DC are distinct from Mo and MoDC which indicates the 
different functional attributes of all these cell types (Dzionek et al., 2000; 
MacDonald et al., 2002; Lindstedt et al., 2005).
A combination of markers is used to define DC in blood of mice (Figure 
1.7b). Mouse PDC and MDC have been defined as CDllc'°'^ C D llb ' CD45RA" '^^  ^
and CDllc"" C D llb '" CD45RA', respectively (O'Keeffe et al., 2003). CD45RA is a 
protein tyrosine phosphatase receptor type C, isoform RA. The CD8a' MDC in 
mouse may be homologous to human CDlc"" blood MDC (Robbins et al., 2008). 
The CLECOA"", a C-type lectin-like receptor, blood MDC are homologous to the 
human CD141^ blood MDC (Caminschi et al., 2008; Robbins et al., 2008). The 
DC subsets, CD8a' and CD8a"" have shown further differences in immunological 
function. The CD8a' DC subset appears to induce Th2 responses (Maldonado- 
Lopez et al., 1999; Pulendran et al., 1999) as well as antigen processing and 
presenting to CD4"" T cells via the MHC class II  pathway (Pooley et al., 2001; 
Dudziak et al., 2007; Villadangos and Schnorrer, 2007). On the other hand, the 
CDOa"" DC subset has the ability to cross-present antigen on MHC class I 
molecules to CDO'" T cells (den Haan et al., 2000; lyoda et al., 2002; Schnorrer 
et al., 2006). CDOa'" DC subset has been shown to play a critical role in the 
induction of protective CD8"" CTL responses essential for the elimination of 
viruses, other pathogenic infections and cancers (Dudziak et al., 2007; Hildner et 
al., 2008; Lopez-Bravo and Ardavin, 2008; Naik, 2008).
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1.3.3. M onocyte-derived dendritic  cells
Monocytes were first studied as MO precursors (de Villiers et al., 1994) 
but can also differentiate into DC (MoDC) both in vitro and in vivo (Romani et 
al., 1994; Sallusto and Lanzavecchia, 1994; Steinbach et al., 1995; Peters et al., 
1996; Banchereau and Stelnman, 1998; Randolph et al., 1999; Va roi et al., 
2007). A recent in vivo study has shown that Mo are recruited to the lymph 
node, in response to bacterial infection, where they differentiate into DC (Cheong 
et al., 2010). As there are very few DC circulating in the blood, in vitro MoDC 
(Figure 1.8) represent a useful tool to study both DC biology and pathogen 
interaction.
In vitro studies showed that human and mouse Mo cultured in the 
presence of exogenous GM-CSF and IL-4 differentiate into DC (Sallusto and 
Lanzavecchia, 1994; PickI et al., 1996). Monocytes are mononuclear phagocytes 
generated in and released from the bone marrow (van Furth and Cohn, 1968; 
Varol et al., 2007). In human and mouse, blood Mo represent 10% and 4% of 
leukocytes, respectively (Au ffra y et al., 2009). Monocytes circulate in the 
bloodstream and possess cell surface receptors that mediate migration to tissues 
during infection, where they mature and differentiate into phagocytic MO and 
inflammatory DC (van Furth and Cohn, 1968; Randolph et al., 1999; Gelssmann 
et al., 2003; Landsman et al., 2007; Varol et al., 2007; Gelssmann et al., 2010; 
Ziegler-Heitbrock et al., 2010). In addition, Mo play important roles in 
homeostasis by uptake of apoptotic cells and toxic molecules and in 
inflammation, which is a mechanism of the innate response to pathogens and 
pathogenesis of inflammatory diseases such as arthritis and atherosclerosis 
(Auffray et al., 2009; Zaslona et al., 2009; Gelssmann et al., 2010; Saha and 
Gelssmann, 2011).
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Chapter 1. General Introduction
Both human and mouse blood Mo are heterogenous and the different 
subsets identified have been defined by their distinct phenotypes and functions 
(Crawford et al., 1999; Grage-Griebenow et al., 2001; Auffray et al., 2009; 
Ziegler-Heitbrock et al., 2010). In recent years investigators have proposed 
three subsets of Mo in both human and mouse blood, which are classical, 
intermediate and non-classical Mo. In humans, these subsets are categorized 
based on the expression of CD14, a co-receptor for the detection of 
bacterial LPS, and CD16, the FcyRIII receptor. In mice, Ly-6C (Bamezai et al
2004), and CD43 (Sperling et al 1998), define these subsets (Figure 1.9). 
Studies in human and mice have demonstrated a developmental relationship 
between Mo subsets and indicated that Mo gradually develop from classical to 
non-classical cells (Weiner et al., 1994; Sunderkotter et al., 2004; Robbins et 
al., 2008; Ancuta et al., 2009; Ziegler-Heitbrock et al., 2010).
Characterisation of Mo and their subsets in many non-rodent mammalian 
species is not extensively described as in humans and mice, however the 
heterogeneity of porcine Mo is the most documented. In the pig. Mo subsets can 
be characterised based on the expression of CD163 (Sanchez et al., 1999), 
which is the scavenger receptor of haemoglobin-haptoglobin complexes 
(Kristiansen et al., 2001). CD163' and CD163"" Mo vary in the expression of 
other surface molecules, cytokine expression and the ability to present antigen 
to T cells (Sanchez et al., 1999; Chamorro et al., 2000; Chamorro et al., 2004; 
Moreno et al., 2010). Porcine Mo can be further divided into additional subsets 
based on the expression of CD14 and SLA-II (swine leukocyte antigen II)/MHC II  
molecules (Figure 1.9).
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CD14++CD16+ Ly6C++CD43++
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Figure 1.9. Nomenclature of blood monocytes in human, mouse and pig.
Human and mouse Mo subsets are divided into classical, intermediate and non- 
classical Mo. The classical Mo are represented by CD14 high expression with no 
CD16 (CD14^^CD16') in humans and Ly6C high with low CD43 expression 
(Ly6C++CD43+) in mice. The intermediate Mo display high CD14 and low CD16 
expression (CD14++CD16^) in humans and high Ly6C and CD43 in mice 
(Ly6C^^CD43^^), whereas the non-classical Mo show low CD14 and high CD16 
expression (CD14+CD16+"^) and low Ly6C and high CD43 expression 
(Ly6C^CD43^^). There are four subsets of porcine Mo characterised by CD163^ 
and CD163' cells, which are either S L A -ir or SLA-IT. These subsets are 
CD163+CD14'SLA-ir, CD163'CD14+SLA-ir, CD163+CD14+SLA-ir and CD163' 
CD14+SLA-II^. This figure is a summary of Chamorro et al., 2004, Auffray et al., 
2009, Ziegler-Heitbrock et al., 2010.
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In vitro, CD14‘^  Mo isolated from PBMC are used for DC differentiation. 
CD14 is predominantly used because it is strongly expressed on Mo, as 
discussed above, and no signal transduction is triggered since CD14 lacks a 
cytoplasmic domain. Differentiated Mo were termed immature MoDC (iMoDC) 
and could be further activated to mature MoDC (mMoDC) by exposure to an 
array of exogenous stimulants including toll-like receptor agonists, cytokines, 
growth factors and inflammatory signals (Gilboa, 2007; Nicolette et al., 2007; 
Han et al., 2009). Since maturation is critical for effective antigen presentation, 
different stimuli have been used to generate mature DC in vitro. Examples of 
these stimuli are the bacterial derivative LPS (Granucci et al., 1999; Janeway 
and Medzhitov, 2002), the double stranded RNA poly I:C (Palucka et al., 1998; 
Celia et al., 1999a) which mimics viral RNA, the cytokine IFN-y (Snrjders et al., 
1998) and the cell surface receptor CD40L (Sallusto and Lanzavecchia, 1994; 
Celia et al., 1996; Snijders et al., 1998). The cocktail of TNF-a, IL -ip , IL-6 and 
PGE2 has been used to induce maturation and has become the most widely used 
stimuli (Jonuleit et al., 1997; Gilboa et al., 2007; Boullart et al., 2008; Landi et 
al., 2011). In vitro, hunnan DC activated with the maturation cocktail showed 
increased DC specific surface marker expression and were better at inducing T 
cell proliferation compared to DC activated with LPS and TNF-a (Nicolette et al., 
2007; Landl et al., 2011).
Recent advances in DC biology have highlighted the heterogeneity of 
these cells in vivo and in vitro. In this context it has been suggested that MoDC 
resemble inflammatory DC in vivo (Geissmann et al., 2010). A recent study in 
mice has demonstrated that in vitro MoDC have crucial features of in vivo DC in 
lymphoid tissues, including antigen-presenting function and cross presentation of 
proteins (Cheong et al., 2010). Therefore, MoDC can imitate all important DC 
functions.
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1.3.4. Im m a tu re  dendritic  ceiis
Hematopoietic bone marrow progenitor cells differentiating into myeloid 
DC initially transform into immature DC (iDC). These immature cells possess low 
T cell activation potential since they lack or have low expression of accessory 
signals, such as CD40 and CD86, which are costimulatory proteins on antigen 
presenting cells for T-cell activation and survival (Figure 1.10) (Banchereau and 
Steinman, 1998). Immature DC have a high endocytic activity which is reduced 
upon maturation (Steinman, 2007). They also possess PRR such as TLR, as 
mentioned previously for MDC, that constantly sample the surrounding 
environment for 'danger signals', such as pathogens (viruses and bacteria) or 
non-physiological cell death or damage (Matzinger, 1994), and recognise specific 
chemical components on their surface. When iDC come into contact with such 
signals they are activated into mature DC (mDC) and begin migration to the 
lymph node (Banchereau and Steinman, 1998). Immature DC endocytose or 
phagocytose and degrade pathogen proteins into small fragments which are then 
presented at their cell surface, upon maturation, using MHC molecules.
Immature DC possess many characteristics that allow them to capture 
antigen. These include phagocytosis (Svensson et al., 1997) and 
macropinocytosis, which is the sampling of extracelluar fluid and solutes in large 
pinocytic vesicles (Sallusto et al., 1995). Another feature includes the expression 
of receptors, such as CD206, the antibody receptors for IgG (FcyR) and IgE 
(FceR), that mediate adsorptive endocytosis which occurs continuously in the 
steady state (Sallusto and Lanzavecchia, 1994; Sallusto et al., 1995; von 
Bubnoff et al., 2002). Hence, these characteristics contribute to the high 
efficiency of antigen capture and processing.
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Figure 1.10. Phenotypic and functional differences between immature 
and mature dendritic cells. DC display many long and thin projections (thus 
the reference to dendrites of neurons) that extend in many directions from the 
cell body. These morphological characteristics apply to both the immature and 
mature states. iDC express high levels of CD206 and intracellular MHC II. They 
possess low levels of surface MHC II, costimulatory molecules CD80, CD86 and 
CD40, the maturation marker CD83 and chemokine receptor (CCR7). In
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contrast, mDC express high surface MHC II, CD80, CD86, CD40, CD83 and CCR7 
but low CD206. Maturation of human DC is defined by the high expression of 
CD83, an immunoglobulin superfamily member. IDC exhibit functional attributes 
such as high endocytic/phagocytic capacity and low T cell stimulatory activity, 
whereas mDC display low endocytic/phagocytic capacity and high T cell 
stimulatory activity. After stimulation by pathogens or cytokines iDC are 
transformed into immunogenic mDC, but this process can be blocked for 
example by the cytokine IL-10. mDC express molecules that enhance antigen 
presentation, such as MHC class I and II, and DC signalling, such as CD40, 
CCR7, chemokine receptor type 4 (CXCR4) and macrophage inflammatory 
protein-3-beta (MIP-3(3)/CCL19. The mature state displays heightened 
expression of other costimulatory molecules, such as the B7 family of ligands 
which include CD80/B7-1, CD86/B7-2, programme cell death ligands PD- 
L1/CD274 and PD-L2/CD273, inducible cotlmulator ligand (ICOS-L/CD275) and 
B7-H3/CD276. This figure has been adapted from Banchereau and Steinman, 
1998.
An important attribute of DC is their mobility (Austyn et al., 1988). DC 
migration and their residence in lymphoid and nonlymphoid organs are tightly 
regulated events (Banchereau et al., 2000). The recruitment of DC to the sites of 
antigen deposition is in response to the production of chemokines upon local 
inflammation. Chemokines are small peptides and are potent activators and 
chemoattractants for leukocyte subpopulations. In vitro, iDC respond to a large 
spectrum of chemokines through specific receptors, such as CCRl-5, CXCRl and 
CXCR4. The regulation of chemokine receptor expression during differentiation 
and following activation gives insight into the complex migratory pathways of DC 
(Moser and Willimann, 2004).
In the immature state DC reside in the peripheral tissues taking up 
antigen, including self-antigen and invading pathogens, and scanning the body 
for evidence of infection (Lutz and Schuler, 2002). I f  no stimulation occurs in the 
peripheral tissues or secondary lymphoid organs, DC remain tissue-resident. 
Here, antigen exposure in the absence of costimulation can induce T cell anergy
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(Lutz and Schuler, 2002; Appleman and Boussiotis, 2003) since T cells will not 
be provided with a second signal. In vivo, IDC continuously take up apoptotic 
material via CD36 receptor (a member of the scavenger receptor family), 
integrins (receptors that mediate the attachment between cells and their 
surrounding tissues) and other molecules (Rubartelll et al., 1997; Schulz et al., 
2002). This may lead to tolerogenic presentation of apoptotic material to CD4+ T 
cells (Inaba et al., 1998). Immature DC, as the sensors for homeostasis of the 
immune response in the host, strictly regulate the induction of an immune 
response and peripheral tolerance (the process by which the body naturally does 
not launch an immune attack against its own tissues).
1.3.5. M ature dendritic  cells
Mature DC are potent stimulators of T cells (Banchereau and Steinman, 
1998) which represents a switch from tolerance to immunity. The complexes 
formed by DC and T cell interaction create a microenvironment for the 
development of immunity (Ingulli et al., 1997; Kudo et al., 1997), hence full DC 
maturation is required for both CD4+ and CD8+ T cell priming. Once activation of 
CD4+ T cells occurs, they can interact with other cells to complete the immune 
response. Some of these cells include MO for cytokine release and B cells for 
antibody formation. Once DC are activated to the mature state, a rapid decrease 
in antigen capture occurs (Banchereau and Steinman, 1998).
Mature DC are known to express increased levels of costimulatory 
molecules such as CD80, CD86 and CD40 (Figure 1.10), which act as co­
receptors in T cells activation. They also produce greater quantities of cytokines, 
which might be crucial to induce T cell immunity, and are superior in the 
stimulation of cytotoxic T cell responses compared to IDC. The ability of mature 
DC to synthesize high levels of IL-12, required to induce T h l priming, (Reis e 
Sousa et al., 1997; Lutz and Schuler, 2002) enhances both innate and acquired 
immunity. Compared to other ARC like B cells, mDC are 10-100 times higher in
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expression of MHC products and MHC peptide complexes (Banchereau and 
Steinman, 1998). CCR7 is upregulated on mDC (Figure 1.10) and induces DC to 
travel through the lymphatic system to the lymph node, where they act as ARC 
(Forster et al., 1996; Banchereau et al., 2000).
All T cells with the exception of natural regulatory T cells are stimulated 
by mDC. CTL express the accessory molecule CD8, therefore interacting with 
cells bearing the MHC class I. Mature DC can influence CTL to proliferate (Bender 
et al., 1995; Cheong et al., 2010). T helper cells express the CD4 accessory 
molecule and interact with the MHC class I I  molecule. T helper cells are 
transformed into INF-y producing T h l cells in the presence of mDC and IL-12 
(Reis e Sousa et al., 1997). However, in the presence of mDC and IL-4, T cells 
differentiate into Th2 cells which secrete IL-4 and aid antibody production from B 
cells (Banchereau and Steinman, 1998).
1,4. MoDC generation in non-rodent mammalian species
DC represent approximately 1% of peripheral blood mononuclear cells 
(RBMC), thus comprising a small fraction of leukocytes throughout the body 
(Sato and Fujita, 2007). Hence, in vitro MoDC can provide sufficient DC numbers 
for downstream analysis.
DC research in other animal models is hindered by the lack of readily 
available sources of reagents, antibodies and most specifically IL-4, which is 
essential for DC differentiation in vitro (Miranda de Carvalho et al., 2006). To 
have a functionally active source of IL-4, the generation of recombinant IL-4 
may be required in each species (Howard et al., 1999). IL-13 shares strong 
homology with IL-4 and may be a possible substitute for IL-4 in generating DC in 
vitro (Riemonti et al., 1995; Morse et al., 1999). However, the effectiveness of 
IL-13 is questionable (Ahn and Agrawal, 2005) and there is no equine IL-13 
available. Attempts can be made to use recombinant cytokines of another 
species, but cross-reactivity is lacking in many cases. DC have now been
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generated in vitro in many different species by adapting methods developed for 
the human and murine systems, which represent the best characterized DC in 
terms of phenotype and function.
Porcine DC have been generated from bone marrow stimulated with 
porcine GM-CSF alone and in combination with TNF-a and from peripheral blood 
Mo stimulated porcine GM-CSF and porcine IL-4 (Carrasco et al., 2001). They 
expressed high levels of molecules such as CDl, MHC class I, MHC class II, 
C D lla , p2-intergrins (C D llb /c  and CD18), CD36 and CD68 (lysosome- 
associated membrane protein) and low levels of CD14 (Paillot et al., 2001). After 
maturation, porcine MoDC continued to express a similar phenotype with the 
expression of other markers such as CD172a/SWC3 (a pan-myeloid marker), 
CD80 and CD86, along with an increase expression of CD14 which contrasted 
that of human mature DC. MoDC functional studies in the pig showed their 
capacity to uptake antigen and stimulate allogeneic T cells in mixed leukocyte 
reactions (MLR) (Carrasco et al., 2001; Paillot et al., 2001).
In cattle, DC have been generated from bovine blood Mo with bovine GM- 
CSF and bovine IL-4 following isolation from PBMC (Werling et al., 1999; Hope et 
al., 2000). Bovine DC expressed high MHC class II, CD80, CD86, CDl and C D lla  
but low CD14 and C D llc . Functionally, bovine MoDC had a moderate phagocytic 
capacity and moderate allostimulatory capacity (ability to stimulate the 
proliferation of allogeneic T cells) in mixed leukocyte reactions (MLR) (Howard et 
al., 1999).
In sheep, DC have been generated in vitro from PBMC stimulated with 
ovine GM-CSF and ovine IL-4 (Chan et al., 2002). Ovine DC express high levels 
of MHC II  (Newland et al., 2004) and are able to capture antigen by endocytosis 
and present antigen to lymphocytes (Coates et al., 2001). DC have also been 
obtained by lymphatic cannulation of sheep as well as cattle (Hope et al., 2006; 
Schwartz-Cornil et al., 2006).
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Feline DC were derived from bone marrow and PBMC stimulated with 
human GM-CSF and human IL-4. The phenotype of these cells included the 
expression of CDla/b/c, C D llc , CD14 and MHC Class I and II. Functionally, 
feline DC had the ability to phagocytose particles and induced proliferation of 
allogeneic T cells in MLR assays (Bienzle et al., 2003). Canine DC were 
generated from bone marrow stimulated with human GM-CSF, FLt3-L and TNF-a. 
They were also generated from PBMC stimulated with canine GM-CSF, canine IL- 
4 and human Flt3-L. The phenotype of these DC included the expression of 
molecules such as CDla/b/c, C D llc  and MHC class II. Canine DC are also potent 
stimulators In MLR assays (Hagglund et al., 2000; Catch pole et al., 2002; 
Yoshida et al., 2003; Wang et al., 2007b). For most of the species described the 
optimal conditions for DC generation are not yet known.
1.4.1. Equine MoDC
Equine DC were isolated from blood by adherence and metrizamide 
(density gradient medium) gradients but resulted In very poor DC amounts and 
high death rates without equine GM-CSF (Siedek et al., 1997). In the equine 
system, recombinant human IL-4 is non-functional as there is only 65% 
homology between human and equine IL-4 amino acid sequences (Steinbach et 
al., 2002). Previous work successfully produced functionally active equine GM- 
CSF (eqGM-CSF) and equine IL-4 (eqIL-4) by expression in insect cells 
(Steinbach et al., 2005; Mauel et al., 2006). It was shown that 60-80% of 
equine Mo (eqMo), isolated by the adherence method, can generate IMoDC 
within 5-7 days (Mauel et al., 2006) with the appearance of veils after 6-7 days 
(Figure 1.11).
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Figure 1.11. Equine MoDC morphology after 7 days in culture with  
equine GM-CSF and equine IL -4 . Monocytes were isolated from horse PBMC 
by adherence and stimulated with eqGM-CSF and eqIL-4 for 6-7 days. Light- 
microscopy revealed clusters of veiled iMoDC with finger-like projections. 
Permission to reproduce these images has been granted by Professor Fa I ko 
Steinbach (Mauel et al., 2006).
Previous analysis of equine MoDC (eqMoDC) derived using the adherence 
method revealed similarities to the human system in that there are also 
immature and mature MoDC states. However, these states were previously 
defined solely on the basis of phenotypic differences (Mauel et al., 2006). 
Furthermore, while LPS or poly I:C induced morphological changes in equine 
MoDC, they did not confer the mature DC phenotype of low CD206 and high 
CD83 previously reported for humans (Sallusto et al., 1995; Zhou and Tedder, 
1995; Mellman et al., 1998; Cochand et al., 1999). This suggested that previous 
studies may have used a mixed population, due to isolation by the adherence 
method, or factors in the experimental protocol that influenced differentiation 
and maturation, such as the lack of highly purified cytokines.
Flow cytometry has been used to analyse the expression of equine DC 
surface molecules. However, it must be noted that research in such a novel 
species as the horse is hindered by the lack of molecular tools and reagents.
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Recent studies determined that some anti-human leukocyte monoclonal 
antibodies cross-react with the horse (Ibrahim et al., 2007; Ibrahim and 
Steinbach, 2007). These include the monocytic associated markers, such as 
CD14 (Big 10/11/12/13 clones), CD163 (Ber-MAC3 clone) and the signal- 
regulatory protein alpha CD172a (DH59B clone). There have been no previous 
investigations on the expression of markers CD163 and CD172a on eqMo. The 
DC associated markers that cross react with horse include CD83 (HB15a clone), 
CD86 (IT2.2 clone), CD206 (3.29B1.10 clone) and MHC II  (TÜ39 clone). I t  has 
been shown that eqMo express high levels of CD14, low levels of MHC II, and 
little or no expression of CD206, CD83 and CD86 (Mauel et al., 2006).
I t  has also been reported that IMoDC expressed low levels of CD86, CD83 
and MHC II  but high CD206 expression whereas mMoDC showed an upregulation 
of CD86, CD83 and MHC II  and downregulation of CD206. However, compared to 
the human system, the expression of CD83 and CD206 were more variable, 
where CD206 downregulated on IMoDC and upregulated on mMoDC and CD83 
upregulated on IMoDC and downregulated on mMoDC (Table 1.1; Mauel et al.,
2006). The phenotypic variation reported in that study may be an indication that 
the current conditions for equine MoDC generation are not optimal, as the ideal 
concentrations of GM-CSF and IL-4 needed to generate in vitro IMoDC are not 
known and the ideal maturation stimulus needed to activate IMoDC to fully 
mature cells is also not known.
The key function of DC is the ability to physically interact with and 
stimulate T lymphocytes. A previous study on equine DC has shown that MoDC 
stimulated T cells in in vitro MLR assays (Mauel et al., 2006). Another study 
showed that there was no difference in the endocytic capacity between the 
immature and mature DC states (Cavatorta et al., 2009), which highlights the 
need to further clarify the activation of DC in the horse.
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Table 1.1. Phenotypic comparison of human and equine in vitro  MoDC.
The expression of the main DC markers, CD206, CD83, CD86 and MHC II, on 
human and equine immature and mature MoDC.
DC Surface markers Human 
iMoDC mMoDC
Equine 
iMoDC mMoDC
CD206 
CD83 
CD86 
MHC II
high
low
low
low
low
high
high
high
variable
variable
low
low
variable
variable
high
high
There has been little research to characterise the phenotype and function 
of eqMo and no studies have assessed the heterogeneity of these cells. Since 
CD14 is highly expressed on most Mo, they can be separated from PBMC by 
positive selection which generates a high purity of recovered cells. The Mo 
isolated by CD14 can be used for various downstream applications including the 
ex vivo generation of DC.
In the past, a more comprehensive analysis of DC biology was hampered 
by a lack of tools but the sequencing of the equine genome (Wade et al., 2009) 
has allowed for transcriptomic studies. The changes occurring at the 
transcriptome level during differentiation and upon activation of eqMoDC have 
not been previously investigated. The availability of a commercial equine 
microarray based on the first partial-draft of the horse genome will provide new 
opportunities to assess the biological processes occurring in equine immune 
cells.
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1.5. Aims and objectives
The understanding of the effect of equine viruses on host immune cells, 
particularly DC, Is imperative for addressing fundamental questions on host 
immunity, virus replication and therapeutic strategies. The in vitro MoDC system 
was used as a model to study DC biology and virus impact on the horse's 
immune response. The eqMoDC system was first set up to address questions 
raised by previous studies which include the inability to obtain fully activated DC 
(Mauel et al., 2006; Cavatorta et al., 2009), and to facilitate a proper 
assessment of equine DC function. The work conducted on DC biology involved 
the use of techniques such as flow cytometry for the phenotypic and functional 
assessment of cells, microarray to assess the gene expression profiles of the 
differentiated and activated cells and real-time qPCR used to detect surface 
molecules for which there were no antibodies available.
Previously, there were no published data describing the alterations on DC 
biology induced by the equine viruses EAV and EEV. Of particular interest, 
however, was the effect of viruses on immune cells before CPE occurred and 
caused destruction. Further investigations were performed to assess the impact 
infection has on the differentiation and activation states of eqMoDC and most 
importantly the function. This thesis studied the interaction of these viruses with 
eqMoDC. The findings presented will contribute to an understanding of virus-host 
interactions in horses, particularly on the impact of DC function in cell-mediated 
immunity against virus infection.
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The hypothesis of this study is that equine viruses prohibit initiation
of host anti-viral immunity by inhibiting DC development and function.
This project has three specific aims:
1. To further characterise an in vitro MoDC system in the horse.
a. To establish the optimal cytokine concentrations and maturation 
stimuli required for /n vitro MoDC differentiation and activation.
b. To compare the morphology, phenotype and function of the key 
stages of MoDC differentiation and activation.
c. To use an equine microarray to identify changes in the gene 
expression profiles during differentiation and activation.
2+3. To analyze the interactions of equine MoDC with EAV and EEV during
differentiation and activation.
a. To determine if EAV and EEV infect and replicate in Mo and MoDC.
b. To analyze the phenotypic and functional changes of Mo and MoDC 
after virus infection.
c. To determine the effect EAV and EEV has on the differentiation and 
activation states of MoDC.
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2.1. In  vitro generation of equine MoDC
2.1.1. Bioactivity o f cytokines equine GM-CSF and IL-4
The recombinant baculovirus-derived equine cytokines, GM-CSF and IL-4, 
were Histidine-tag (His-tag) purified by metal chelate affinity chromatography, 
which was improved by optimising the imidazole concentration in the samples 
and binding buffer to achieve a balance between the purity and protein yield 
(Oxford Expression Technologies, Oxford, United Kingdom). This method 
maintained the activity and structure of the purified cytokines. Prior to 
stimulation of Mo with GM-CSF and IL-4, the bioactivity of these cytokines was 
determined to assess the optimal concentrations required for differentiation. 
These cytokines were first titrated on TF-1 cells and subsequently on equine Mo 
to adjust for species differences. TF-1 (ECACC, Salisbury, United Kingdom) is a 
non-adherent human pre-myeloid cell line established from a patient with 
erythroleukemia and is used in proliferation bioassays. They are growth 
dependent on GM-CSF or IL-3 and show responsiveness to IL-4 (Kitamura et al., 
1989; Keegan et al., 1995). They were propagated in RPMI (Roswell Park 
Memorial Institute)-1640 (Life Technologies-Gibco, Paisley, United Kingdom) 
supplemented with 2 mM L-Glutamine (Life Technologies-Gibco, Paisley, United 
Kingdom), 1% Sodium pyruvate (NaP) (Life Technologies-Gibco, Paisley, United 
Kingdom), 0.1 mg/ml penicillin and streptomycin (Life Technologies-Invitrogen, 
Paisley, United Kingdom), 3 ng/ml human GM-CSF (kindly provided by Novartis 
Pharmaceuticals Limited, Surrey, United Kingdom) and 10% heat inactivated 
Foetal Calf Serum (FCS). Fresh human GM-CSF was added every 48 hours.
Cells were seeded in 96-well plates (Greiner bio-one, Stonehouse, United 
Kingdom) at a density of 3 x 10^ cells per well and incubated for 3 days. The 
cytokines to be tested were independently added to the respective wells in 
various dilutions of the stock material with each dilution having 8 consecutive 
repeats and human GM-CSF as a positive control. The cells were assessed daily
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to determine the minimum dilution of cytokine, in international units of biological 
activity (U)/ml, which stimulated proliferation of cells. One unit represented the 
biological activity to keep cells alive. Once this dilution was identified, the 
cytokines were further tested on equine Mo to determine the optimal 
concentration for differentiation.
2.1.2. Endotoxin testing o f recombinant cytokines and maturation stimuli
The detection of endotoxin contamination in biological reagents was 
required to assure that the activation of inflammatory cells was caused 
exclusively by the materials and not by bacterial products. The interaction of 
blood cells (amebocytes) of the horseshoe crab Limuius poiyphemus with 
endotoxin, (lipopolysaccharide) in the gram negative bacterial cell wall, results in 
intravascular coagulation (Bang et al., 1953; Levin and Bang, 1964a and b; 
Levin and Bang 1968). Activation of enzymes in the amebocytes is directly 
responsible for this coagulation. The chromogenic limuius amebocyte lysate 
(LAL) assay (GenScript, New Jersey, United States) using the LAL reagent 
prepared from horseshoe crab blood is a sensitive and specific means of 
measuring bacterial endotoxins (Hochstein, 1987). In the LAL assay, the LAL- 
endotoxin reaction activates an enzyme which in turn releases the chromophore, 
para-nitro aniline (pNA), from a synthetic substrate thereby producing a yellow 
color. The level of p-nitroaniline can be determined photometrically at a 
wavelength of 545 nm and is proportional to the amount of endotoxin present.
The reagents tested included the differentiation and maturation 
recombinant cytokines/stimuli (GM-CSF, IL-4, TNF-a, IL -lp , IL-6 and PGEz), 
media and FCS. These samples were mixed with sterile IX  phosphate buffered 
saline solution (PBS) (Life Technologies-Gibco, Paisley, United Kingdom) and the 
content of endotoxin was measured following the manufacturer's instructions. 
Carefully, 100 pi of standards, samples and LAL reagent water were dispensed
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into different endotoxin free vials labelled accordingly. A blank was also included. 
Samples were mixed thoroughly for 30 seconds with a vortex mixer. To each vial 
100 pi of reconstituted LAL was added and swirled gently. The vials were sealed 
and incubated at 37°C for 45 minutes. After incubation, 100 pi of reconstituted 
chromogenic substrate solution was added to each vial, mixed gently and 
Incubated for 6 minutes at 37°C. To each vial, 500 pi of reconstituted stop 
solution was added and mixed gently followed by the addition of 500 pi of color- 
stabilizer 2. Finally, 500 pi of reconstituted color-stabilizer 3 was added to each 
vial and gently mixed for 3 seconds. The absorbance of each reaction was read 
at 545 nm. Distilled water was used as the blank in order to adjust the 
photometer to zero absorbance. The absorbance at 545 nm was plotted with the 
standards on the x-axis and the corresponding endotoxin concentration in EU/ml 
on the y-axis. The absorbance showed a linear relationship with the 
concentration in range of 0.01 - 0.1 EU/ml. The best fit straight line was drawn 
among these points and the endotoxin concentrations of samples determined 
graphically. The endotoxin content of all investigated samples was below the 
detection lim it of the kit.
2.1.3. Isolation o f horse peripheral blood monocytes
Fresh whole blood samples (450 ml per sample) were collected from 
healthy horses (Equus caballus), of different breeds and ages, into sterile single 
blood bags with 35 ml of anticoagulant citrate phosphate dextrose solution (CPD) 
(Baxter, München, Germany). Sampling of blood was carried out by trained staff 
at Animal Health and Veterinary Laboratories Agency (AHVLA) under a project 
license held by the Animal Service Unit of AHVLA.
Peripheral blood mononuclear cells (PBMC) were isolated from healthy 
horses by FI col I density centrifugation previously described in the literature 
(Mauel et al., 2006). Horse blood was diluted with room temperature sterile IX
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PBS containing 5 mM Ethylenediaminetetraacetic acid (EDTA), pH 7.4 (Life 
Technology-Invitrogen, Paisley, United Kingdom) at a ratio of 5:1. The diluted 
blood was centrifuged for 15 minutes at 754 xg (times gravity), 20°C to obtain 
buffy coats. The upper plasma layer was removed and the buffy coat area 
collected to which an equal volume of room temperature IX  PBS + 5 mM EDTA 
was added. The diluted buffy coat was layered on top of 16.5 ml of the 
separating solution Fiocoll 400 density 1.090 g/ml (Source BioScience 
LifeSciences, Nottingham, United Kingdom) and subjected to gradient 
centrifugation for 20 minutes at 596 xg, 20°C. Ficoll 400 is a highly branched 
polymer formed by the copolymerization of sucrose and epichlorohydrin. The 
density 1.09 g/ml was prepared by adding 1 part PBS plus 8.5 parts Fiocoll 
density 1.10 g/ml (Source BioScience LifeSciences, Nottingham, United 
Kingdom). This step ensured the separation of leukocytes from erythrocytes. 
Thereafter, the upper layer was removed and the leukocyte fraction collected 
carefully to avoid cell loss. Leukocytes were diluted again with IX  PBS + 5 mM 
EDTA and subjected to a second gradient centrifugation with Fiocoll 1.077 g/ml 
(Source BioScience LifeSciences, Nottingham, United Kingdom) for 20 minutes at 
596 X g, 20OC. This step ensured the removal of granulocytes from PBMC, which 
were then collected, washed three times with PBS containing 5 mM EDTA and 
centrifuged for 8 minutes at 596, 456 and 335 xg, 200C to remove the majority 
of platelets. The cells were resuspended in 20 ml of PBS with EDTA.
PBMC counts were performed by diluting 10 pi of the cell suspension in 
90 pi of PBS and running on the MACSQuant flow cytometer (Miltenyi Biotec, 
Bergisch Gladbach, Germany). The cell suspension was centrifuged for 10 
minutes at 233 xg, 20oc and the pellet resuspended in 800 pi of magnetic
activated cell sorting (MACS) buffer per 1x10 cells. The MACS buffer consisted 
of 500 ml of IX  PBS, 2% FCS and 0.5 pM EDTA. The primary antibody, anti­
human CD14 big 13 clone (Biometec GmbH, Grelfswald, Germany), was added
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to PBMC at a concentration of 4.8 mg/ml for every 1 x 10 cells and incubated for 
30 minutes at 4°C. The cells were resuspended in 15 ml of MACS buffer and 
centrifuged for 10 minutes at 233 xg, 4°C. The cell pellet was resuspended with
600 pi MACS buffer plus 150 pi Goat anti-mouse IgG Microbeads (Miltenyi Biotec,
8
Bergisch Gladbach, Germany) for every 1 x 10 cells and incubated for 15 
minutes at 4°C. The cells were resuspended in 15 ml of MACS buffer and 
centrifuged for 10 minutes at 233 x g, 4°C. The supernatant was completely
removed and the cell pellet resuspended in a final volume of 500 pi MACS buffer
8
for every 1 x 10 cells.
The LS separating column (Miltenyi Biotec, Bergisch Gladbach, Germany) 
was attached to the magnet followed by the addition of 3 ml of MACS buffer. The 
flow through was discarded. The microbead labelled cells were applied to the 
magnetic column and the elute reapplied twice more. The total effluent was put 
aside as a negative fraction. The positive fraction (Mo) bound to the magnetic 
column was washed by passing 3 x 3 ml of MACS buffer through the column. The 
wash fractions were pooled with the negative fraction. The separating column 
was detached from the magnet, 5 ml of MACS buffer applied to the column and 
the Mo flushed through with a plunger. A clean separating column was attached 
to the magnet and the negative fraction applied once to the column as described 
previously to increase Mo recovery. The Mo eluted from the first and second 
columns were pooled and centrifuged at 233 xg for 5 min. The pellet was 
resupended in 1 ml supplemented RPMI media. Monocyte counts were performed 
as described previously for PBMC and the purity of this population assessed by 
flow cytometry (section 2.3.1).
2.1.4. Differentiation o f monocytes to immature MoDC
Monocytes were seeded into 24-well flat bottom tissue culture plates 
(Greiner bio-one, Stonehouse, United Kingdom) at a density of 1 x 10® cells per
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well. Cells were cultured in the presence of 2 ml RPMI-1640 media supplemented 
with 10% FCS, 0.1 mg/ml penicillin/ streptomycin and 2% 4-(2-hydroxyethyl)-l- 
piperazineethanesulfonic acid (HEPES) (Life Technologies-Invitrogen, Paisley, 
United Kingdom). Different concentrations of GM-CSF (100 to 1000 U/ml) and 
IL-4 (10 to 500 U/ml) were added to the respective wells individually and In 
combination. Cultures were incubated at 37°C in 5% CO2. The morphology and 
phenotype of the cells were assessed after 2 days by light microscopy with the 
Leica DM IL LED Microscope (Leica Microsystems CMS GmbH, Wetzlar, Germany) 
and flow cytometry, respectively. The concentration of GM-CSF and IL-4 that 
gave the desired morphology and phenotype to that present in the literature for 
equine and human MoDC was selected as the optimal concentration.
Monocytes were seeded and cultured in supplemented media as described 
above, but the media in addition contained the optimal cytokine concentrations 
of 1000 U/ml of eqGM-CSF and 500 U/ml of IL-4. Cultures were incubated at 
37°C in 5% CO2. The cells were assessed daily by microscopy and flow cytometry 
to determine the optimal IMoDC morphology and phenotype, respectively.
2.1.5. Activation o f immature MoDC into mature MoDC
To determine the optimal maturation stimuli, iMoDC were activated with 
the following stimuli: 1 pg/ml LPS (Axxora, Nottingham, United Kingdom); 20 
pg/ml poly I:C (Enzo Life Sciences, Exeter, UK); 1 ^ig/ml LPS plus pg/ml poly 
I:C; a cocktail of 20 ng/ml eqTNF-a, 10 ng/ml eqlL-ip, 20 ng/ml eqIL-6 (R&D 
Systems, Abingdon, United Kingdom) and 1 pg/ml PGE2 (Enzo Life Sciences, 
Exeter, UK); cocktail plus 0.5 pg/ml CD40L (R&D Systems, Abingdon, United 
Kingdom); cocktail plus 100 ng/ml eqIFN-y (R&D Systyems, Abingdon, United 
Kingdom); cocktail plus 0.5 pg/ml CD40L and 100 ng/ml eqIFN-y. Activated 
MoDC were incubated at 37°C in 5% CO2 for 24 and 48 hours. The phenotype of 
the main DC markers such as CD206, CD83, CD86 and MHC II  were analysed by
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flow cytometry (section 2.3.4). The stimuli and incubation period which gave the 
best phenotypic transition to mature MoDC (mMoDC) were selected for all 
further mMoDC cultures.
2.2. Virus propagation and infection
2.2.1. Virus strains
The three EAV strains investigated were the velogenic and attenuated 
variants of the US Bucyrus reference strain and the UKl strain (section 1.1.4). 
The reference strain was obtained from the Gluck Equine Research Centre, 
Kentucky, United States. The virus stocks were in the freeze dry form and were 
dissolved by adding 1ml of supplemented MEM. These stocks were used to 
further propagate large quantities of the EAV strains in EEL to a maximum 
passage of 3.
The EEV strain used in this study was a recent field isolate obtained from 
the 2008-2009 outbreak of EEV infected horses in Israel (Kimron Veterinary 
Institute, Israel). This strain was isolated from a blood sample and cultured on 
Vero with a five day incubation period giving titres of 10®® TCIDso/ml (D. 
Westcott, unpublished data, 2009). This stock was used to further propagate 
large quantities of EEV in Vero to a maximum passage of 3. All strains will be 
referred to throughout this thesis as shown in Table 2.1.
Table 2.1. Abridged versions of virus names
Virus strains Reference
EAV US Bucyrus velogenic Velogenic
EAV US Bucyrus attenuated Attenuated
EAV UKl UKl
EEV Israel EEV
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2.2.2. UV inactivation o f virus
An ultraviolet (UV) Inactivated virus was included in all infection assays. 
UV light disrupts nucleic acids with minimal or no modification of the viral 
proteins, therefore leaving the virus particles Intact. Hence, the virus particles 
cannot replicate but will bind to their receptors and act as antigen. This 
comparison was included to determine the effect of inactivated virus particles on 
immune cells. For UV inactivation, sterile petri dishes (cp 60 mm) (Thermo 
Scientific, Surrey, United Kingdom) were coated with FCS for 30 minutes to 
prevent the viruses from sticking to the petri dishes. The FCS was removed by 
pipetting, 1 ml of virus suspension was added and the open petri dishes were 
exposed to 254 nm of short UV wavelengths for 1 hour In a class I I  biological 
safety cabinet (Contained Air Solutions Limited, Manchester, United Kingdom). 
To ensure the virus had lost its infectlvity, virus titration assays (section 2.2.5) 
were performed and confirmed the lack of infectious virus. The EAV ORFl 
TaqMan assay (sections 2.4.7) confirmed the presence of virus after UV 
inactivation shown by the viral amplification plot (Appendix II).
2.2.3. Virus propagation
Monolayer cultures of equine embryonic lung cells (EEL) (Newmarket 
Animal Health Trust, Suffolk, United Kingdom) were propagated in Minimal 
Essential Medium (MEM) (Life Technologies-Gibco, Paisley, United Kingdom) 
supplemented with 10% FCS, 0.1 mg/ml penicillin and streptomycin. EEL were 
cultured In 75 cm^ tissue culture flasks (Fisher Scientific, Loughborough, United 
Kingdom) with 20 ml of supplemented MEM. Cultures were incubated at 37°C in 
5% CO2 until cells were 80% confluent. Volumes of 19 ml of supernatants were 
removed from sub-confluent monolayers of EEL cell cultures and 1 ml of 
dissolved freeze dry virus was Inoculated into 1 ml of supernatant at the first 
passage. Cultures were incubated for 1 hour at 37°C in 5% CO2 followed by the
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addition of 20ml of fresh supplemented MEM to each 75 cm^ culture flasks and 
incubated for 3 days or until the disappearance of 80-90% of the cells. 
Subsequently, infected EAV cultures were frozen at -80°C overnight and thawed 
afterward to release virus particles from remaining cells. The virus-cell 
suspensions were centrifuged at 930 xg for 10 minutes at 4°C to separate the 
cell debris. The virus supernatants (around 10® TCIDso/ml) were collected and 
used to inoculate more EEL cultures. MEM was subsequently supplemented with 
2% FCS instead of 10%. High proportions of FCS can inhibit filtering of the virus 
suspension after concentration (section 2.2.4). The latter allowed for the 
expansion of virus cultures with the aim of achieving substantial volumes of virus 
suspensions with high titres.
The propagation of EEV was similar to that described above for EAV. 
However, Vero cells were used instead of EEL. Volumes of 1 ml of 10®® 
TCIDso/ml of original virus suspensions were inoculated into 75 cm^ flasks of 
sub-confluent monolayers of Vero cells. Infected culture flasks were incubated 
for 5 days until the disappearance of 80-90% of the cell monolayer.
2 .2 .4. Concentration and purification o f virus suspensions
The virus concentration protocol applies to both EAV and EEV. All virus 
suspensions obtained from propagation were pooled giving a total volume of 500 
ml. The pooled suspensions were concentrated using cellulose visking tubing 
(The Scientific Instrument Centre, Hampshire, United Kingdom) and 
polyethylene glycol (PEG) (Sigma Aldrich, Dorset, United Kingdom) (Figure 2.1). 
One end of the visking tube (filter size less than 20 kDa) was sealed and the 
virus suspension added using a 25 ml sterile pi pet (Greiner Bio One, Stonehouse, 
United Kingdom). The other end of the tubing was subsequently sealed. The 
visking tube with virus suspension was then submerged in a tray of PEG powder 
(molecular weight greater than 1000 g/mol) and incubated at 4°C until the
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volume of virus suspension was reduced approximately 50-fold to a final volume 
of 10 ml or approximately 8 hours. PEG removed the water and small salt 
molecules from the virus suspensions by diffusion hence drastically reducing the 
volume. After concentration, the virus suspensions were dialysed using visking 
tubing with a 300 kDa molecular weight cut off. The virus suspensions were 
equilibrated against IX  isotonic PBS which reduced high concentrations of small 
salt molecules in the virus suspensions. This was performed by submerging the 
visking tube with concentrated virus in 500 ml of cold PBS and incubating at 4°C 
for 4 hours. The PBS solution was changed once every hour. The virus 
suspensions were then filtered with 0.20 pm syringe filters to exclude any 
potential contamination since the visking tubing was not sterile. The virus 
suspensions were then aliquoted into 1 ml cryogenic vials and stored at -80°C.
Visking tubing 
containing 500ml of 
virus suspension
Visking tubing 
submerged in PEG
Volume reduced 
50-fold to 10 ml
Figure 2.1. Concentration of virus suspensions. A total volume of 500 ml of
virus suspension was concentrated 50-fold using visking tubing and PEG.
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2 .2.5. Virus titration
Infection titres of the concentrated virus stocks and of cell supernatants 
from infected cells were determined in vitro by inoculating increasing dilutions 
of the virus material to a susceptible cell line. All viruses were titrated using the 
cell lines on which they were propagated.
Confluent monolayers of EEL or Vero cells in 25 cm^ tissue culture flask 
were trypsinised with 2% Trypsin containing 0.2% Versene (Life Technology- 
Invitrogen, Paisley, United Kingdom). Cells counts were made using the 
haemocytometer (Bright-Line, Hausser Scientific, USA). Here, EEL cells were 
diluted 1 to 10 in 0.45% of the viability stain trypan blue (Life Technologies- 
Gibco, Paisley, United Kingdom) and 10 pi of the cel I-stain mixture loaded onto a 
haemocytometer. Trypan blue selectively traversed the non-intact membrane of 
dead cells and coloured them blue, hence they were excluded from the viable 
counts. The final cell count was adjusted to 3 x 10^ cells in 10 ml of MEM with 
2% PCS. Ten-fold dilutions of the sample to be titrated were prepared by placing 
100 pi of the virus suspensions into 900 pi of MEM containing 2% PCS. 
Subsequently, 100 pi of the previous dilution was transferred to the next 900 ml 
of media.
To flat-bottomed 96-well microtitre plates (Greiner bio-one, Stonehouse, 
United Kingdom), 100 pi of 3 x 10"^  cells in suspension was dispensed into each 
well followed by 50 pi of MEM and 25 pi of the respective virus dilution. Each 
dilution was added to 8 wells (1 column of a microtitre plate), starting with the 
lowest dilution. To the control wells the addition of 25 pi of MEM with 2% PCS 
replaced the test sample. The plates were covered and incubated at 37°C in 5% 
CO2. Plates were read under the microscope after 3 days for EAV and 5 days for 
EEV and weils that displayed cytopathic effects (CPE) were scored with a plus 
(+). CPE consisted of the rounding of cells and detachment from the surface of 
the culture plate resulting in the disappearance of the cell monolayer for both
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EAV and EEV. The 50% end point dilution expressed as TCIDso/ml (50% 
Tissue Culture Infective Dose) was calculated using the Karber formula (Karber, 
1931) shown below:
Log TCIDso = L-d(S-0.5) where,
L = log of lowest dilution in the test showing 100% CPE,
d = difference between the log dilution steps which was always 1 for a 10-fold
dilution,
S = sum of the proportion of positive tests showing CPE.
The virus titre, equivalent to Log TCID50/O.2 ml (total reaction volume) was 
represented as lO’' TCID50/O.2 ml of virus, which was converted to TCIDso/ml by 
multiplying by 5 (1 ml divided by 0.2 ml) to correct for the original dilution.
2.2 .6. Determining virus muitipiicity o f infection (MOI)
The actual number of virus particles that will enter any given cell is a 
random process. Multiplicity of infection (MOI) represents the ratio of pathogens 
(here infectious viral units) to infection targets (immune cells in this study). The 
probability that a cell will absorb virus particles when inoculated with a high MOI 
can be calculated for a given population using the Poisson distribution. The more 
virions in contact with target cells increased the chances of most cells being 
infected simultaneously in an in vitro system. A MOI of 5 (5 virus particles per 
target cell) were used for the infection of immune cells. With a MOI of 5, the 
percentage cells infected by at least one virus particle may be assumed to be > 
99% (Flint et al., 2009). The simulatneous infection of cells assured the primary 
replication occurred in parallel. This guaranteed that the maximum amount of 
cells was infected in parallel and all downstream analysis was representative of 
the highest amount of cells infected and not just a few cells.
MOI is generally calculated on the basis of absolute infectious units (for 
cytopathogenic viruses call plaque forming units, PFU) and not on the basis of a
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50% infectious does. PFU/ml and TCIDso/ml are related on the assumption that 
the conditions used for plaque assay and TCID assay do not alter the expression 
of infectious virus and are related by the equation below (Carter and Saunders,
2007):
PFU/ml = 0.7 X TCIDso/ml 
Hence, to inoculate 1 x 10® cells with a MOI of 5, a volume containing 5 x 10® 
PFU was applied. The same volume was used to infect cells with the mock 
control and UV inactivated virus.
2 .2 .7. Virus infection o f monocytes and MoDC
Mo were seeded into 24-well tissue culture plates at a density of 1 x 10® 
cells per well and MoDC were differentiated/activated as described above 
(section 2.1.4 and 2.1.5). Cells were inoculated with EAV or EEV at MOI of 5 
(section 2.2.6). Mo and MoDC were also treated with supernatants from the cells 
lines in which the viruses were grown, EEL or Vero. These were concentrated and 
purified in the same manner as the infected supernatants and referred to as the 
mock infections. Mock controls were included to ensure that the effects observed 
were due to the virus and not due to molecules that may have been released 
from the cells in which the viruses were cultured. Cultures were incubated at 4°C 
for 90 minutes to allow virus attachment to cells. Cells were washed gently three 
times with cold media and centrifuged at 500 xg for 2 minutes after each wash 
to remove virus inocula. Fresh media was added to the cultures and the third 
wash collected to analyse the success of washing. Samples collected immediately 
after incubations were referred to as the zero hour time points. I f  necessary, 
cells were harvested by scraping them gently off the plates with a thin, flexible 
blade cell scraper (Sarstedt Limited, Leicester, United Kingdom). Pellets for 
subsequent qPCR analysis were resuspended in lysis buffer and stored at -80°C 
for RNA extractions. The remaining cells were incubated at 37°C in 5% CO2. The
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viability (section 2.3.2) of infected cells was determined first, to assess the time 
kinetic of cytopathogenic one step replication in myeloid cells.
2.3. Flow cytometry
2.3.1. Technology
A flow cytometer analyses particles and cells in suspension. The 
expression of cell surface and intracellular molecules can be monitored in single 
or simultaneous multi-parameter analysis of single cells. Cells in suspension are 
hydrodynamically focused in a sheath of fluid and pass by a laser beam, which is 
the source of light excitation. The cells passing through the beam scatter the 
light, which is detected as forward scatter (FSC) and side scatter (SSC) and 
analysed by a series of detectors that convert the light signal into electrical 
impulses. FSC correlates with the cell size and SSC relates to the cell 
density/granularity. Fluorochromes used for staining emit light when excited by a 
laser with corresponding excitation wavelength.
2.3.2. Viability and apoptotic assays
For all flow cytometry analysis, cell viability was evaluated with the 
live/dead fixable near-IR (infra red) or violet dead cell stain kits (Fisher 
Scientific, Loughborough, United Kingdom) with adjustments to the 
manufacturer's protocol. The principle of these assays is based on the reaction of 
a fluorescent reactive dye with cellular amines. The dye can penetrate the 
compromised membranes of dead or dying cells and react with free amines in 
the interior and on the cell surface, resulting in intense fluorescent staining. For 
viable cells, only the cell surface amines react with the dye resulting in very 
weak staining and usually a 50-fold difference in intensity between the live and 
dead cell populations. This difference is preserved following fixation of cells with 
paraformaldehyde by cross-linking the proteins. The near-IR and violet dyes are
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detected only in the red 780 nm emission) and violet (~  405 nm emission) 
channels of the flow cytometer, respectively leaving the other channels available 
for multicolour experiments. Fluorescent reactive dyes were reconstituted with 
50 pi of Dimethyl sulphoxide (DMSO) (Life Technologies-Invitrogen, Paisley, 
United Kingdom). Cells were washed once with 1 ml of PBS and resuspended in 1 
ml of PBS. Cell counts were performed, as described for PBMC and Mo (section 
2.1.3), to adjust the density to 5 x 10® cells/50 pi of PBS for each well of a round 
bottom microtitre plate (Greiner bio-one, Stonehouse, United Kingdom). 0.25 pi 
of the reconstituted fluorescent reactive dye was added to each cell suspension, 
mixed well and incubated at 4°C for 30 minutes, protected from light. Cells were 
washed twice with 200 pi of cold PBS, which included centrifugation at 500 xg for 
2 minutes after each wash, and resuspended in 200 pi of IX  cell fix prepared 
from a lOX stock (containing PBS and 4% paraformaldehyde) (Sigma-Aldrich, 
Dorset, United Kingdom). The fixed cell suspensions were analyzed by flow 
cytometry (section 2.3.1).
Apoptosis, a process of programme cell death, triggers morphological and 
biochemical changes in the cellular life cycle. In apoptotic cells, the phospholipid 
phosphatidylserine (PS) is no longer restricted to the cytosolic part of the 
membrane and translocates to the cell surface (Martin et al., 1995). Annexin V is 
a calcium dependent phospholipid-binding protein (Moss et al., 1991) that has a 
high affinity for PS (Andree et al., 1990) and binds to cells with exposed PS. 
Annexin V was used conjugated to the fluorochrome Fluorescein isothiocyanate 
(FITC) (Becton Dickinson, Oxford, United Kingdom). The later stages of cell 
death are accompanied by the loss of membrane integrity from apoptotic or 
necrotic processes. Therefore, Annexin V was used in conjunction with the 
viability dye 7-Amino-Actinomycin (7-AAD) (Becton Dickinson, Oxford, United 
Kingdom) to allow identification of both early and late stage apoptotic cells. Cells 
were washed twice with cold PBS and resuspended in IX  binding buffer (Becton
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Dickinson, Oxford, United Kingdom) at a concentration of 1 x 10® cells/ml. 100 pi 
(1 X 10® cells) of cell suspension was added to a FACS tube followed by the 
addition of 5 pi of both Annexin V-FITC and 7-AAD. The cells were gently 
vortexed and incubated for 15 minutes at room temperature in the dark. 
Controls included unstained cells, cells stained with Annexin V-FITC only and 
cells stained with 7-AAD only. After incubation, 400 pi of IX  binding buffer was 
added to each tube and cells immediately analyzed by flow cytometry (section 
2.3.1).
2.3.3. Gating strategy
For all flow cytometric analysis, viability assays (section 2.3.2) were 
performed to distinguish live and dead cells. Gates were drawn around the live 
cell population acquired on the logarithmic scale of the fluorescent dye signal 
versus the linear scale of the forward side scatter area (FSC-A). The live cell 
population was then assessed on the linear scales of side scatter area (SSC-A) 
versus FSC-A to gate the target population. Duplex cells were then excluded 
from the target population by gating the single cells displayed on the linear 
scales of SSC-A versus side scatter height (SSC-H). This population of interest 
was used for further analysis of all fluorescent antibodies on a logarithmic scale. 
Acquisition of cells on the logarithmic scale increases the resolution of weak 
signals and the range of data (both weak and strong signals) that can be 
recorded on the same scale (Ormerod, 2008). However, for cell cycle 
measurements such as using a DNA stain, a linear scale was used as it indicated 
subtle changes in cellular DNA content.
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2.3.4. Phenotypic assays
Cells were stained in 96-weli round bottom microtitre plates with 5 x 10® 
cells per well for each antibody (Table 2.2). In some cases, dual staining of cells 
was performed. Some antibodies were not directly labelled and were either 
labelled via the zenon kits (Table 2.2) or indirectly labelled. Labelling of 
unconjugated antibodies with the zenon kit involved incubating 1 pg of primary 
monoclonal antibody diluted in 20 pi of PBS with the zenon labelling reagent 
(fluorophore-labelled Fab fragment binding the Fc fragment of the IgG antibody) 
in a 4:1 ratio for 5 minutes at room temperature. The reaction was then stopped 
by the addition of a blocking agent (non-specific IgG which neutralized excess 
Fab fragments) also in a 4:1 ratio and incubated for 5 minutes at room 
temperature. Cells were stained with the conjugated antibodies for 30 minutes at 
4°C and washed twice with 200 pi of cold PBS, which included centrifugation at 
500 xg for 2 minutes after each wash. Cells were resuspended in 200 pi of IX  
cell fix. For the indirect labelling, cells were stained with the primary antibody for 
30 minutes at 4°C, washed and centrifuged as described above, labelled with the 
secondary antibody for 30 minutes at 4°C and again washed and resuspended as 
described above. Along with the labelled samples, a number of controls were 
used in these assays. Controls include untreated and treated cells only which 
controlled for background autofluoresence, the primary antibody which 
controlled for its non-specific binding on untreated and treated cells, the 
secondary antibody which controlied for its non-specific binding on treated cells 
and the same antibody isotype as the primary antibody which confirmed its 
specific binding and no non-specific Fc receptor binding or other protein 
interactions.
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Chapter 2. Materials and Methods
Stained cells were analyzed using the MACSQuant Analyzer by acquiring 
10,000 events in the target gate excluding debris. Fiuorescent dyes were 
automatically compensated for any spectral overlap during analysis of 
simultaneous or multicolour staining using flow cytometry. Spectral overlap of 
different fluorochromes was corrected, as this would have lead to emission of a 
given fluorochrome into other detectors. A lack of compensation for spectral 
overlap would have given false positive populations and led to misinterpretation 
of data and artificial populations on multicoiour dot plots. Therefore, 
compensation of spectral overlap was accomplished by the inclusion of single 
colour controls which electronically subtracted unwanted signals and led to 
accurate analysis of multicolour stained cells. The expression of cell surface 
markers on target populations was analysed by applying the gating strategy 
described in section 2.3.3.
2 .3.5. Endocytic and phagocytic assays
The ability of MoDC to endocytose Alexa Fluor 647/APC* conjugated 
ovalbumin (OVA-APC"') (Life Technologies-Invitrogen, Paisley, United Kingdom) 
or phagocytose FITC-labelled FluoSphere carboxylate-conjugated microsphere 
particles, 1.0 pm diameter (Life Technologies-Invitrogen, Paisley, United 
Kingdom) was assessed by flow cytometry following previously published 
protocols (Schuler et al., 1985; Zhang et al., 2007; Cavatorta et al., 2009). 
Freshly isolated monocytes, IMoDC or mMoDC were washed once and 
resuspended in cold RPMI 1640 media at a density of 1 x 10® cells per well of a 
flat-bottomed 96-well plate (Greiner bio-one, Stonehouse, United Kingdom). All 
plates were incubated on ice for 30 minutes before adding OVA-APC* to a final 
concentration of 20 pg/ml or FITC-conjugated carboxylate-modified microsphere 
at a ratio of 5:1 (bead:cell). Cells were incubated at 4°C (control) and 37°C for 1 
hour or 4 hours for the endocytic and phagocytic assays, respectively.
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Subsequently, cells were washed three times with cold PBS and resuspended in 
cold PBS for flow cytometric analysis.
2.3.6. Mixed ieukocyte reactions (MLR)
Equine T lymphocytes were enriched using anti-horse CDS, clone CVS5 
(Table 2.1) indirectly labelled to anti-mouse IgG microbeads and magnetically 
sorted, as described for CD14^ monocytes (section 2.1.3). MoDC from one horse 
were added in graded doses to 5 x 10® CFSE labelled CD5^ T lymphocytes from 
another horse. CFSE (carboyfluorescein diacetate succinimidyl ester), a 
fiuorescein-based dye, readily crosses intact cell membranes and cleavage of the 
acetate groups by intracellular esterases results in its change from non- 
fluorescent to highly fluorescent carboyfluorescein succinimidyl ester. The 
succinimidyl ester group reacts with intracellular primary amines and these 
interactions crosslink the dye to intracellular proteins. These dye-protein 
complexes are retained by fiuorescent cells during development. After cell 
division, the fluorescent is inherited by daughter cells. Successive halving of the 
fluorescence intensity of CFSE is a measure of celi division and the CellTrace 
CFSE Cell Proliferation kit was used (Life Technologies-Invitrogen, Paisley, United 
Kingdom). The protocol for labelling of cells with CFSE was performed as 
previously described (Quah et al., 2007). I t  included incubating 5 x 10® cells with 
10 pM of CFSE solution (prepared by adding 2 pi of a 5 mM stock to 1 ml of 
PBS), which was then added to 1 ml of resuspended cells and incubated for 5 
minutes at room temperature. Cells were washed by diluting with 10 voiumes of 
20°C PBS containing 5% FCS and centrifuged at 300 xg for 5 minutes at room 
temperature.
Cells were co-cultured at 37°C for 3 days, before proliferation of T cells 
was measured by flow cytometry. Concavalin A (Con A) (Sigma-Aldrich, Dorset, 
United Kingdom) stimulated CD5^ T cells were used as a control. Cells were
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harvested, washed twice using PBS with 10% FCS and stained with the live/dead 
fixable violet dead cell kit to exclude all dead cells from analysis (section 2.3.2) 
and the anti-horse CDS conjugated to Alexa Fluor 700 APC* via the zenon 
labelling kit (Table 2.2; section 2.3.4) to define the T cells in the analysis.
2.3.7. Antigen presentation
Graded numbers of iMoDC were incubated at 37°C for 2 hours with 1 
mg/ml of LPS-free OVA (Sigma-Aldrich Company Limited, Dorset, United 
Kingdom), which can be considered an antigen horses do not encounter. After 
incubation, iMoDC were matured overnight as described before (section 2.1.S). 
CDS^ T cells were magnetically sorted as in section 2.1.3. S x 10® CFSE-labelled 
CDS^ T cells from the same horse were added to the graded numbers of mMoDC 
in ratios of 1:10, 1:20, 1:40, 1:80 and 1:160, and co-cultured at 37°C. T cells in 
the presence of OVA only were used as a control. After 4 days, proliferation of 
live T cells was evaluated by flow cytometry as in the MLR assays (section
2.3.6).
2.3.8. Cross-presentation
The protocol for this cross-presentation is as described above for the 
antigen presentation assay (section 2.3.7). However, autologous CFSE labelled 
CD8^ T cells, magnetically sorted as in section 2.1.3, were added to mMoDC in a 
DC:T cell ratio of 1:10 and co-cultured at 37°C for 5 days. Controls included 
mMoDC only, mMoDC in the presence of either OVA or T cells and Con A 
stimulated T cells in the presence of OVA. Staining was performed as described 
in section 2.3.6, but cells were stained with anti-horse CD8 conjugated to Alexa 
Fluor 700 APC* via the zenon labelling kit (Table 2.2; section 2.3.4) to define T 
cells in the analysis.
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2.4. Nucleic acid handling and expression analysis
2.4.1. RNA extraction from cell culture supernatants
Extractions of viral RNA from cell culture supernatants were performed 
using the QIAmp Viral RNA Mini Kit (Qiagen, West Sussex, United Kingdom) 
which uses the selective binding properties of a silicia gel-based membrane with 
the microspin speed. The membrane ensured high recovery of pure, intact RNA. 
This involved thoroughly mixing 140 pi of cell culture supernatants with 560 pi 
lysis buffer containing 5.6 pi of carrier RNA. The lysis buffer containing guanidine 
thiocyanate, inactivated ribonucleases (RNases; catalyzes the degradation of 
RNA into smaller components) and denatured proteins, releasing intact viral 
RNA. Carrier RNA was used to increase the viral RNA recovery by improved 
binding of viral RNA to the membrane. The mixture was incubated at room 
temperature for 10 minutes, followed by the addition of 560 pi of > 99.5% 
ethanol (Sigma-Aldrich, Dorset, United Kingdom). The mixture was then applied 
to the column and centrifuged at 6000 xg for 1 minute. The ethanol adjusted 
buffering conditions, thus providing optimum binding conditions of the RNA to 
the silica gel-based membrane in the column. The membrane bound RNA was 
then washed in two steps using two different buffers to remove any 
contaminants including ethanol. The first washing step was centrifuged at 6000 
xg for 1 minute and the second at 20,000 xg for 3 minutes. RNA was eluted in 
60 pi of RNase-free water by centrifugation at 6000 xg for 1 minute. Elutes were 
stored on ice whiie the RNA concentration was determined using the Nanodrop 
2000 Spectrophotometer (Thermo Scientific, Surrey, United Kingdom) (section
2.4.3), then immediately stored at -80°C.
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2.4.2. RNA extractions from ceils
RNA extractions from cells were performed using the RNeasy Plus Mini Kit 
(Qiagen, West Sussex, United Kingdom) which removed genomic DNA 
contamination using a genomic DNA (gDNA) eliminator spin column. Genomic 
DNA removal was tested using the Agilent 2100 Bioanalyser (Agilent 
Technologies, Wiimington, United States) (section 2.4.3). This RNA extraction 
procedure selectively excluded RNA molecules smaller than 200 nucleotides, 
most of which consist of 5.8S or 5S ribosomal RNA (rRNA) and transfer RNA 
(tRNA). Cells were first disrupted by the addition of the 350 pi of lysis buffer per 
5 X 10® cells. The lysis buffer contained guanidine-isothiocyanate and (3- 
mercaptoethanol ((3-ME) to denature all proteins including RNases and inhibit 
oxidation. The homogenized lysate was added to the gDNA eliminator column 
and centrifuged for 30 seconds at 8000 xg. The column, in combination with the 
high-salt buffer, allowed the efficient removal of genomic DNA. To the flow 
through, 350 pi of 70% ethanol (provided appropriate binding conditions for 
RNA) was added, mixed by pipetting and transferred to a second column. 
Centrifugation was performed at 8000 xg for 15 seconds which allowed the 
binding of total RNA to the membrane. The membrane bound RNA was then 
washed in three times using two different buffers to remove any contaminants. 
The first and second washing steps were centrifuged at 8000 xg for 15 seconds 
and the third at 8000 xg for 2 minutes. RNA was eluted in 40 pi of RNase-free 
water by centrifugation at 8000 xg for 1 minute. Elutes were quantified and 
stored as previously described for RNA extractions from cell supernatants.
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2.4.3. Testing RNA quantity and quality
RNA quantity and quality was assessed using the RNA Nano or Pico 6000 
Labchip kits (Agilent Technologies, Wilmington, United States) and the Agilent 
2100 Bioanalyzer, which is a microfluidics-based platform for rapid analysis of 
RNA quality and quantity. The Nano and Pico kits have different RNA detection 
ranges, which include 5-500 ng/pl and 50-5000 pg/pl, respectively. Therefore, 
all samples were initially quantified on the Nanodrop 2000 Spectrophotometer, 
which assisted in identifying the kit to be used with the Agilent 2100 Bioanalyzer. 
The Spectrophotometer is based on the principle that nucleic acids absorb UV 
light in a specific pattern and in the case of RNA/DNA wili absorb UV light at 260 
nm which directly reflects the quantity of nucleic acid. The purity is based on the 
absorbance ratio of 260/280 and for RNA a pure sample will yield a ratio of 
approximately 2.0. The Agilent 2100 Bioanalyzer is more precise and 
reproducible compared to the spectrophotometer and is the standard RNA 
quantity/quality check for downstream experiments such as microarray. The 
protocol described below is the same for both the Nano and Pico kits used with 
the Bioanalyzer.
The chip contained wells for the gel, samples and an external standard or 
ladder. The wells are interconnected by micro-channels which were filled with a 
gel (sieving polymer) and fluorescence dye. The gel was prepared by pipetting 
550 pi of the gel matrix into the spin column provided and centrifuged at 1500 
xg for 10 minutes at room temperature. To 65 pi of the filtered gel, 1 pi of dye 
concentrate was added and centrifuged at 13,000 xg for 10 minutes at room 
temperature. The chip was placed on the chip priming station, to which 9 pi of 
gel-dye mix was added to an already assigned well. The plunger was positioned 
at the 1 ml mark, the chip priming station closed and the plunger pressed until 
held by the chip. After 30 seconds the chip was released and the plunger slowly 
pulled back to the 1 ml position. The chip priming station was opened and 9 pi of
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gel-dye mix added to the remaining gel wells. The marker was added to all 
sample wells and the ladder well at 5 pi each. This marker was used to 
compensate for drift effects that may occur during the course of a chip run. In 
addition, the Pico kit contained a conditioning solution of which 9 pi was added 
to the assigned well on the chip. To the well assigned for the ladder, 1 pi of heat 
denatured RNA ladder was added along with 1 pi of the samples in each of the 
sample wells; 12 samples for the NanoChip kit and 11 samples for the PicoChip 
kit.
Once the wells and channels were filled, the chip became an integrated 
electrical circuit. The chip was placed in the adapter of a vortexer (IKA GmbH 
and Company, Staufen, Germany) for 1 minute, then run in the Agilent 2100 
bioanalyer. The RNA was electrophoretically separated by a voltage gradient, 
where the smaller fragments migrated faster than the larger ones. The Dye 
molecules bind to RNA strands and these complexes were detected by a laser- 
induced fluorescence at different speeds. The RNA 6000 Nano or Pico ladders 
were at total concentrations of 150 ng/pl and 1 ng/pl, respectively and were run 
on every chip as references for data analysis. The ladders contained six RNA 
fragments ranging in size from 0.2 to 6 kb (0.2 kb, 0.5 kb, 1.0 kb, 2.0 kb, 4.0 kb 
and 6.0kb).
The data analyses were translated into gel-like images and 
electropherograms (Figure 2.2), which displayed the 18S and 28S rRNA 
bands/peaks and reflected RNA quality. The baseline between the internal 
marker and the 18S peak was relatively flat and free of small rounded peaks 
corresponding to small RNA molecules that are degraded products of the rRNA 
transcript. The RNA concentrations were determined by the software which 
automatically compared the samples to the ladder fragments. All samples were 
graded with RIN (RNA Integrity Number) values, which also indicated the quality 
of RNA. The RIN software algorithm. Expert 2100 software version 2.01 (Agilent
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Technologies, Wilmington, United States) already built into the Bioanalyzer, 
automatically assigned an integrity number of the total RNA using a numbering 
system from 1 (most degraded) to 10 (most intact). This algorithm took the 
entire electrophoretic trace in to account and gave a better estimation of the 
integrity of total RNA samples, compared to the ratio of the ribosomal bands 
(28S/18S), and ensured better reproducibility of samples. Furthermore, 
anomalies like genomic DNA contaminations are indicated with weighted error 
messages (critical/non-critical) to achieve maximum reliability. For highly 
demanding and expensive assays such as microarray analysis, RIN values higher 
than 8 were required for cultured cells. The quality of RNA for all samples 
analysed by microarray (section 2.4.10) displayed RIN values from 9.8 to 10.
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Figure 2.2. RNA quality control using the Bioanalyzer RNA Nano 6000  
LabChip. The Bioanalyzer electropherogram of total intact RNA from Mo showed 
two distinct ribosomal peaks corresponding to 185 and 285 for eukaryotic RNA. 
The 285/185 ratio was greater than 2 which indicated good quality RNA. The RIN 
of all samples were > 9.8. The electropherogram is representative of all Mo and 
MoDC samples.
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2.4.4. Complementary DNA (cDNA) production
RNA was reverse transcribed into complementary DNA (cDNA) using 
Superscript I I  Reverse Transcriptase (RT) (Life Technologies-Invitrogen, Paisley, 
United Kingdom). This DNA polymerase synthesizes a cDNA strand from single­
stranded RNA. The introduction of point mutations in the Ribonuclease H (RNase 
H) active centre resulted in Superscript I I  RT with reduced RNase H activity. This 
structural change eliminates degraded RNA molecules during first-strand cDNA 
synthesis. The protocol is such that 10 pi of template was mixed with 1 pi of 
random hexamer primers (Promega, Southampton, United Kingdom) and heated 
to 65°C for 5 minutes followed by the addition of the PCR reaction mix. This 
reaction mix consisted of 11 pi of nuclease-free water, 8 pi of 5X buffer (Life 
Technologies-Invitrogen, Paisley, United Kingdom), 2 pi of 10 pM dNTPs 
(Promega, Southampton, United Kingdom), 4 pi of 0.1 M DTT (Dithiothreitol) 
(Life Technologies-Invitrogen, Paisley, United Kingdom), 2 pi of 0.25 U RANsin 
ribonuclease inhibitor and 2 pi of Superscript I I  RT. A no reverse transcription 
control (No RT) and no template control (NTC) were included. The reaction was 
cycled on the GeneAmp PCR System 9700 (Applied Biosystems, California, 
United States) at 25°C for 12 minutes, 42°C for 1 hour and 70°C for 15 min. To 
the PCR mix, 1 pi of RNase H (Life Technologies-Invitrogen, Paisley, United 
Kingdom) was added and cycled further at 37°C for 20 minutes. RNase H 
degrades the RNA strand of an RNA-DNA hybrid to produce 5' phosphate- 
terminated oligoribonucleotides and single-stranded DNA. Quantification of the 
cDNA was measured using the Nanodrop 2000 Spectrophotometer (section
2.4.3) and stored at -20°C.
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2.4.5. The 2 '^ ^ "  (L ivak) M ethod
The 2''“ ’"' method for relative gene expression assumes that both target 
and reference genes are amplified with efficiencies near 100% and within 5% of 
each other. Before using this method, the amplification efficiencies of the target 
and the reference gene were verified. The amplification efficiency (E) of the 
target and the reference gene was calculated from the slope of the standard 
curve using the MxPro QPCR software version 4.01 (Agilent Technologies, 
Wilmington, United States) with the built in formula:
E = 10-1/slope
The amplification efficiency was presented as a percentage based on the 
equation:
% Efficiency = (E -  1) x 100%
Once it was established that the amplification efficiencies of the target 
and reference genes were similar and near to 100%, the relative difference in 
expression level of the target gene in different samples was determined after 
simultaneous amplification using the steps described below (Livak and 
Schmittgen, 2001):
First, Ct (Cycle threshold) of the target gene was normalised to that of the 
reference (ref) gene (18S), for both the test sample and the calibrator sample: 
ACt(test) = Ct(target, test) -  Ct(ref, test)
ACt(calibrator) = Ct(target, calibrator) -  Ct(ref, calibrator)
Second, the ACt of the test sample was normalised to the ACt of the calibrator:
AACt = ACt(test) -  ACt(calibrator)
Finally, the expression ratio was calculated:
2 -AAct _ Normalized expression ratio 
All the relative normalisation steps were carried out automatically using the 
formulae generated in Excel (Microsoft Excel 2007, Seattle, United States). The 
standard error of the relative quantification values were calculated on the
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average relative quantification values of the biological replicates in GraphPad 
Prism 5 software (GraphPad Software Incorporated, California, United States).
2.4.6. 18S rRNA TaqMan qPCR
Endogenous controls must have a constant RNA transcription level under 
different experimental conditions and be abundant across different cell types 
(Nolan et al., 2006). The eukaryotic 18S ribosomal RNA (rRNA), which makes up 
greater than 80% of total cellular RNA, has been widely used to normalize 
expression. Studies have shown that it is a reliable reference gene for total RNA 
mass, had the least variability among the genes tested and is specifically 
suitable for horses (Lossos et al., 2003; Ahmed Abdel-Gawad, 2007; Capelli et 
al., 2008).
The use of the 18S rRNA gene was evaluated to ensure its similarity 
between the different stages of DC differentiation and activation. Serial dilutions 
to generate a standard curve were used to determine the sensitivity of the 18S 
TaqMan assay across all cell types. Serial dilutions of 1/10 of the target cDNA 
were performed, assays conducted on the Stratagene Mx3005P thermal cycler 
(Agilent Technologies, Wilmington, United States) and data analyzed with the 
MxPro QPCR software version 4.01 (Agilent Technologies, Wilmington, United 
States). A standard curve of Ct values obtained during amplification of each 
dilution against the quantity of template was generated from the software. The 
gradient of the linear regression line (optimal range of -3.6 to -3.1), the 
coefficient of determination, R^  (optimal range of 0.980 to 1.000) and the 
amplification efficiency, E (optimal range of 90% to 105%) were all used to 
assess assay optimization (Stratagene, 2004). The gradient of the standard 
curve represents the number of cycles between the fluorescence threshold of 
dilutions or the difference between Ct values obtained for each dilution 
(Stratagene, 2004). The R^  value of the standard curve represents the linearity
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of the data and gives a measure of the variability across replicates. The closer 
is to 1.000 means no significant difference is observed in the Ct values between 
replicates. The amplification efficiency was automatically calculated from the 
gradient of the standard curve (Stratagene, 2004).
The data from the standard curves of 18S rRNA in myeloid cells showed 
that the gradients, R^  and % E were all within the optimal ranges (Table 2.3). 
Since the amplification efficiencies were similar between Mo, IMoDC and mMoDC, 
18S rRNA was stable and the assay optimal across these different cells. Hence, 
the 18S gene was used as a normaliser in all downstream qPCR assays, which 
employed the method. The eukaryotic 18S rRNA control was supplied as a 
kit (Applied Biosystems, California, United States) which contained a 20X stock 
concentration of limited primers at 3 pM and probe, labelled with VIC reporter 
dye and the quencher MGB (Minor groove binding), at 5 pM. This 18S rRNA mix 
was already optimised for singleplex or multiplex qPCR reactions with an optimal 
annealing temperature of 60°C. The 18S rRNA TaqMan qPCR reaction mix 
consisted of a 5X QuantiTect PCR buffer, IX  18S primer-probe mix, 50 ng/pl 
cDNA and nuclease-free water to a final reaction volume of 25 pi. The QuantiTect 
PCR buffer contained DNA polymerase, dNTPs and ROX reference dye. The ROX 
reference dye is composed of a glycine conjugate of 5-carboxy-X-rhodamine, 
succinimidyl ester and was used to normalise the VIC signal. The IX  working 
stock of the 18S rRNA contained 250 nM of probes and 150 nM per primer. All 
assays were performed in triplicate. The qPCR cycling conditions for this assay 
was 95°C for 10 minutes and 40 cycles of 95°C for 30 seconds followed by 60°C 
for 1 minute.
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Table 2.3. Efficiency of the TaqMan and SYBR Green qPCR assays.
Standard curves for all target assays were based on 10-fold serial dilutions of 
cDNA. The amplification efficiencies (E) for all targets were between 90 to 105%. 
The R^  values, which indicated the linearity of the data, were close or equal to 
1.000. The gradients of the standard curves were within the acceptable range of 
-3.6 to -3.1. The amplification efficiency of 18S was similar between Mo, IMoDC 
and mMoDC.
Targets %E R^ Gradient
18S_Mo 1 0 0 .0 1 .0 0 0 -3.320
I 8 SJM 0 DC 101.3 1 .0 0 0 -3.290
18S_mMoDC 97.1 0.990 -3.390
US Bucyrus velogenic 1 0 0 .0 1 .0 0 0 -3.320
US Bucyrus attenuated 1 0 1 .2 1 .0 0 0 -3.290
UKl 100.5 1 .0 0 0 -3.322
EEV 1 0 0 .1 0.998 -3.319
18S_PBMC 101.3 1 .0 0 0 -3.290
PD-L1/CD274 1 0 0 .0 1 .0 0 0 -3.320
PD-L2/CD273 101.3 1 .0 0 0 -3.290
ICOS-L/CD275 1 0 0 .2 1 .0 0 0 -3.316
B7-H3/CD276 96.1 0.988 -3.419
IL-10 100.5 1 .0 0 0 -3.340
IL-29 1 0 0 .2 1 .0 0 0 -3.316
2.4.7. EAV ORFl TaqMan qPCR
An ORFl real-time TaqMan quantitative PCR (qPCR) was developed at 
AHVLA for the detection of EAV (Fazal, 2010). I t  was further assessed for its 
ability to detect all strains investigated in this thesis and used to determine the 
relative detection of EAV in Mo and MoDC. This assay detected the expression of 
the replicase gene ORFl (Chapter 1, Figure 1.2). The primer and probe
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sequences for this assay are shown in Table 2.4. The detection of virus was 
carried out relative to the eukaryotic 18S rRNA to control for sample-to-sample 
variation (Wu et al., 2011).
The EAV qPCR assay employed a sequence-specific, fluorescently labelled 
oligonucleotide TaqMan probe in addition to the sequence-specific primers. The 
TaqMan assay exploited the 5'-exonuclease activity of the thermostable Taq 
polymerase. The EAV probe contained a fluorescent reporter at the 5' end (6- 
carboxyfluorescein -  FAM, which emits green fluorescence) and a quencher at 
the 3' end (BlackBerry Quencher -  BBQ). When the probe was intact, the 
fluorescence of the reporter was quenched due to its proximity to the quencher. 
During the combined annealing/extension step of the amplification reaction, the 
probe hybridised to the target and the dsDNA-specific 5' to 3' exonuclease 
activity of Taq cleaved off the reporter. As a result, the reporter was separated 
from the quencher, and the resulting fluorescence signal was proportional to the 
amount of amplified product in the sample.
Table 2.4. Primer and probe sequences used to detect EAV and EEV. EAV
TaqMan qPCR detects the replicase open reading frame 1 (ORFl) of the virus 
genome. EEV Sybr green qPCR detects the non-structural protein NS3 of the 
virus genome. Sequences were designed in Primer3 version 0.4.0 from 
unpublished virus genome sequence data"”.
Virus Genome region Primer and probe sequence 5' -^3'
EAV ORFl
EEV NS3
TAGCCATTGAAGAGGCAAGT = 
GGCAAAAGTTTTAACCAGCA 
6FAM-GACCACGCGTCTGCTAAGCG-BBQ 
GCGGCI I I I IGTATATGTGC ® 
GTCGCATTTGGGTTTGATCT ^
a. forward primer sequence; b. reverse primer sequence and c. probe sequence 
*  The virus sequences were made available by D. Westcott of the Animal Health and 
Veterinary Laboratories Agency.
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The sensitivity of the EAV ORFl assay was evaluated as described in 
section 2.4.6. The gradients of the standard curves, R^  and %E obtained for all 
strains were within the acceptable ranges (Table 2.3). The melting curve 
analysis, described in section 2.4.8, of the primer pair targeting all strains 
investigated in this study, showed a single peak of the target with no unspecific 
products (Appendix III) . This demonstrated the specificity of the assay. The 
detection lim it of the ORFl assay is 10 TCIDso/reaction for all strains.
The amplification efficiencies of the EAV ORFl and 18S genes were close 
to 100% and within 5% of each other (Table 2.3), which fulfilled the assumption 
of the Livak method (section 2.4.5). Hence, the relative detection of the EAV 
ORFl gene was analysed using the 2'^^^ (Livak) method. These assays were 
robust and reproducible with good primer design, the absence of inhibitors and 
optimal reaction conditions. In this approach, equivalent amounts of sample 
cDNA were compared and normalised to the 18S rRNA control. Normalisation 
controlled for inter-sample variation such as RNA preparation and quality, 
reverse transcription efficiency, pipetting errors and differences in cell numbers 
between various treatments. RNA extracted from myeloid cells (section 2.4.2) 
were first reverse transcribed to complementary DNA (cDNA) using random 
hexamer primers in a separate reaction (section 2.4.4) and this cDNA was used 
in the TaqMan assays. RNA extracted from supernatants of infected EEL (section 
2.4.1), the cell line in which all strains were propagated (section 2.2.3), was 
used as the positive control in all assays. Other controls such as no template 
controls (NTC) and no reverse transcriptase (No RT) were included in the 
optimisation assays and all downstream assays. The master mix was prepared 
using the QuantiTect Virus Rox Vial Kit (Qiagen, West Sussex, United Kingdom). 
An ORFl qPCR reaction mix consisted of a 5X QuantiTect PCR buffer (section
2.4.6), 400 nM each of the forward primer EAVQ2F and the reverse primer 
EAVQ2R (Metabion International AG, Martinsried, Germany), 5 pM of the probe
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EAVQ2P (Metabion International AG, Martinsried, Germany), 50 ng/pl of cDNA 
and nuclease-free water (Qiagen, West Sussex, United Kingdom) to a final 
reaction volume of 25 pi. Both the EAV ORFl and 18S TaqMan assays were run 
in parallel as singleplex reactions. The ORFl TaqMan qPCR reaction mix and the 
cycling conditions for both assays were as described in section 2.4.6. The 
baseline threshold in the Livak method is always 1 since the calibrator (0 hour 
post infection in this assay) has a relative quantification value of 1 and all 
samples are compared to the calibrator.
2.4.8. EEV Sybr Green qPCR
The EEV SYBR Green qPCR was developed in this project for detection of 
the non-structural protein NS3 gene. SYBR Green is a DNA-binding dye that 
binds non-specifically to dsDNA. It exhibits little fluorescence when free in 
solution and increased fluorescence up to 1000-fold when bound to dsDNA. 
Hence, the amount of dsDNA present in a sample is directly proportional to the 
overall fluorescent signal and Increases as the target is amplified. Four primer 
pairs were designed from the NS3 sequence data available (D. Westcott, 
unpublished data, 2010) using the Primer3 version 0.4.0 online software (Rozen 
and Skaletsky, 2000). The primer pair that resulted in the lowest cycle threshold 
(Ct) value and gave one specific peak in the melting curve was selected for the 
assay. The sequence of this primer pair is shown in Table 2.4.
The SYBR Green Real Time PCR Kit (Life Technologies-Invitrogen, Paisley, 
United Kingdom) was used for primer optimization and preparation of the master 
mix. The ideal forward and reverse primer concentrations were 400 nM each, 
after testing a range of concentrations from 100 pM to 600 pM. The primer pair 
was designed to have an optimal annealing temperature of 60°C. Controls such 
as NTC and No RT were included in all optimisation and downstream assays. The 
optimized qPCR assay consisted of the 2X SYBR Green master mix containing
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buffer, DNA polymerase, dNTPs and SYBR Green dye, IX  reference dye ROX 
(Qiagen, West Sussex, United Kingdom), 400 nM of both the forward primer 
(EEVf2) and reverse primer (EEVr2) (Metabion International AG, Martinsried, 
Germany), 50 ng/pl cDNA and of nuclease-free water (Qiagen, West Sussex, 
United Kingdom) to a final reaction volume of 25 pi. All assays were performed 
in triplicate. The cycling conditions included a PCR thermal profile with an initial 
dénaturation step at 95°C for 10 minutes, amplification of cDNA with 40 cycles of 
95°C for 30 seconds, 60°C for 1 minute and 72°C for 1 minute. The detection 
lim it of this optimised EEV NS3 SYBR Green assay is 10 TCIDso/reaction.
This assay has a melting curve generated by monitoring the fluorescent 
signal across a temperature range recording small increases in temperature. The 
fluorescence decreased as a result of the dénaturation of dsDNA in the reaction. 
This negative first derivative of the change in fluorescence was plotted as a 
function of temperature (-d(RFU)/dT) and at the amplicon's melting temperature 
(Tm, the temperature at which 50% of the base pairs of a DNA duplex are 
separated) produced a characteristic peak which distinguished it from other 
potential products, hence indicating assay specificity. The standard melting curve 
analysis was performed at 95°C for 1 minute, 55°C for 30 seconds and 95°C for 
30 seconds. The EEV SYBR Green assay is specific as shown by the melting curve 
(Appendix IV).
The sensitivity of the EEV SYBR Green assay was assessed from the 
gradient of the line, R^  and E generated from the standard curve (section 2.4.6), 
by preparing 10-fold serial dilutions of the template with a known viral 
TCIDso/ml. The gradient of the linear regression line, R^  and the %E were within 
the acceptable ranges (Table 2.3). The relative detection of EEV in myeloid cells 
was carried out as described for EAV (section 2.4.7). It must be noted that 
although the EEV and 18S rRNA detection assays involved different technologies, 
the two assays can be compared due to their robust specificities and similar
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amplification efficiencies, which were dose to 100% and within 5% of each 
other. The latter fulfilled the criteria for use of the Livak method to caicuiate the 
reiative detection of the NS3 gene. However, as the 18S assay was TaqMan 
based it couid not be carried out as a duplex reaction with the EEV SYBR Green 
assay, but had to be carried out in paraliel.
2 .4.9. Costimulatory molecules and cytokines TaqMan qPCR assays
A selected set of co-stimulatory genes (PDL1/CD274, PDL2/CD273, 
ICOSL/CD275, B7-H3/CD276) was used to compare the results of microarray 
and qPCR as well as to provide insight into moiecules not represented on the 
array. Equine specific primers and probes were designed with the Primer3 
version 0.4.0 and the sequences shown in Tabie 2.5. These assays were 
developed using RNA extracted from PBMC stimulated with ConA for 24 hours, 
which ensured expression of genes for assay optimization and for use as a 
positive controi in downstream assays. Ali assays were optimised as duplex 
reactions with 18S as the endogenous control (section 2.4.6). I t  was important 
to ensure the best combination of primer and probe concentrations for 18S and 
the target molecules, since the 185 couid otherwise overtake nucleotides in the 
PCR reaction resuiting in the loss of signal for the target molecule. To prevent 
this, the commercialiy avaiiabie 185 kit was supplied in limited primer 
concentration (section 2.4.6). The optimal primer concentrations were 
determined as described in section 2.4.8 and the primers were designed to have 
optimal annealing temperatures of 60°C. The assays were shown to be specific 
from the single peaks of the melting curves anaiysed by 5YBR Green technoiogy 
(Appendix V; section 2.4.8). The amplification efficiencies were carried out as 
described before in section 2.4.6. The duplex TaqMan assays of the 
costimulatory molecules and 185 in activated PBMC were shown to be efficient 
from the gradients of the linear regression lines, R^  values and the %
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amplification efficiencies (E), which were all within their acceptable ranges (Table
2.3). These optimised assays can detect at ieast 10 copies per reaction.
Relative quantification using the (Livak) method was used to assess 
the fold change of the costimulatory molecules in Mo and MoDC (section 2.4.5). 
Synthesis of cDNA from RNA of myeloid ceiis was performed using the 
Superscript I I  First-Strand Synthesis System with random hexamer primers as 
described previously (section 2.4.4). Real-time qPCR was performed in tripiicate 
each with a 25 pL final reaction voiume containing 400 nM of each primer, 1 ^M 
of probe and 5x Quantitect PCR Master Mix with ROX reference dye (section
2.4.6). The 18S gene was used as the endogenous controi for normalisation of 
all samples (section 2.4.6) and the mock infected cells as the calibrator. The 
thermal profile consisted of a dénaturation step at 95 °C for 10 minutes followed 
by 40 cycles at 95°C for 15 s and 60°C for 1 minute. Singlepiex assays for 18S 
and target molecules were included to test the efficiency of all duplex reactions. 
Activated PBMC were included in ail assays as a positive control.
Cytokine anaiysis was performed on infected Mo and MoDC. The cytokines 
anaiyzed were interleukin-10 (IL-10) and interleukin-29 (IL-29). Equine specific 
primers were designed with the Primer3 version 0.4.0 and the primer/probe 
sequences are shown in Tabie 2.5. The protocol for qPCR assays and data 
analysis is as described above for the costimulatory molecules. The amplification 
efficiency of the 18S rRNA TaqMan qPCR was similar to that of IL-10 and IL-29 
TaqMan qPCR assays (Table 2.3). The specificity of both assays was shown from 
the single peak of the melting curves anaiysed by SYBR Green technology 
(Appendix VI).
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Table 2.5. Primer and probe sequences of costimulatory molecules and 
cytokines. These primers and probes were used to measure changes in gene 
expression of the costimulatory molecules and cytokines in eqMoDC.
Genes Primer and probe sequence 5' ->3' GenBank Accession #
PD-Ll/ TGGTGGTGCTGACTACAAGC ^ XM_001492842
CD274 GTGGTCACTGCTTGTCCAGA
6FAM-ATTTCTGTGGATCCGGTCAC-BHQ-1
Primer3 version 0.4.0
PD-L2/ CTTTGGATGACCCAGCACTT ^ XM_001492097
CD273 AAGGAGCCTCAGGACACTCA
6FAM-TGTGCTCAAAGGAAGTCAGGC-BHQ-1
Primer3 version 0.4.0
ICOSL/ TCCAAGGCCGAATGTCTACT = NC_009169
CD275 GCACGTTCTCTATGCAGCAG 
6FAM-TCAACAAGACGGACAACAGC -BHQ-1^
Primer3 version 0.4.0
B7-H3/ AATCAGACCATCCAGCGTGT = XM_001493661
CD276 GAGGCAGAACCACAGCACTC
FAM-GAGAGCCAGCTGTCAGCTG-BHQ-1
Primer3 version 0.4.0
IL-10* GACATCAAGGAGCACGTGAAC TC^
CAGGGCAGAAATCGATGACA
FAM-AGCCTCACTCGGAGGGTCTTCAGCTT-BHQ-1
U38200 
Fiaminio et ai., 2007
C
IL-29 GGCAGGTTCCAATCTCTGTC  ^
CAGCGTCAGGTGTAGCTCAG 
6FAM-TCTTCCCCATGACCAGAGAC-BHQ-1 ^
XM_001501189 
Primer3 version 0.40
a. forward primer sequence; b. reverse primer sequence and c. probe sequence 
*  represents the primer and probe sequences taken from the literature.
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2.4.10. M icroarray
The Agilent Horse Gene Expression Microarray (Agilent Design ID 021322) 
(Agilent Technologies, Wilmington, United States) was used to measure the 
expression levels of large number of genes simultaneously. The horse array was 
manufactured using the Agilent SurePrint inkjet technoiogy. This in situ synthesis 
printing process prints 60-m er length oligonucleotide probes base-by-base (5 '- 
to -3 ' direction) from digital sequence files. The process is very precise and high 
coupling efficiencies are maintained by phosphoramidite chemistry. The array 
contained 4 identical arrays on each slide (also referred to as subarrays) and 
each subarray contained 43,803 probes representing the equine transcriptome 
and a number of control probes (Figure 2 .3 ). Each probe corresponds to a 
particular horse RNA. However, some genes were represented by 5 or 6 replicate 
probes. The composition of genes was sourced from the following databases: 
RefSeq (Release 30), July 2008; UniGene (Build 9 ), April 2008; UCSC mRNA, 
August 2008; EnsembI (Release 50), July 2008 and UCSC equCabl, January 
2007. Microarray experiments were performed following the Agilent one-colour 
gene expression system.
Figure 2.3. Im age of the Agilent Horse Gene Expression Microarray 4 x 
44k format after processing and scanning. There are four subarrays, each 
representing 43,803 probes.
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2.4 .10 .1 . Sample preparation and labelling
Agilent's Low input quick amp labelling kit (Agilent Technologies, 
Wilmington, United States) was used for sample preparation and labelling. This 
kit allows the use of low sample input RNA between 10 ng and 200 ng. This 
protocol converts sample RNA into cDNA using reverse transcriptase and an oligo 
dT-promoter primer. The cDNA is further transcribed to fiuorescentiy labelled 
complementary RNA (cRNA) using T7 RNA polymerase to simultaneously amplify 
target material and incorporate cyanine 3-CTP (Cy3-CTP). Amplification is 
typically at least 100-fold from the total RNA to cRNA.
For the one-colour processing total target RNA of 90 ng/1.5 pi was mixed 
with 2 pi of diluted RNA spike-in control (Agilent Technologies, Wilmington, 
United States) to which 1.8 pi of the T7 promoter primer was added, then 
incubated at 65°C for 10 minutes. This sample mix was immediately placed on 
ice for 5 minutes. The spike-in mix contained ten in vitro synthesised, 
polyadenylated transcripts in predetermined ratios constructed by cloning of a 
55-mer sequence into the human adenovirus type 6 ElA 13S gene. The cDNA 
master mix was prepared as follows: 5X first strand buffer, 0.1 M DTT, 10 mM 
dNTPs and Affinity Script RNase block mix (which is a blend of enzymes) in a total 
volume of 4.7 pi. The cDNA master mix was added to the sample mix and 
incubated for 2 hours at 40°C followed by incubation at 70°C for 15 minutes. The 
mix was moved to ice and incubated for 5 minutes. The transcription master mix 
was prepared as follows: nuclease-free water, 5x transcription buffer, 0.1 M DTT, 
10 mM dNTPs, T7 RNA polymerase and Cy3-CTP in a total volume of 6 pi. This 
transcription master mix was added to the sample mix and incubated for 4 hours 
at 40°C.
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2.4 .10 .2 . Purification o f  am plified  and labelled cRNA
The RNeasy mini spin columns (Qiagen, West Sussex, United Kingdom) 
were used for purification of the amplified cRNA as in section 2.4.2. Nuclease- 
free water at 84 pi was added to 16 pi the cRNA sample followed by 350 pi of 
lysis buffer and 250 pi of > 99.5% ethanol. The cRNA sample was transferred to 
the spin column and centrifuged at 16,200 xg for 30 seconds at 4°C. The cRNA 
was washed in two steps using the same buffer to remove any contaminants. 
The first washing step was centrifuged at 16,200 xg for 30 seconds at 4°C and 
the second wash at 16,200 xg for 60 seconds at 4°C. RNA was eluted in 30 pi of 
RNase-free water by centrifugation at 16,200 xg for 30 seconds at 4°C.
2.4 .10 .3 . CRN A quantifica tion and hybrid ization
The cRNA was quantified using the Nanodrop 2000 Spectrophotometer 
(section 2.4.3). The cRNA yield and specific activity were determined using the 
following equations:
pg cRNA yield = concentration of cRNA (ng/pl) x 30 pi (elution volume)/1000 
pmoi Cy3 per pg cRNA = concentration of Cy3 (pmol/pl)/concentration of cRNA
(ng/pi) X 1000
For each microarray hybridized, the hybridization sample was prepared using the 
Gene Expression Hybridization Kit (Agilent Technologies, Wilmington, United 
States) as follows: 1.65 pg of Cy3 labelled cRNA, 11 pi of lOX blocking agent, 
2.2 pi of 25X fragmentation buffer and the volume brought to 52.8 pi with 
nuclease-free water. The sample was incubated at 60°C for 30 minutes to 
fragment the RNA and immediately cooled on ice for 1 minute, followed by the 
addition of 55 pi of the 2X G EX hybridization buffer to stop the fragmentation 
reaction. The array slides were placed in the hybridization assembly (Agilent 
Technologies, Wilmington, United States). On each subarray 100 pi of sample 
was loaded and hybridized at 65°C for 17 hours in a hybridization chamber
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(Agilent Technologies, Wilmington, United States). The degree of hybridisation 
between the spike-ins and the control probes was used to normalise the 
hybridisation measurements for the target probes.
After hybridization the array slides were disassembled in gene expression 
wash buffer 1 containing 0.005% Triton X-102 (Agilent Technologies, 
Wilmington, United States) and washed on a magnetic stir plate for 1 minute. 
The slides were then washed with pre-warmed (37®C) wash buffer 2 containing 
0.005% Triton X-102 (Agilent Technologies, Wilmington, United States) for 1 
minute on a magnetic stir plate. Triton X-102 reduced the possibility of array 
wash artefacts. The washing step removed non-specific bonding sequences while 
the strongly paired strands remained hybridized. They were then air-dried after 
briefly submerging in drying solution (Sigma-Aidrich Company Limited, Dorset, 
United Kingdom) and transferred to the slide holder for processing in the Agilent 
High-resolution C Microarray Scanner (Agilent Technologies, Wilmington, United 
States).
2.4.10.4 . M icroarray data analysis
Fiuorescentiy labelled target sequences bound to a probe sequence 
generated a signal strength, which depended upon the amount of target sample 
bound to the probes present on that spot. The arrays were scanned and the raw 
data extracted with Agilent's Feature extraction software (Agilent Technologies, 
Wilmington, United States). Data quality was assessed by the specific quality 
control reports of metrics targeted to the experiment. These included the feature 
extraction project analysis which informed about processing artefacts and 
replicate microarray outliers, analysis of the effect specific variables, such as 
wet-1 ab protocols, had on processing performance and analysis of background 
signals. For each subarray, the spatial distribution of outliers and the net signals 
of the spike in controls and non-control probes were assessed.
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All microarray data were analysed (Stekel, 2003) using GeneSpring GX 
software version 11.5.1 (Agiient Technologies, Wilmington, United States). The 
raw data was pre-processed by logz transformation followed by scale 
normalization. The parametric statistical test of AN OVA unequal variance (Welch 
AN OVA) was used to test differential expression between Mo and iMoDC (where 
Mo were used as the reference) and differential expression between iMoDC and 
mMoDC (where IMoDC were used as the reference). Bènjamini Hochberg test 
was used to correct for multiple testing (false discovery rate of 0.05). The 
threshold of significance was set to a minimum fold change of 2. Unsupervised 
hierarchial clustering on both probes and ceil types was performed to identify 
patterns within the datasets using the Eucidean similarity metric and Hierarchial 
clustering algorithm method with the Centroid linkage rule. The output 
differential gene expression lists were curated by eliminating ail un-annotated 
EST sequences. The average fold change was determined for repeat probes. The 
gene symbols were assigned to each probe based on the Agilent description of 
each probe. Principal component anaiysis (RCA) was performed on the curated 
differential expression gene lists to assess differences in expression profiles 
between ceil types.
2.5. Statistical Analysis
Statistical analysis was performed using GraphPad Prism 5 software. The 
average mean of independent experiments were represented as ± standard error 
mean (SEM). Statistical significance was determined using a two-taiied paired 
Student t  test (Zimmerman, 1997) with Bonferroni post test for single 
comparisons and either a 1 way analysis of variance (ANOVA) with Dunn's 
multiple comparison test or 2 way ANOVA with Bonferroni post test to compare 
replicate means of grouped data sets (Box, 1953).
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3.1. Introduction
Dendritic cells (DC) are the main immune regulators. placed at the 
interface of innate and adaptive immunity. As described in chapter 1, they 
function as antigen presenting cells (APC) and are the only cells with the ability 
to induce a primary immune response in naïve T lymphocytes (Steinman, 1991; 
Banchereau and Steinman, 1998). In vitro DC systems can be used as models to 
better understand host-pathogen interactions, for vaccine development and 
eventually to aid therapeutic protocols.
Myeloid DC can be differentiated from peripheral blood monocytes (Mo) 
when cultured with cytokines granuiocyte-macrophage colony stimulating factor 
(GM-CSF) and interieukin-4 (IL-4) (Sailusto and Lanzavecchia, 1994; Peters et 
al., 1996). The resulting cells are then referred to as monocyte-derived DC 
(MoDC) (Steinbach et al., 1995; Peters et al., 1996). Like DC in vivo. Mo are first 
differentiated into immature (iDC) which are activated to mature DC (mDC) in 
the presence of inflammatory signals (Sailusto and Lanzavecchia, 1994; Thery 
and Amigorena, 2001). Recent advances in DC biology have highlighted the 
heterogeneity of DC in vivo and in vitro. In this context it has been suggested 
that MoDC resemble inflammatory DC in vivo (Geissmann et al., 2010). A recent 
study has demonstrated that MoDC when compared to classical DC, can 
substitute for all important DC functions such as stimulating T lymphocyte 
proliferation in in vitro mixed leukocyte reactions (MLR), presenting protein 
antigens and cross-presentation (Cheong et ai., 2010). Thus, MoDC represent an 
appropriate model for myeloid DC.
Compared to humans or mice, the MoDC system of veterinary animals 
has not been well characterised, but previous studies have shown that MoDC 
could be generated in various species including pig, cattle, dogs and horses 
(Howard et al., 1999; Carrasco et al., 2001; Paillot et al., 2001; Mauel et al., 
2006; Wang et al., 2007b; Cavatorta et al., 2009) as discussed in chapter 1.
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However, previous studies failed to demonstrate the clear distinction between 
immature and mature DC described in humans.
In horses, DC were previously demonstrated in peripheral blood and 
generated from monocytes (Mauel et al., 2006; Cavatorta et al., 2009). In this 
study, the establishment and characterisation of in v/tro equine MoDC (eqMoDC) 
gave insight into the biology of eqDC. The morphological, phenotypic and 
functional attributes of this MoDC system allowed for a better understanding into 
the differentiation and activation states of eqDC. The challenge faced in studying 
a novel species such as the horse, is the lack of available monoclonal antibodies. 
Therefore, transcriptomic analysis using microarray technology was employed to 
determine the expression of a broad range of markers for which monoclonal 
antibodies were not available and to analyse the changes in gene expression 
profiles between the differentiation and activation states of DC.
Due to the importance costimuiatory molecules, such as programme cell 
death ligand-1 (PD-L1/CD274), programme cell death ligand-2 (PD-L2/CD273), 
inducible costimulator ligand (ICOS-L/CD275) and B7-H3, play in the 
development of an effective immune response (Collins et al., 2005), the 
expression profiles of these markers were assessed in IMoDC and mMoDC using 
microarray and quantitative real-time PCR. This study demonstrated clear 
differences in phenotype, function and gene expression between eqMoDC 
differentiation and activation states.
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3.2. Results
3.2.1. Characterisation of equine monocytes
3.2.1 .1 . Monocyte p u r ity
To establish an in vitro MoDC system, it was important to start with a 
pure Mo population. Previous studies on the generation of eqMoDC used the 
adherence method for Mo isolation, which exploits their ability to adhere to glass 
or plastic. This method involved culturing PBMC for 1 hour or more to allow 
attachment of Mo, followed by washing cells to remove the non-adherent 
lymphocytes (Mauel et al., 2006; Cavatorta et al., 2009). I t  is comparatively 
easy but can induce cell activation and results in contamination of > 10% non- 
monocytic cells (Fuhlbrigge et al., 1987; Haskill et al., 1988; Wahl and Smith, 
1997). A previous study showed great phenotypic variation of eqMoDC derived 
from Mo isolated by two Ficoll gradients (densities 1.09 and 1.077 g/m l) and 
adherence (Mauel et al., 2006). Other studies used one Ficoil gradient (density 
1.077 g/mi) followed by either adherence (Cavatorta et al., 2009) or magnetic 
separation (Steinbach et ai., 2009). In this study. Mo isolation was performed by 
expanding technologies previously used for eqMo. This method comprised 
centrifugation with two Ficoli gradients followed by magnetic separation with 
magnetic microbeads coupled to CD14 antibodies. This combination of 
technologies was not previously explored for eqMo isolation.
The isolation of equine PBMC with two Ficoli gradients showed distinct Mo 
and lymphocyte populations (Figure 3.1a). Fragments of cellular debris were 
excluded from all downstream gating as they can influence accurate flow 
cytometric anaiysis. As CD14 is considered a marker of Mo, PBMC were assessed 
to identify the mean percentage of CD 14"*^  cells, which was 14.6% ± 4.6 (Figure 
3.1b). The CD14^ cells in Figure 3.1b were back gated on the PBMC population in 
Figure 3.1a. Back gating is the gating on populations in one plot followed by the
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examination of other piots to identify the position of those populations. Figure 
3.1c shows that the CD14^ cells have the same position as Mo on the iight side 
scatter gates. Both populations were positioned between 250 and 700 for both 
cell size and granularity (Figures 3.1a and c). Therefore, CD14^ PBMC seem to 
be Mo and there is no indication that neutrophils carry this marker.
The Mo isolation by magnetic separation resulted in a high mean 
percentage ceil purity of 96.4% ± 2.1 and minimal contamination of non- 
monocytic cells or lymphocytes shown by the low percent of cells at 2.6% ± 1.6 
(Figure 3.Id ). The low contamination reduced influences on the differentiation 
and activation of MoDC (section 3.2.2). On the light scatter gates, there is the 
regular occurrence of a population with 2.1% ± 1.2 cells, which is larger in size 
(between 600 and 1000) and granularity (between 350 and 650), compared to 
the population with 94.3% ± 0.2 ceils, which is smaller in size (between 250 and 
600) and granularity (between 180 and 350). Staining of the magnetically 
isolated cells with CD14 confirmed that 97.1% ± 2.7 are indeed Mo (Figure 
3 .le ). There is the presence of a CD14^ '®'^  and CD14'°'^ population which will be 
discussed further in section 3.2.1.2. The 2.1% ± 1.2 population of larger cells, is 
also CD14 '^®  ^and CD 14'°'^ (Figure 3 .le ). As a result, it is believed that these cells 
are Mo and not granulocytes. Therefore, eqMo are heterogenous but the larger 
size and granularity could just resemble duplets.
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Figure 3.1. Flow cytometric dot plots of CD14^ Mo purity, (a ) Horse PBMC 
were separated from whole blood by double Ficoll density centrifugation (section
2.1.3). Plot of SSC-A (cell granularity) versus FSC-A (cell size) shows the 
different cell populations comprising PBMC which are Mo and lymphocytes 
labelled in blue. The gate excludes debris from PBMC. (b ) PBMC were stained 
with CD14 conjugated to the fluorochrome Zenon APC*. Approximately, 14.6% ± 
4.6 of PBMC are CD14 positive (CD14^). (c) The CD14^ PBMC population was 
back gated onto the PBMC population and classified as Mo from the SSC-A 
versus FSC-A plot, (d ) The CD14^ Mo were isolated from PBMC by magnetic 
separation (section 2.1.3). The mean percentage Mo purity was 96.4% ±2.1 and 
the mean percentage contaminated lymphocytes was 2.6% ± 1.6. There are two 
populations that differ in size and granularity, (e ) Magnetically isolated CD14^ 
Mo were stained with the secondary antibody IgGl-APC*, which confirmed that 
the Mo isolated are CD14'*" with high and low populations. The percentages of 
cells in quadrants of the dot plots are shown as mean ± SEM (n=6).
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3.2.1.2 . Equine blood Mo subsets characterised by  the expression o f  
CD 14 and CD 163
For the phenotypic assessment of equine blood eqMo, dead and duplex 
cells were excluded from all flow cytometric analysis (section 2.3.3; Figures 3.2ai 
and aii). The phenotype of eqMo was assessed by single and multicolour staining 
of PBMC with the surface markers CD14, CD163 and CD172a/MyD-l, all 
conjugated to flourochromes via the zenbn labelling kit (section 2.3.4). Attempts 
were made to use sorted Mo by indirectly labelling the CD14 antibody with the 
secondary IgG l APC* conjugated antibody, followed by staining cells with 
CD163-Vioblue and CD172a-PE. This method resulted in. the occurrence of 
artificial subpopulations and warranted the use of CD14^ cells in PBMC (Figure 
3.2aiii), which are Mo as established in section 3.2.1.1. The subpopulations that 
exist in this isolated population were identified.
Single colour staining revealed that all Mo are CD14^ with high (36.6%)
and low (63.2%) populations (Figure 3.2bi). Figure 3.2bii shows that the 
expression of CD163 on Mo is such that 56.9% are CD163^ and 43.1% CD163'. 
CD172a was expressed on 99.4% of Mo (Figure 3.2biii). There is a small Mo 
population larger in cell size that is maintained throughout the single colour 
staining and its pattern of expression for these markers is similar to that 
described for the larger cell size population. Multicolour staining revealed that 
both CD14++(*''9h) and CD14+C°'') cells are CD172a+ (Figure 3.2d), all CD163+ 
cells are CD14‘^ ‘^ '^^ '®'^  ^ (Figure 3.2cii) and finally CD163^ and CD163' cells are 
CD172a^ (Figure 3.2ciii). Thus, three distinct major eqMo subpopulations were 
identified, namely CD14+'"('''9h) cD172a‘" CD163+, CD14++('"'9h) cD172a+ CD163' 
and CD14+c°'") CD172a+ CD163'.
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Figure 3.2. Flow cytometry density plots of Mo subpopulations. PBMC 
were isolated by double Ficoll density centrifugation (section 2.1.3). PBMC were 
stained with the live/dead fixable near-IR dead cell stain, Zenon FITC conjugated 
to CD14, Zenon Vioblue conjugated to CD163 and Zenon PE conjugated to 
CD172a. Staining of cells was performed and analysed as described in section 
2.3.4. (a ) Gating strategy similar to Figure 3.1, identifying all Mo as CD14^ cells, 
(b ) Single staining of surface markers, (bi) Mo are CD14^ with high (36.6%) and 
low (63.2%) populations, (bii) 56.9% of Mo express CD163. (biii) 99.4% of Mo 
are CD172a^. (c) Triple staining of surface markers, (ci) All CD14^ Mo expressed 
CD172a. (cii) All CD14++( '^9h) ,v|o are positive for CD163. (ciii) CD163+ and 
CD163' cells are CD172a+. There are three Mo subsets CD14++('''^^) CD172a+ 
CD163+, CD14++("'s'') CD172a+ CD163' and CD14+('°'^) CD172a+ CD163'. Gates 
drawn were based on unstained cells and isotype IgG l control samples. Density 
plots are representative of 4 independent repeats.
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3.2.2. Establishment of equine MoDC in vitro
3.2.2 .1 . The op tim a l cytokine concentrations fo r d iffe rentia tion
Histag purified baculovirus-derived eqGM-CSF and eqIL-4 were used to 
differentiate eqMo. This purified form ensured the exclusion of any protein 
expression or host proteins such as PAMP that can influence differentiation. The 
bioactivity of eqGM-CSF and eqIL-4 (section 2.1.1) was determined to be 8 x 10^ 
and 1 X 10^ U/ml, respectively.
In humans and mice, in vitro Mo differentiation resulted in the
downregulation of CD14 expression and the upregulation of CD206 when 
cultured in combination with GM-CSF and IL-4. To assess the optimal
concentrations of GM-CSF and IL-4 required for eqMo differentiation, cells were 
cultured independently with different concentrations of cytokines. The
percentages of cells expressing CD14 and CD206 were assessed, since induction 
of these markers have been previously shown to be dose dependent on GM-CSF 
and IL-4, respectively. I t  was indeed confirmed that a dose dependent
expression of both markers was influenced by these cytokines. An increase in the 
GM-CSF concentration increased the expression of CD14 on eqMo and a clear 
dose-response was observed between 250 U/ml and 1000 U/ml (Figure 3.3a). 
However, lower concentrations of 50 U/ml and 100 U/ml had no significant 
changes on the expression of CD14 compared to 0 U/ml or media control. Mo 
cultured in media alone showed a reduced CD14 expression after 2 days 
compared to the high CD14 expression on freshly isolated Mo (section 3.2.1). 
Due to the role of GM-CSF in inducing differentiation of myeloid lineage cells 
(Caulfield et al., 1997; Lehtonen et al., 2007) and the 5-fold increase in the 
percentage of CD14^ cells, 1000 U/ml was selected for Mo differentiation.
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Figure 3.3. Dose dependent effect of equine GM-CSF and IL -4  on the  
expression of CD14 and CD206, respectively. Peripheral blood Mo were 
cultured independently with different concentrations of GM-CSF and IL-4 for 48 
hours at 37°C. Cells were stained with CD14 indirectly labelled to IgGl-APC* or 
CD206-PE and assessed by flow cytometry (section 2.3.4). (a ) An increase in 
GM-CSF concentration increases the expression of CD14. Statistical significance 
was determined using a 1 way ANOVA with Dunn's multiple comparison test was 
used for comparisons between 0 U/ml (media alone) and other test conditions. * 
and * *  indicate significant differences between sample means where p < 0.05 
and 0.001, respectively, (b ) An increase in IL-4 concentration increases the 
expression of CD206. Data are represented as the mean percentage positive 
cells expressing either CD14 or CD206 ± SEM (n=3).
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The induction of CD206 was also dose dependent on IL-4 with an increase 
in concentration increasing the CD206 expression. However, at best only around 
half of all Mo responded to eqIL-4 with an induction of CD206 that remained 
stable above 200 U/ml (Figure 3.3b). This is in contrast to the human system 
where a lower concentration of IL-4 maximally Induced the expression of CD206 
on around % of Mo (den Dekker et al., 2008). The optimal dose of IL-4 used to 
induce differentiation of eqMoDC from eqMo was 500 U/ml. The MFI of the cell 
populations, that is the shift in fluorescence intensity of the populations relative 
to the control, were assessed and directly reflected the trends observed with the 
percentage positive cells (data not shown).
3.2.2.2 . Determ ination o f  the im m ature  MoDC state
Time kinetic experiments were performed on the differentiation whereby 
Mo were stimulated with 1000 U/ml of GM-CSF and 500 U/ml of IL-4. This 
analysis allowed for the identification of the best iMoDC state.
The morphology was assessed daily to determine at which time point the 
cells possessed the classical DC morphology of clusters with finger-like 
projections (dendrite-like structures). Figure 3.4 shows how the iMoDC 
morphology gradually evolves over time with very heterogenous cell populations. 
Clusters of cells developed and became most dense in the later stage IMoDC. 
Dendrite-like structures became more visible and showed prominence in the 
later stage IMoDC, particularly after day 4. The stretched cells observed were 
maintained during the differentiation. Thus on day 5 IMoDC resembled what was 
previously described in both human and horse DC (Sailusto and Lanzavecchia, 
1994; Mauel et al., 2006, Cavatorta et al., 2009).
The main DC markers, such as CD206, CD83, CD86 and MHC II, were 
used to assess the phenotype of IMoDC daily. The expression of CD206 increased 
substantially on day 1 IMoDC and remained constant until day 5 (Figure 3.5a). 
CD83 also increased on day 1 IMoDC. The number of cells expressing this marker
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increased further by 30% on day 2, then remaining fairly constant up to day 5 
(Figure 3.5b). The slight decrease around day 4 was not significant. The overall 
expression of CD86 on iMoDC was low but increased slightly on days 1 and 2, 
then remained fairly constant from day 2 onwards (Figure 3.5c). The expression 
of MHC II  was already high on cells initially isolated (day 0) and remained 
constant up to day 5 (Figure 3.5d). Therefore, during differentiation the 
expression of these markers remained relatively constant after 4 days. The 
trends observed for the percentage cells expressing these markers were similar 
to the MFI data (not shown).
Since the morphology and phenotype of IMoDC after 4 days were in line 
with published literature (Mauel et al., 2006; Cavatorta et al., 2009), this time 
point was selected as the best IMoDC state.
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Figure 3.5. Time kinetics of Mo differentiation. Mo were stimulated with 
1000 u/m l of GM-CSF plus 500 U/ml of IL-4 and the phenotype assessed daily 
for 5 days by flow cytometry. Day 0 cells were assessed immediately after 
stimulation. Cells were stained with (a ) CD206-PE, (b ) CD83-PE-Cy5, (c) 
CD86-PE-Cy5 and (d ) MHC I I  indirectly labelled with IgGl-APC*. Staining of cells 
was performed and analysed as described in section 2.3.4. Data are represented 
as the mean percentage positive cells expressing ± SEM (n=3).
3.2.2 .3 . Determ ination o f  the m atu re  MoDC sta te
DC maturation is phenotypically defined by the downregulation of CD206 
and the upregulation of CD83, CD86 and MHC II, as discussed in chapter 1. To 
identify the best maturation stimuli, iMoDC were activated with a range of 
maturation stimuli for 24 hours and 48 hours.
LPS or polyI:C were unable to influence any significant downregulation of 
CD206 after 24 hours and 48 hours, but the cocktail (section 2.1.5) plus IFNy 
had the most significant effect after 48 hours with the smallest percentage of 
cells expressing this marker (Figure 3.6a). The expression of CD83 on mMoDC 
was only significantly upregulated In the presence of the cocktail plus IFN-y
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and/or CD40L with no statistical difference in the number of cells expressing this 
marker between 24 hrs and 48 hrs (Figure 3.6b). The cocktail plus IFN-y and/or 
CD40L were the only stimuli that significantly upregulated the expression of 
CD86 after 24 hours and 48 hours with more cells expressing this marker after 
48 hours (Figure 3.6c). However, the cocktail in the presence of IFN-y was the 
most significant at upregulating CD86, particularly after 48 hours, compared to 
the other cocktails. The expression of MHC II was more significantly upregulated 
at 48 hours compared to 24 hours for the cocktail in combination with IFN-y 
and/or CD40L (Figure 3.6d).
The results revealed that LPS, polyI:C and both in combination were 
insufficient to drive the maturation of iMoDC. This correlates with previously 
published literature on the increased CD206 expression and decreased or 
unchanged CD83 expression upon activation (Mauel et al., 2006). As an 
alternative, it can be proposed that the cocktail plus IFNy is the most suitable to 
drive activation of eqMoDC. Hence, the cocktail plus IFNy was selected as the 
maturation stimuli as cells displayed the better phenotype compared to the 
cocktail plus CD40L. I t  was also readily available and inexpensive. The 48 hours 
incubation with the maturation factors were more effective since the number of 
cells expressing CD206 reduced and those expressing CD86 increased compared 
to the 24 hours incubation. However, the 24 hours incubation is also sufficient 
for activation. I t  must be noted that too fully assess DC maturation between 
stimuli additional assays, such as antigen uptake and presentation, is necessary 
to define function. However, in this experiment these assays were not 
conducted.
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Figure 3.6. Activation of immature MoDC with different maturation 
stimuli. Immature MoDC were stimulated with either of the following stimuli : 1 
pg/ml LPS; 20 pg/ml poly I:C; 1 pg/ml LPS plus pg/ml poly I:C; a cocktail of 20 
ng/ml eqTNF-a, 10 ng/ml eqIL-1^, 20 pg/ml eqIL-6 and 1 pg/ml PGE2; cocktail 
plus 0.5 pg/ml CD40L; cocktail plus 100 ng/ml eqlFN-y; cocktail plus 0.5 pg/ml 
CD40L and 100 ng/ml eqIFN-y. Activated MoDC were incubated at 37°C in 5% 
CO2 for 24 and 48 hours. The phenotype of mMoDC was analysed for the main 
DC markers which include CD206-PE, CD83-PE-Cy5, CD86-PE-Cy5 and MHC II 
indirectly labelled with IgGl-APC*. Staining of cells was performed and analysed 
as described in section 2.3.4. Data are represented as the mean percentage 
positive cells ± SEM (n=6). A 1 way ANOVA with Dunn's multiple comparison 
test was used for comparisons between iMoDC and other test conditions. * and 
* *  indicate significant differences between sample means where p < 0.05 and 
0.001, respectively. The significant differences highlighted in red represent 
comparisons between maturation stiumuli.
The morphology of mMoDC was assessed for 24 hrs and 48 hrs after 
activation with the cocktail plus IFNy. This revealed that the activated cells 
possessed less adherent clusters with numerous dendrite-like structures, as 
observed for iMoDC (Figure 3.7a). However, mMoDC incubated for 48 hrs 
showed much larger and very dense clusters (Figure 3.7b). Based on the 
morphologic and phenotypic data, eqMoDC activated for 48 hrs with the 
maturation cocktail plus IFN-y or CD40L represents the best mMoDC state.
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(a) Day 6 mMoDC
(b)
.4
Day 7 mMoDC
Figure 3.7. Morphology of mature MoDC. (b ) Immature MoDC were 
activated by the addition of the cocktail (containing 20 ng/ml eqTNF-a, 10 ng/ml 
eqIL-l(3, 20 ng/ml eqIL-6 and 1 pg/ml PGE2) plus 100 ng/ml eqlFN-y to the cell 
culture media and incubated at 37°C in 5% CO2 for 48hrs. The morphology of the 
activation was assessed daily and photographed with the microscope. Observe 
the loosely adherent clusters with multiple cellular projections on day 6 and the 
larger dense clusters also with cellular projections on day 7. All images were 
magnified x 20.
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3.2.3. Phenotypic characterisation of in vitro eqMoDC
3.2.3 .1 . Co-expression o f  CD83 and CD206 on eqMoDC
In contrast to studies with human DC, a previous study on eqMoDC 
demonstrated that CD206 was not necessarily expressed on all eqMoDC. Another 
intriguing finding of that study was the co-expression of CD206 and CD83 on 
iMoDC (Mauel et al., 2006), which are considered markers of differentiation and 
maturation in humans, respectively (Wollenberg et al., 2002; Klein et al., 2005; 
Weiping et al., 2005). Having determined 500 U/ml of IL-4 as an ample 
concentration for equine monocytic cells to express CD206, the kinetics of 
CD206 and CD83 expression during MoDC differentiation and activation was 
studied. Early state iMoDC quickly expressed mainly CD206 but gradually 
became double positive for CD206 and CD83. Late stage iMoDC showed CD83^ 
oniy cells prior to any activation signal (Figure 3.8a). In addition to the majority 
of CD83VCD206‘ cells, mMoDC still possessed a minor population of cells co- 
expressing both markers along with a very small percentage of cells expressing 
only CD206 (Figure 3.8b).
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Figure 3.8. Co-expression of CD206 and CD83 on equine MoDC. Mo were 
cultured in the presence of 1000 U/ml of GM-CSF and 500 U/ml of IL-4 for 5 
days then activated with the cocktail. The cells were harvested daily and stained 
with CD206-PE and CD83-PE-Cy5 for 30 minutes at 4°C and analyzed by flow 
cytometry (section 2.3.4). Stained cells were analyzed by acquiring 10,000 
events in the target gate excluding debris. The flow cytometry density plots 
show the relationship between CD206 and CD83 on (a ) iMoDC from days 0 to 5 
and (b ) mMoDC from days 6 to 7. The expression of CD206 was high on early 
stage iMoDC with cells gradually becoming double positive for CD206 and CD83. 
The late stage iMoDC and mMoDC showed an increase in CD83 expression but 
still maintaining the co-expression of CD206 and CD83. Data are representative 
of 3 independent repeats.
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3.2.3.2. Comparison o f the main DC markers between Mo and MoDC
The expression of the main DC markers, CD206, CD83, CD86 and MHC II, 
was assessed on Mo, iMoDC and mMoDC. The percentage cells expressing CD206 
dramatically increased in the immature state and reduced by 40% in the mature 
state (Figure 3.9a). CD83 was already highly expressed on iMoDC and increased 
further upon activation (Figure 3.9b). The expression of CD86 remained low on 
iMoDC and was drastically upregulated on mMoDC (Figure 3.9c). The expression 
of MHC II  mirrored that of CD83 in that it was already highly expressed on 
iMoDC and upregulated on mMoDC (Figure 3.9d). The expression of all markers 
was low on eqMo. The trends observed for the percentage positive cells directly 
reflected the MFI of these cell populations (data not shown).
3.2.4. Functional characterisation of in vitro eqMoDC
Phenotypic profiles may vary largely between DC, but equally important 
are the functional parameters which define DC as discussed in chapter 1. The 
functional assays used in this study were antigen uptake assays such as 
endocytosis and phagocytosis, mixed ieukocyte response (MLR) to assess the T 
cell stimulatory capacity, antigen presentation and cross-presentation.
3.2.4.1. Antigen uptake ability o f eqMoDC
To assess the endocytic capacity of eqMoDC, a fluorescent conjugate 
(Alexa Fluor 647 or APC*) of the protein OVA was used as the endocytic tracer. 
This is a relatively low molecular weight protein (45 kD) that is internalised by 
DC through receptor-mediated uptake using antigen specific uptake molecules 
such as CD206 and FcyR. On the other hand, FITC-conjugated carboxylate- 
modified microsphere beads were used to assess phagocytosis, which is a form 
of endocytosis.
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Figure 3.9. Phenotypic analysis of equine MoDC. Mo were stimulated with 
equine GM-CSF and IL-4 for 5 days then matured. Cells were stained with the 
live/dead fixable vioblue dead cell stain, CD206-PE, CD83-PECy5, CD86-PECy5 
and MHC II  conjugated to the zenon APC* dye. Staining of cells was performed 
and analysed as described in section 2.3.4. The bar graphs represent the 
expression of the main DC surface markers on Mo, iMoDC and mMoDC. (a ) The 
percentage cells expressing CD206 increased during differentiation but reduced 
upon maturation, (b ) CD83 showed minimal expression on Mo but was highly 
expressed on IMoDC and increased further on mMoDC. (c) The expression of 
CD86 was low on both Mo and iMoDC but increased on mMoDC. (d ) MHC I I  was 
highly expressed on IMoDC and increased further on mMoDC. Data are 
represented as the mean percentage positive cells ± SEM (n=3). A 1 way ANOVA 
with Dunn's multiple comparison test was used for comparisons between cell 
types. * and * *  indicate significant differences between sample means where p 
< 0.05 and 0.001, respectively.
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Phagocytosis has adapted to eliminate particles such as cellular debris and 
pathogens (Ishimoto et al., 2008; Mukundan et al., 2009), hence 1.0 pm 
diameter beads were used to analyse this process (Zhang et al., 2007). Both 
assays were performed at 4°C, in addition to 37°C (antigen uptake temperature), 
as receptor binding but not uptake occurs at this temperature. Hence, the 
difference between the percentage cells expressing these fluorescent molecules 
at 4°C and 37°C was represented.
Mo showed the highest ability to endocytose OVA-APC* (Figure 3.10a). 
Immature MoDC exhibited a more potent endocytic and phagocytic capacity than 
mMoDC (Figures 3.10a and b).
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Figure 3.10. The capacity of eqMoDC to internalise antigen, (a ) Effect of 
differentiation and activation on endocytic capacity of eqMoDC. Mo, IMoDC and 
mMoDC were incubated with 20 pg/ml of OVA-APC* at 4°C and 37°C for one 
hour. The percentage cells expressing OVA-APC* represented the difference in 
values obtained between the 37°C and 4°C. Mo have the highest ability to uptake 
OVA compared to MoDC, while IMoDC are better at uptake than mMoDC. (b) 
Effect of differentiation and activation the phagocytic capacity of eqMoDC. 
Immature MoDC and mMoDC were incubated at 4°C and 37°C for 4 hours with 
FITC-conjugated microsphere beads (1.0 pm) in a 5:1 (beads/cell) ratio. 
Immature MoDC have a higher phagocytic activity, which, was significant 
compared to mMoDC. Cells were assessed by flow cytometry and data are 
represented as the percentage positive cells ± SEM (n=3). A 1 way ANOVA with 
Dunn's multiple comparison test was used for comparisons between cell types. * 
indicates significant differences between sample means where p < 0.05.
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3 .2 A .2. EqMoDC a llos tim u la to ry  function and antigen presentation ab ility
Cultured iMoDC and mMoDC were further examined for their ability to 
stimulate proliferation of allogeneic CD5+ T cells in a primary MLR assay. Figure 
3.11a shows that eqmMoDC have a high allostimulatory potential whereas 
eqiMoDC are relatively modest T cells stimulators compared to mMoDC. T cells 
stimulated with the mitogen ConA was used as a control. ConA is known to 
stimulate proliferation of T cells by cross-linking receptors for activation 
(Palacois, 1982). However, the low proliferation of T cells in the presence of 
ConA confirmed its dependence on antigen presenting cells.
To test the capacity of eqMoDC to present exogenous proteins, iMoDC 
were incubated with soluble OVA prior to maturation and the addition of 
autologous T cells. OVA, an antigen not encountered by horses, was internalised 
by the high uptake ability of iMoDC (section 3.2.4.1) and presented to CD5+T 
cells upon maturation. Figure 3.11b shows the ability of eqMoDC to induce naïve 
T cell proliferation in the presence of exogenous protein OVA in a primary 
stimulation. Thus, eqMoDC although not identical to human MoDC in phenotype, 
fully resemble functional DC.
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Figure 3.11. The ability of eqMoDC to stimulate T cells and present 
antigen, (a ) Comparative ability of iMoDC and mMoDC stimulation of allogeneic 
T cells in in vitro MLR. Graded doses of MoDC were incubated with CFSE labelled 
allogeneic T cells at 37°C for 3 days. Cells were then harvested and stained with 
an anti-equine CDS antibody to gate T cells and a fixable violet dead cell stain to 
exclude dead cells from the analysis. Mature MoDC have a higher T cell 
activation potential than iMoDC. (b ) Presentation of OVA to autologous T cells by 
graded doses of MoDC. Graded doses of IMoDC were incubated for two hours 
with 0.02 mg/ml of OVA, subsequently matured with the cocktail and left 
overnight. CFSE labelled autologous T cells were added to cultures and incubated 
at 37°C for 4 more days. MoDC have the ability to present antigen to autologous 
T cells. Cells were assessed by flow cytometry and data are represented as 
proliferating T cell numbers ± SEM (n=3).
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3.2 .4 .3 . The a b ility  o f  eqMoDC to cross-present antigen
Cross-priming is the stimulation of CD8+ T cells by antigen presenting 
cells after uptake of extracellular antigen, processing and presentation via the 
MHC class I molecules. To assess this, CD8+ T cells were isolated by magnetic 
separation (section 2.1.3), CFSE labelled and incubated with DC in a 1:10 DC:T 
cell ratio. This ratio was selected as a result of DC displaying the highest ability 
to stimulate T cells and present antigen as shown in section 3.1.4.2. EqMoDC 
were able to cross-present OVA to autologous CD8+ T cells, thereby inducing 
proliferation (Figure. 3.12). I t  was shown that mMoDC only, mMoDC in the 
presence of either OVA or T cells and Con A stimulated T cells in the presence of 
OVA were unable to cross-present OVA to CD8+ T cells. This confirms that for 
cross-presentation to occur, the interaction of DC with CD8+ T cells is crucial.
3.2.5. Gene expression analysis of in vitro eqMoDC
While the above results demonstrate the differentiation and activation of 
eqMoDC, there is a considerable lack of antibodies in the horse system to 
perform a more comprehensive analysis. Therefore, gene expression profiling 
studies were performed using a commercially available equine-specific 
microarray designed from the first partial draft of the horse genome sequence. 
The expression levels of thousands of genes were simultaneously monitored to 
study the effects of developmental stages on gene expression.
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Figure 3.12. Presentation of soluble antigen to CD8+ T cells by mMoDC.
Immature MoDC were incubated for two hours with 0.02 mg/ml of OVA and 
subsequently matured. Autologous CD8+ T cells were magnetically sorted with 
CD8 antibody conjugated to anti-mouse IgG microbeads, CFSE labelled, added to 
cultures in a DC:T cell ratio of 1:10 and incubated at 37°C for 5 days. MoDC 
have the ability to cross present antigen to CD8+ T cells. Cells were assessed by 
flow cytometry and data are represented as proliferating T cell numbers ± SEM 
(n=3). For single comparisons between mMoDC + T cells + OVA and mMoDC + T 
cells - OVA, a two-tailed paired Student t test was used. * *  indicate significant 
differences between sample medians where p < 0.005, respectively.
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3 .2 .5 .1 . M icroarray analysis showed differences In the expression pro files  
o f  Im m ature and m ature  MoDC
Principal Component Analysis (PCA) in 3D, a mathematical procedure 
which converts correlated variables Into linearly uncorrelated variables, has 
shown that the expression profiles of Mo, IMoDC and mMoDC are Indeed distinct 
(Figure 3.13a). Therefore, these three cell types are different populations. The 
relationship between Mo, IMoDC and mMoDC was also examined by unsupervised 
hlerarchlal clustering. Here, the distinction of the three cell types was further 
confirmed with the heat map and revealed that IMoDC and mMoDC are closer to 
each other than to Mo, but differences In their gene expression profiles confirms 
they are clearly separate populations (Figure 3.13b).
An unpaired standard t-test (p < 0.01) provided a list of 8268 and 8276 
differentially expressed probes for the differentiation and activation states, 
respectively. The number of probes significantly upregulated and downregulated 
In IMoDC only were 1926 and 1988, respectively. While 1988 and 1926 probes 
were upregulated and downregulated, respectively In mMoDC only. However, 
2342 upregulated probes and 2020 downregulated probes were common to both 
IMoDC and mMoDC (Figure 3.14). However, as the gene lists were curated by 
eliminating all un-annotated EST and cDNA library sequences and averaging the 
mean fold change of repeat probes, a final list of 526 genes were differentially 
expressed between Mo and IMoDC and 535 genes were differentially expressed 
between IMoDC and mMoDC (Appendix I). I t  was hardly possible to perform 
gene ontology analysis on the data obtained from this first generation equine 
array, due to Its poor representation of the equine RefSeq database and poor 
annotation.
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Figure 3.13. Gene expression analysis of eqMoDC. Microarray experiments 
were performed using the Agilent Horse Gene Expression Array system (4 x 
44K). This array design Is based on the first partial draft sequence of the horse 
genome (Agilent design ID 021322 released 2009). All data sets represent three 
were analyzed using GeneSprlng. (a ) 3D-PCA performed on the differentially 
expressed genes In Mo, IMoDC and mMoDC shows the differences In their gene 
expression profiles that make them distinct, (b ) Heat map by unsupervised 
hierarchical clustering of the differentially expressed probes between Mo, IMoDC 
and mMoDC. The IMoDC and mMoDC are closer to each other than to Mo, but the 
expression profiles of the three cell types are clearly segregated Indicating 
differences In the total RNA expression pattern In Mo and MoDC phenotypes. Red 
represents upregulatlon, blue downregulatlon and yellow represents no change 
for expressed genes (False discovery rate, FDR < 0.05, fold change > 2.0), 
(n=3).
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Figure 3.14. Venn diagram representing the number of genes up and 
downregulated in the differentiation and activation states. The expressed 
genes of Mo and iMoDC were used as the calibrator for IMoDC and mMoDC, 
respectively. There were over 4000 genes differentially expressed in iMoDC and 
mMoDC. 1926 genes were up-regulated in iMoDC only and 1988 in mMoDC 
whereas 1988 genes were down-regulated only in iMoDC and 1926 only in 
mMoDC.
3.2.5.2 . Expression pro files o f  eqMoDC surface m olecules
The array confirmed the already high expression of CD83 on iMoDC, 
which suggests that maturation in the equine system is not linked to CD83 
expression as in the human system. Within the differentially expressed genes, 
we then assessed the expression of the costimulatory B7 family ligands. These 
molecules modulate immune responses by T and B lymphocytes and can have 
both positive and negative modulatory effects on T and B cell activation. Similar 
to CD86 (Figure 3.9c), CD80 was expressed at low levels on IMoDC but further 
upregulated on mMoDC. Analysis of other costimulatory molecules such as PD- 
L1/CD274, PD-L2/CD273, and CD276/B7-H3 revealed that they were
upregulated on IMoDC during differentiation. Upon activation, the expression of
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B7-H3 remained unchanged on mMoDC, while PD-Ll and PD-L2, which are 
negative regulators of Immunity, were down-regulated (Table 3.1).
3.2.5 .3 . Expression pro files o f  chemokine receptors and th e ir ligands
Chemokine receptors and their ligands are involved in the migration of 
DC and reflect their differentiation and activation states (Sallusto et al., 1998; 
Sozzani et al., 1998). The chemokine receptor CCR7 was highly induced on 
iMoDC with the expression level slightly increasing on mMoDC (Table 3.1). The 
molecule Rho GTPase, which is downstream the CCR7 signalling cascade (Riol- 
Blanco et al., 2005), showed low levels of expression in iMoDC and high 
expression levels in mMoDC (Table 3.1). The chemokine receptor CCR5 was 
upregulated on IMoDC and further upregulated during maturation. The 
expression of other chemokines was similar or varied between the differentiation 
and activation states. Chemokine ligands such as CCL17/TARC, CXCL13/BCA-1 
and CCL2/MCP-1 were highly expressed by IMoDC and mMoDC, whereas 
chemokines CXCL9/Mig, CXCLll/I-TAC and CXCLlO/IP-10 were negatively 
modulated or low on IMoDC but positively modulated on mMoDC (Table 3.1).
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Table 3.1. A selection of genes differentially expressed in the 
differentiation and activation of eqMoDC. The table is based on the total 
RNA analysis of immature and mature DC performed by microarray. To 
determine the differentially expressed genes during differentiation and upon 
activation, Mo and iMoDC were used as the reference samples, respectively. The 
threshold of significance was set to a minimum fold change of 2.
Gene Symbol Fold Change
Differentiation 
Mo -> ipc
Activation 
iDC —> mDC
CD83 12.7 8.0
Co-stimulatory PD-L1/CD274 56.0 -15.3
molecules PD-L2/CD273 42.0 -12.9
B7-H3/CD276 21.5 -2.3
B7-1/CD80 2.1 3.5
Dendritic ceil CCR7 1137.5 2.3
migration Rho 3.42 19.1
CCR5 7.7 2.1
CCL17/TARC 13579.9 -2.7
CXCL13/BCA-1 479.36 -18.9
CCL2/MCP-1 116.0 -2.0
Chemokines CXCL9/Mlg -3.0 726.8
CXCLll/I-TAC 3.6 168.8
CXCLlO/IP-10 -6.4 75.8
3.2.5.4 . Valida tion o f  m icroarray da ta
Microarray results should be confirmed by an independent gene 
expression profiling method such as real-time PCR. Validation is important not 
only to avoid non-specific background signals on the array but also to confirm 
values as the array had not been validated itself. Costimulatory molecules, such 
as PD-L1/CD274, PD-L2/CD273, ICOS-L/CD275 and B7-H3/CD276, were 
selected to probe the array due to their role in the development of an effective 
immune response. They are expressed on antigen presenting cells and provide
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the costimulatory signal, which is antigen non-specific, essential for T cell 
activation. The expression levels of PD-L1/CD274, PD-L2/CD273, ICOS-L/CD275 
and B7-H3/CD276 were analyzed using duplex TaqMan based real-time PCR 
assays which were developed in this project and shown to be efficient at 
identifying the respective target genes (section 2.4.9).
The data from the duplex TaqMan assays on Mo, IMoDC and mMoDC 
confirmed the expression profiles obtained by microarray analysis for PD-Ll, PD- 
L2 and B7-H3 and added valuable information for ICOS-L, since this gene was 
not represented on the array. The negative regulators of immunity, PD-Ll and 
PD-L2, were positively modulated on IMoDC and negatively modulated on 
mMoDC. ICOS-L and B7-H3 were positively modulated during differentiation and 
upon activation their expression remained stable on mMoDC (Figure 3.15). 
Therefore, both the array and qPCR data confirm the notion that Mo, IMoDC and 
mMoDC represent separate entities and that a full maturation was obtained 
through the activation cocktail including IFNy.
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Figure 3.15. Validation of differentialiy expressed costimuiatory 
molecules by TaqMan real-tim e qPCR. The B7 costimulatory molecules were 
analyzed using TaqMan based real-time PCR. For the (Livak) method, the 
reference Mo Ct values were used as the calibrator for iMoDC and the reference 
iMoDC Ct values as the calibrator for mMoDC. The expression of these 
costimulatory molecules was upregulated on iMoDC. PD-L1/CD274 and PD- 
L2/CD273 were downregulated on mMoDC while ICOS-L/CD275 and B7- 
H3/CD276 remained stable. Data are represented as the average fold change ± 
SEM (n=3). For single comparisons between Mo^iMoDC and iMoDC^mMoDC, a 
two-tailed paired Student t  test was used. * and * *  indicate significant 
differences between sample means where p < 0.05 and 0.005, respectively.
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3.3. Discussion
3.3.1. CD14^ monocyte subsets in equine peripheral blood
In this study DC were generated from magnetically sorted CD14+ Mo. The 
purity of sorted Mo was greater than 95% (section 3.2.11), which excluded 
many contaminating lymphocytes that were still present by the adherence 
method and may have influenced the variable phenotypic changes observed for 
equine MoDC in a previous study (Mauel et al., 2006).
Heterogeneity in peripheral blood Mo has been shown in humans and 
mice, as discussed in chapter 1 (Crawford et al., 1999; Grage-Griebenow et al., 
2001; Auffray et al., 2009; Ziegler-Heitbrock et al., 2010), and demonstrated to 
a lesser extent in veterinary species such as pigs (Chamorro et al., 2000; 
Chamorro et al., 2004) but not in horses. Monocyte subsets have not been 
previously described for the horse. Attempts were made to identify Mo subsets 
using CD14, CD163 and CD172a monoclonal antibodies. CD172a ensured that 
CD14 isolation did not exclude a prominent subset of eqMo and CD163 is 
potentially exploited by viruses for cell entry particularly PRRSV which is related 
to EAV (Calvert et al., 2007; Van Gorp et al., 2008).
In this study, the heterogeneity of equine blood Mo was demonstrated by 
the Identification of three distinct subsets with different phenotypes (section 
3.2.1.2). I t  was observed that the percentage CD14' '^^('''^^) eqMo was less than 
the CD14^('°'^) eqMo, which contrasts that reported for human and porcine Mo 
where the percentage high subset was greater than the low subset (Passlick et 
al., 1989; Chamorro et al., 2000; Nyugen et al., 2010). All CD1 4 ++( '^8h) gqwo 
were CD163^ and CD14^ '^°'^  ^ cells were either CD163' or CD163^, but mostly 
CD163'. Porcine Mo are also characterised by CD163' and CD163^ subsets, 
where the negative cells are associated with the CD14^‘®^ immature Mo and the 
positive cells were linked to CD14'°'^ mature Mo (Chamorro et al., 2000;
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Chamorro et al., 2004). The association of high or low CD14 expression with 
negative or positive CD163 porcine Mo contrasts that described in this study for 
equine Mo. Recently, in humans, there has been the emergence of a protective 
scavenging Mo phenotype which is CD163^ '^^^  ^ (Boyle et al., 2009; Quimby et al.,
2010). Porcine CD163^ Mo are considered to exhibit a pro-inflammatory function 
due to the high production of TNF-a and high levels of adhesion molecules 
whereas CD163" Mo can produce anti-inflammatory IL-10 (Sanchez et al., 1999). 
I t  has been proposed that porcine CD163^ Mo are homologous to the human 
CD14^CD16^ Mo (section 1.3.3, Figure 1.9), also considered to be pro- 
inflammatory and a major source of TNF-a in the blood (Frankenberger et al., 
1996; Belge et al., 2002). In terms of the functional attributes, porcine CD163^ 
and CD163' Mo differ in their antigen presenting capacity with the CD163^ subset 
being more efficient at presenting soluble antigen to T cells (Sanchez et al., 
1999; Chamorro et al., 2004), due to the high expression of SLA-II and the 
costimulatory molecules CD80/86 on these cells (Chamorro et al., 2004). 
CD14( '^ "^ )^ cells In humans, mice and pigs have been shown to be more 
responsive to the chemokine ligand CCL2 and are recruited to inflammatory sites 
giving rise to macrophages and dendritic cells (Geissmann et al., 2003; Tacke 
and Randolph, 2006; Auffray et al., 2007; Moreno et al., 2010). Therefore, 
functional studies would be required to characterise the different subsets df 
eqMo giving insight into the mechanisms that control migration of Mo to specific 
tissues.
It  must be noted that to clearly define the eqMo gate from PBMC other 
cell surface markers must be used to exclude lymphocytes such as B cells 
(CD19), NK cells (CD56) and T cells (CD2, CD3, CDS and CD7). Of the pan T cell 
markers, CD2 and CD3 are the most T cell specific whereas CDS is strongly 
associated with T cells but present on a small subset of B cells. Of the 
lymphocyte markers mentioned above, CDS is currently the most readily
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available horse specific antibody. In the future eqMo can be sorted based on the 
expression of CD163 and phenotypically characterised further by their 
transcriptome as was conducted in pigs and humans (Moreno et al., 2010; 
Tippett et al., 2011).
3.3.2. MoDC differentiation and activation from equine Mo
Purified recombinant cytokines were used to drive the controlled 
differentiation of eqMo to eqiMoDC, which were matured upon activation by a 
cocktail of inflammatory stimuli. Maturation is one of the important 
characteristics of DC and is crucial for successful antigen presentation to naïve T 
cells. The application of stringent conditions ensured the establishment of fully 
mature MoDC and a highly reproducible system.
The optimal conditions for equine MoDC differentiation and activation 
have not been previously investigated. The best immature state of MoDC and the 
duration of activation resulting in fully mature MoDC were examined by time 
kinetic experiments on the morphology and phenotype during differentiation and 
activation (section 3.2.2.2). The morphological transition of Mo from round and 
adherent cells to clusters of veiled cells with finger-like protrusions reflected 
previous findings (Mauel et al., 2006; Cavatorta et al., 2009). Day 5 of culture 
was chosen for activation based on the well defined classical DC clusters with 
visible protrusions and the comparison of the surface markers between cells 
stimulated on days 1 to 5.
The activation of MoDC was examined in vitro using different 
inflammatory stimuli (section 3.2.2.3). LPS and/or PolyI:C are unable to activate 
eqDC in vitro, disagreeing with the effect on human DC (Ceppi et al., 2009; 
Wischke et al., 2009; Abediankenari et al., 2010). This data is also in line with a 
previous study attempting to stimulate equine DC with inactivated E. coii. In that 
study, there was no detectable difference in the CD206-mediated endocytic
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capacity of unstimulated and activated equine DC (Cavatorta et al., 2009). This 
highlights the importance of using an appropriate activation stimulus to obtain a 
robust maturation. Hence, the maturation cocktail used in the human system 
(IL -lp , IL-6, TNF-a and PGE2) (Jonuleit et al., 1997; Landi et al., 2011) was 
explored with other additions namely IFN-y and CD40L. The cytokine 
combination of IL -lp , IL-6 and TNF-a simulates the original use of monocyte 
conditioned medium (O'Doherty et al., 1993). The addition of the signalling 
molecule PGE2 was shown to override the enzyme indoleamine 2,3-dioxygenase 
(IDO) activity in DC during T cell stimulation, hence blocking the induction of 
tolerance (Krause et al., 2007), which is associated with the immature DC state. 
CD40L is primarily expressed on activated CD4+ T cells in vivo but also found in 
a soluble form. It  is also expressed on other cells such as platelets, MO, NK cells, 
B cells, basophils and mast cells (Schonbeck and Libby, 2001). In humans, it 
was demonstrated that CD40L is a potent stimuli in the upregulation of DC 
markers such as CD80, CD86, MHC class I and II and results in the increased 
capacity of DC to trigger proliferative responses by T cells (Sallusto and 
Lanzavecchia, 1994; Celia et al., 1996; Snijders et al., 1998). However, in this 
study CD40L did not provide any added value, rather in contrast it seemed to 
lim it the effects of the maturation cocktail selected. IFN-y is produced 
predominantly by NK cells as part of the innate immune response and once 
antigen-specific immunity develops, it is produced by CD4 T h l and CD8 CTL 
effector T cells (Schoenborn and Wilson 2007). It is another important DC 
maturation stimulant which enhances the TLR signalling pathway, produces 
mature DC that are more efficient at stimulating in wVo and in vitro OVA-specific 
CD8+ T cell responses and up regulates DC inflammatory cytokines (Vieira et al., 
2000; Czerniecki et al., 2007; Dohnal et al., 2007; He et al., 2007; Han et al., 
2009). There Is sufficient evidence that these stimuli can induce DC maturation
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both in vivo and in vitro. In this study, it is unknown why CD40L limits the 
effects of IFN-y on eqMoDC maturation.
The cocktail plus IFN-y in combination with 24 hours or 48 hours 
incubation resulted in the best mature MoDC phenotype and thus is the best for 
maturation in the equine system. This data is in line with a recent study which 
demonstrated that human MoDC activated with the cocktail of IL -lp , IL-6, TNF-a 
and PGE2 are more phenotypically mature than DC treated with LPS (Landi et al.,
2011). In addition, that and others studies showed that DC activated with the 
cocktail were best functionally including enhanced allostimulatory capacity, 
enhanced motility toward chemokine ligand 19 (CCL19) in chemotaxis assays 
and were the best at inducing a Thl-biased response (Jefford et al., 2003; Rubio 
et al., 2005; van Helden et al., 2006; Landi et al., 2011). PGE2 appears to play a 
crucial role in mature DC migration as studies reported that in vivo injected DC 
only left the site of injection with the addition of PGE2 to the maturation cocktail. 
Hence, the competent function displayed by equine MoDC, discussed further in 
section 3.3.3, was indeed influenced by the maturation cocktail.
3.3.3. Phenotypic and functional characterisation of in vitro 
eqMoDC
The spontaneous transition of iMoDC to mMoDC could be excluded in this 
system since phenotypic, functional and genomic studies clearly demonstrated 
differences between eqiMoDC and eqmMoDC, while sufficient similarities to 
human and mouse immature and mature DC exist to classify them as such.
The phenotypic data, obtained by flow cytometry, microarray and qPCR, 
demonstrated the modulation of key cell surface markers on eqMoDC. The 
traditional markers used to define DC, include CD83, MHC II, CD206 and CD86, 
were not expressed or displayed at very low levels on eqMo (section 3.2.3.2), 
which is similar to that of human Mo (Brooks and Moore, 1988; Hart et al..
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1996; Cochand et al., 1999). The expression patterns of CD83, CD206 and to 
some extent MHC II on eqMoDC are not fully in agreement with what has been 
described in humans or mice. CD83 is considered to be a marker of maturation 
on human and murine DC (Zhou and Tedder, 1995; Berchtold et al., 1999) but it 
is already highly expressed on eqIMoDC (sections 3.2.3.1, 3.2.3.2 and 3.2.5.2). 
Previous studies in humans and mice have shown that CD83 is correlated with 
the density of MHC II  on antigen presenting cells and conversely a lack of CD83 
on mature DC is associated with their inability to stimulate T cells during in vitro 
MLR (Kruse et al., 2000b; Kuwano et al., 2007; Tze et al., 2011). It is thus not 
surprising that MHC II  was also co-expressed on eqlMoDC and the ability of 
iMoDC to already stimulate T cells (Figure 3.11a) is possibly correlated to the 
MHC II  and CD83 expression on these cells. The high expression of MHC II  on 
iMoDC was also observed in other animal species such as pigs, cows and sheep 
(Werling et al., 1999; Paillot et al., 2001; Newland et al., 2004). Porcine MoDC 
also possess a potent allostimulatory capacity in in vitro MLR assays and mMoDC 
are better T cell stimulants than IMoDC (Carrasco et al., 2001). The ability of 
porcine iMoDC to already stimulate T cells, like eqiMoDC, albeit to a lesser extent 
than mMoDC has also been correlated to the high MHC II  expression. Bovine 
iMoDC have also showed a moderate capacity to stimulate proliferation of 
allogeneic T cells (Pinchuk et al., 2003).
The expression of CD206 has been the hallmark of immature DC 
differentiation in humans. It is not expressed on mature DC in humans and its 
link to receptor-mediated endocytosis by DC has been well described (Sallusto et 
al., 1995; Mellman et al., 1998; Cochand et al., 1999). In the equine system, 
the high expression of CD206 on iMoDC (sections 3.2.3.1 and 3.2.3.2) is possibly 
linked to their increased ability to endocytose antigen (section 3.2.4.1). There is 
a small population of mMoDC, approximately 25%, in the equine system that 
maintains expression of CD206 with the majority of these cells coexpressing
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CD83 (section 3.2.3.1). Possibly, these cells were likely conveying the capacity 
of mMoDC to endocytose antigen, however not to the capacity displayed by 
IMoDC. Maturation was accompanied with a reduction in receptor-mediated 
uptake activity and an increase in the MLR stimulatory capacity (sections 3.2.4.1 
and 3.2.4.2), which represents a shift from the processing stage to the 
presenting stage. This phenomenon has been demonstrated for, pig and ovine 
MoDC (Paillot et al., 2001; Newland et al., 2004) and is also widely characterized 
in the literature (Sallusto and Lanzavecchia, 1994; Sallusto et al., 1995; Cheong 
et al., 2010). Murine MoDC were shown in vitro to be as good or better than 
classical DC at cross-presentation (Cheong et al., 2010). Here, it is also shown 
that eqMoDC possess the ability to cross-present antigen (section 3.2.4.3), 
which in myeloid DC is otherwise a particular attribute of DNGR1/CLEC9A (C- 
type lectin-like domain family 9) positive DC (Iborra et al., 2012; Zelenay et al.,
2012).
In order to obtain further insights into the differentiation and activation 
status of equine MoDC, gene expression studies were applied where equine 
specific antibodies were not available. Microarray data, through PCA analysis and 
hierarchical clustering (section 3.2.5.1), and qPCR data (section 3.2.5.4) 
underpinned that equine iMoDC and mMoDC are two distinct cells. Costimulation 
is essential for the development of an effective immune response providing 
crucial signals to the MHC-driven antigen presentation. Costimulatory molecules 
were generally regulated along the functional parameters of equine MoDC 
previously discussed. The expression of B7-1/CD80 was low on eqlMoDC but 
upregulated on eqmMoDC, which is comparable to the expression on human and 
porcine MoDC (Cochand et al., 1999; Paillot et al., 2001). Likewise, the 
expression of B7-2/CD86, data from flow cytometry analysis, was upregulated 
on eqmMoDC. The presence of CD80 and CD86 on mMoDC contributed to the 
potent allostimulatory capacity of these cells.
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In humans, PD-L1/CD274 and PD-L2/CD273 are significantly up-regulated 
on mMoDC (Brown et al., 2003). These markers were upregulated on eqlMoDC 
but upon activation downregulated, while still expressed. Both can suppress the 
immune system by transmitting an inhibitory signal, which negatively regulates 
T cell activation (Freeman et al., 2000; Latch man et al., 2001; Carter et al., 
2002; Curiel et al., 2003) but have also been reported to stimulate T cell 
proliferation (Dong et al., 1999; Tseng et al., 2001; Hobo et al., 2010). While 
the negative modulation of PD-Ll and PD-L2 on mMoDC implies a more 
inhibitory role in the equine immune responses, these markers are still 
expressed on eqmMoDC and may provide a stimulatory role. The expression of 
these markers on mMoDC may have the ability to regulate an immune response 
by initially stimulating T cells, then inhibiting T cell activation to curb this 
response.
ICOS-L/CD275 is expressed at low levels on human monocytes and 
remains unaltered during differentiation and maturation of MoDC (Aicher et al., 
2000). Differentiation of eqMoDC strongly induced ICOS-L expression, which was 
sustained during maturation. ICOS-L is a positive costimulatory signal for T cells, 
which drives the production of the Th2 cytokine IL-10 and seems to be 
particularly relevant to the induction of Th2 cells and to a lesser extent T h l cells 
(Hutloff et al., 1999; McAdam et al 2000; Sperling and Bluestone 2001; Witsch 
et al., 2002; Bellinghausen et al., 2004). IL-10 has potent immuno-regulatory 
effects on the maturation and antigen function of DC by suppressing the 
expression of costimulatory molecules and the capacity to stimulate T cells, 
thereby inducing tolerance (Enk et al., 1993; Buelens et al., 1997; De Smedt et 
al., 1997; Steinbrink et al., 1997; Al la vena et al., 1998; Brossa rt et al., 2000; 
Takayama et al., 2001). The induction of ICOS-L on eqMoDC and the ability of 
these cells to maintain functionality in T cell proliferation assays, argues against 
the induction of tolerance.
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The expression pattern of B7-H3/CD276 on human MoDC is such that it is 
upreguiated on iMoDC and stable on mMoDC (Zhang et al., 2005). Similarly, in 
the equine system B7-H3 is upreguiated on IMoDC and remained stable on 
mMoDC. B7-H3 was reported to be involved in T cell activation (Wang et al., 
2000; Chapoval et al., 2001) but further studies suggested that it may 
negatively regulate T cells (Ling et al., 2003; Suh et al., 2003; Prasad et al., 
2004). The activity of equine MoDC argues against an inhibitory role of B7-H3 on 
eqMoDC.
To better understand the physiological function of these costimulatory 
molecules, technologies targeting these genes of interest are essential. 
Technologies such as blocking antibodies or gene modification, which includes 
small interfering RNA (siRNA), are useful approaches to reveal individual gene 
function. In the human system, PD-Ll and PD-L2 si RNA DC have been proposed 
as a means for improving the efficacy of DC vaccines (Hobo et al., 2010).
To gain some insight into the potential migratory ability of equine MoDC, 
the results from the microarray were used to analyse the expression of 
chemokine receptor and their ligands in more detail. These molecules were some 
of the most highly regulated genes (section 3.2.5.3) and indicate the ability of 
eqMoDC to interact with other cells. The expression of CCR7 is vital for homing 
of mature DC to the T cell areas of lymphoid organs (Sallusto et al., 1998). This 
receptor is already highly expressed on eqlMoDC which is maintained on 
eqmMoDC, while in the human system its expression is mostly upreguiated 
during maturation (Dieu et al., 1998; Sallusto et al., 1998; Yanagihara et al., 
1998; Allavena et al., 2000). The ligands for CCR7 are produced in secondary 
lymphoid organs and include CCL19/macrophage inflammatory protein 3 beta 
(MIP-33) and chemokine ligand 21 (CCL21)/secondary lymphoid chemokine 
(SLC). These ligands were not represented on the equine array used, however 
there was the expression of GTPase Rho, whose activation is induced by CCR7 in
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the human system. In the equine system, CCR7 may thus be functionally active 
as indicated by the upregulation of its downstream adapter.
The chemokine receptor CCR5 recognises inflammatory chemokines such 
as RANTES (regulated upon activation normal T cell expressed and presumably 
secreted)/chemokine ligand 5 (CCL5), macrophage inflammatory protein 1 alpha 
(MIP-la)/chemokine ligand 3 (CCL3) and macrophage inflammatory protein 1 
beta (MIP-l(3)/chemokine ligand 4 (CCL4), and are responsible for the 
recruitment of immature DC to inflamed tissues. CCR5 was upreguiated during 
differentiation and activation of equine MoDC. In contrast, human MoDC (Dieu et 
al., 1998; Sallusto et al., 1998; Cravens and Lipsky, 2002) have been reported 
to downregulate CCR5 and to lose their responsiveness to its ligands upon 
maturation (Sallusto et al., 1998; Dieu et al., 1998), while CCR5 on eqmMoDC 
possibly maintain their responsiveness to its ligands. RANTES and MIP-lp are 
secreted by T lymphocytes (Song et al., 2000), thus the expression of CCR5 may 
support the interaction of equine mature DC and T cells.
Chemokine production by DC enhances their capacity to attract other 
cells. Chemokine ligand 17 (CCL17)/Thymus and activation regulated chemokine 
(TARC), chemokine ligand 13 (CXCL13)/B cells attracting chemokine 1 (BCA-1) 
and chemokine ligand 2 (CCL2)/monocyte chemotatic protein-1 (MCP-1) were all 
highly regulated during differentiation and remained expressed. CCL17, one of 
the ligands for CCR4, was the most highly regulated chemokine detected and has 
a selective activity towards Th2 cells (D'Ambrosio et al., 1998; Sallusto et al., 
1998; Imai et al., 1999). CXCL13, a ligand for CXCR5, has been implicated in 
establishing the interaction of DC with T and B cells which specifically suits the 
function of mature DC (Vissers et al., 2001). CCL2 has been shown to inhibit IL- 
12 production and promote Th2 polarization, also indicating a balance of equine 
MoDC towards Th2 (Chensue et al., 1996; Gu et al., 2000). Further studies will
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be required to establish if these molecules negatively impact the ability of 
eqMoDC to initiate a T h l response.
The expression of chemokines such as chemokine ligand 9 
(CXCL9)/monokine induced by gamma-interferon (Mig), chemokine ligand 11 
(CXCLll)/interferon-inducible T Cell alpha chemoattractant (I-TAC) and 
chemokine ligand 10 (CXCL10)/interferon gamma-induced protein 10 (IP-10), all 
ligands for receptor CXCR3, was also specifically up-regulated upon activation. 
Human DC expressing high levels of these chemokines have been shown to 
attract CD8+ T cells expressing the CXCR3 receptor (Padovan et al., 2002). Their 
high expression on eqmMoDC may suggest that these cells are also efficient at 
attracting CD8+ T cells which is supported by the cross-presenting ability of 
these cells.
While transcriptome analysis may contribute substantially to our 
understanding of the differentiation and maturation of equine DC, it must be 
noted that this first generation equine array resembled only part of the equine 
RefSeq database and was poorly annotated. The minimal annotation available 
and the lack of important genes made it impossible to explore pathway analysis 
tools that can be used to identify the main cellular biological processes. Thus, 
further work is necessary to exploit the advancements in equine genomics.
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4.1. Introduction
In the previous chapter, an in vitro equine monocyte-derived dendritic 
cells (eqMoDC) system was established and characterised both phenotypically 
and functionally. DC are potent antigen presenting cells (APC) and are the only 
cells that can initiate a primary immune response by priming naïve T cells, as 
demonstrated in section 3.2.4. The inhibition of this primary DC function by 
invading pathogens, such as viruses, can have severe consequences on the 
establishment of an anti-viral immunity. Therefore, the in vitro eqMoDC system 
was used to study the interaction with Equine arteritis virus (EAV), which has not 
been investigated in the past. A previous study has shown that EAV can infect 
CD14^ Mo (Go et al., 2010) but the ability of this virus to replicate in these cells 
and the impact on phenotype and function of Mo has not been researched.
EAV strains of different genotypes and pathogenicity were studied and 
included the US Bucyrus velogenic and attenuated strains from the American 
group, as well as the UKl strain from the European group (sections 1.1.4 and 
2.2.1). The UV inactivated variant of the US Bucyrus reference strain was 
included to assess any effect viral preparations may have regardless of infection. 
All strains were cultured, concentrated and purified to high titres to achieve a 
multiplicity of infection (MOI) of 5, which confers infection of greater than or 
equal to 99% of susceptible cells (Flint et al., 2009; section 2.2.6). I t  was 
determined whether EAV can infect and replicate in Mo and MoDC, using real­
time qPCR and viral titration assays. The effect of the virus on morphology, 
phenotype and function of cells was assessed using light microscopy, flow 
cytometry and in vitro co-cultivation assays. Comparisons were also made 
between strains and cell types to assess whether differences in viral 
pathogenicity and differentiation of cells influenced the ability of EAV to replicate.
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4.2. RESULTS
For the in vitro infection assays, it was important that cell cultures were 
infected synchronously with an amount of virus which ensured that the majority 
of susceptible cells were infected. To achieve a high infection rate, cultures were 
inoculated with a MOI of 5. Since virus infection of cells is a random process and 
follows a Poisson distribution, the MOI required to infect a given proportion of 
cells within a culture can be calculated (Flint et al., 2009). Here, MOI of 5 was 
used as it was assumed based on the Poisson distribution that 99% of 1 x 10® 
cells were infected (section 2.2.6). To achieve synchronicity, infection was 
started at 4°C (which is equivalent to virus attachment) followed by incubation at 
37°C (for starting replication in parallel), thereby the first replication cycle was 
measured. The UV inactivated US Bucyrus reference strain was included to 
assess the effect viral preparations and intact virions may have on these immune 
cells.
4.2.1. Effect of EAV on Mo and MoDC morphology and viability
4.2 .1 .1 . The m orphologica l effects o f  EAV on Mo and MoDC
Changes induced by EAV on Mo and MoDC have not been previously 
investigated. In section 3.2.2 the morphology of equine Mo and MoDC was 
characterised. Mo were shown to be round and adherent cells. Immature MoDC 
possessed the characteristic DC morphology of loosely adherent clusters with 
finger-like projections, while mMoDC displayed large dense clusters that 
maintained the finger-like projections.
The morphology of cells was assessed by light microscopy after 24 hours 
and 48 hours post infection. After 24 hours, the mock control (cell supernatant 
from EEL cultures, section 2.2.7) did not influence the previously described Mo 
morphology of round and adherent cells (Figure 4.1a). In fact, the data from all
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downstream assays showed that the mock had no influence on myeloid cells and 
the effects observed were due to the virus. In the Attenuated cultures, Mo 
appeared to adhere less but there were no other observable differences 
compared to the mock control (Figure 4.1b). There were noticeably less cells in 
the Velogenic cultures compared to the Attenuated cultures (Figure 4.1c). 
Interestingly, after 48 hours Mo infected with the attenuated strain seemed to 
have acquired a more DC-like cell morphology characterised by the presence of 
numerous finger-like projections (Figures 4 .le  and ei) compared to the mock 
(Figure 4 .Id ). Furthermore, there were visible very few Mo, infected with the 
Velogenic strain, left in culture and this has confirmed that EAV has a lytic effect 
on Mo (Figure 4 .If) .
Infected Mo was further assessed in the presence of GM-CSF and IL-4, to 
observe their ability to obtain a differentiated DC morphology. In the presence of 
the Attenuated strain. Mo were still able to differentiate into DC clusters but 
there appeared to be less clusters present (Figure 4.2b) after 24 hours post 
infection compared to the mock (Figure 4.2a). However, the same could not be 
said for the Velogenic strain where Mo were unable to differentiate and there 
were noticeably less cells in culture with no clusters present (Figure 4.2c). After 
48 hours post infection, the mock control (Figure 4.2d) was similar in 
morphology to the day 2 IMoDC described in section 3.2.2, Figure 3.4iii. For cells 
infected with the Attenuated and Velogenic strains there were no clusters 
present, particularly in cultures with the Velogenic strain (Figures 4.2e and f). 
Therefore, based on the morphology, EAV has the ability to inhibit the 
differentiation of Mo to MoDC.
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The effect of the virus on iMoDC morphology was fairly minimal. There 
were no distinct differences observed between the Attenuated and Velogenic 
strains. However, the virus infected cultures (Figure 4.3b and c) compared to the 
mock infected cultures (Figure 4.3a) appeared to have less clusters, especially 
for cells infected with the Velogenic strain. After 24 hours many IMoDC were still 
present with minimal ceil destruction, even for those cells cultured with the 
Velogenic strain. The mock infected mMoDC after 24 hours displayed the 
described mMoDC morphology in chapter 3 (Figure 3.7) of very dense clusters 
with numerous dendrite-iike structures (Figure 4.3d). Mature MoDC cultured with 
the US attenuated strain maintained the classic DC morphology (Figure 4.3e). 
On the other hand, mMoDC succumbed to the virus's pathogenic nature. The 
Velogenic strain destroyed these ceils with only cellular debris and less live cells 
remaining in cultures (Figure 4.3f).
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Chapter 4: Interaction of EAV with eqMoDC
4.2.1 .2 . The e ffec t o f  EAV on equine Mo and MoDC v iab ility
Based on the morphological changes observed, it was important to 
determine the time point at which there were sufficient cel is left, particularly for 
the velogenic strain, to conduct phenotypic and functional studies. Therefore, cell 
viability assays were performed, with the fixable violet dead cell stain kit, at 
different time points ranging from 8 to 24 hours post infection covering the time 
for a primary EAV replication cycle (Snijder and Meulenberg, 1998).
The data revealed that already early after infection there were significant 
differences in the Mo and mMoDC viability between the mock and Velogenic 
strain as weii as between virai strains, particuiarly the Attenuated or UKl strains 
and the Velogenic strain (Figure 4.4a). The same effect was observed 16 hours 
post infection (Figure 4.4b). The significant differences between the mock and 
UKl were not shown on the graph but were similar to that shown for the 
Attenuated versus mock. The percentage of viable Mo and mMoDC inoculated 
with the Velogenic strain decreased further 24 hours post infection to 20% and 
10%, respectively (Figure 4.4c). The virus had no significant effect on the 
viability of iMoDC 8, 16 and 24 hours post infection (Figure 4.4a, b and c). 
Overali the US Velogenic strain most significantly reduced the percentage of 
viable cells. At 16 hours post infection approximateiy 30% viable cells were left 
with mMoDC, representing the most detrimentai effect. Hence, sufficient viable 
cells were present at the end of a first replication cycle, thus this time was 
seiected as the most appropriate one to conduct phenotypic and functional 
assays.
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Figure 4.4. Time kinetics on the viability of EAV infected Mo and MoDC.
Mo, iMoDC and mMoDC were inoculated at MOI of 5 with different strains of live 
or UV inactivated EAV (section 2.2.7). Cultures were incubated 37°C in 5% CO2 
for (a ) 8 hours, (b ) 16 hours and (c) 24 hours post infection (hpi). Controls 
included uninfected cultures (media only) and mock infected cultures. Cells were 
stained with the violet dead cell stain and analysed by flow cytometry as in 
section 2.3.2. Cells of the different treatments were assessed by comparing the 
same number of events (10,000) in the target gate. Live cells were negative for 
the violet stain and gated on the FSC and SSC axes to remove cellular debris. 
This population was determined as the percentage of viable cells. Data are 
represented as the mean percentage viable cells expressing ± SEM (n=4). 
Statistical significance was determined using a 2 way ANOVA with Bonferroni 
post test to compare replicate means. * and * * *  indicate significant differences 
between sample means where p < 0.05 and 0.0001, respectively.
162
Chapter 4: Interaction of EAV with eqMoDC
4.2.2. Detection and replication of EAV in equine Mo and MoDC
The morphological observations and viability assays have identified 
changes in Mo and MoDC cultures inoculated with EAV strains of different 
pathogenicity. Therefore, it was crucial to detect and quantify the virus within 
these immune cells and further investigate the ability of the virus to replicate in 
these cells. The TaqMan qPCR for ORFl was used to quantify viral RNA through 
comparison of Ct values between target (ORFl) and reference (18S rRNA) 
genes, described in section 2.4.7. ORFl has the benefit that, contrast to other 
genes that are expressed in nested sets of RNA, it only exists in the genomic 
form and the antisense replication intermediate. Thus, its quantification parallels 
replication. ORFl is the replicase gene encoding non-structural proteins and 
specifically targets the replicase poly proteins ppla and pplab. Normalisation 
controlled for differences in cell numbers between cultures of various treatments. 
While the qPCR assay was used to determine active replication in cells, it was 
complemented by the traditional method of virus titration to determine the 
amount of infectious virus released into the cell culture supernatant.
The ORFl TaqMan qPCR assay detected viral replication of all strains in 
the three cell types 16 hours post infection. The 0 hour post infection was used 
as the calibrator sample in the relative quantification data analysis to exclude 
virus attached to the cells. The relative detection of ORFl was the highest in 
mMoDC followed by Mo and the least iMoDC (Figure 4.5). Hence, mMoDC 
seemed the most susceptible to EAV whereas iMoDC were the least susceptible. 
The comparison of the relative detection between strains revealed that the 
Velogenic strain had the most significant expression of the ORFl gene in Mo and 
mMoDC. In iMoDC, the overall expression of the ORFl gene for all strains was 
low (< 100 relative detection) with no significant differences. The Attenuated 
and UKl strains had similar ORFl expression levels in Mo and MoDC. The UV 
inactivated virus was equal to the baseline levels which meant there was no
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increase of the viral ORFl gene in the three cell types. Therefore, the UV 
inactivated virus did not replicate in Mo and MoDC.
c
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cell type
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I B  Velogenic 
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Figure 4.5. Detection of viral replication in equine Mo and MoDC by qPCR 
targeting the O RFl region of EAV. Horse Mo, iMoDC and mMoDC were 
inoculated at MOI of 5 with different strains of live or UV inactivated EAV (section 
2.2.7). RNA was extracted from cells 16 hpi, reverse transcribed into cDNA and 
EAV replication quantified by TaqMan qPCR, using 18S rRNA gene as the 
reference (section 2.4). The normalized fold difference ratio was calculated using 
the formula 2"^^^  ^ and the 0 hpi as the comparator. Results were represented as 
the average fold difference ± SEM (n=9). Statistical significance was determined 
using a 2 way ANOVA with Bonferroni post test to compare replicate means. * *  
and * * *  indicate significant differences between sample means where p < 0.005 
and 0.0001, respectively.
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The results of the TCID50 assays are displayed as the difference in 
infectivity titres between the 0 hour and 16 hours post infection for each virus 
strains in Mo and MoDC supernatant. Thus, newly produced virus can be 
distinguished from the infectious dose that remained after washing. The virus 
titres in Mo cultures ranged from 10^° to 10^° TCIDso/ml (Figure 4.6a). 
Immature MoDC cultures had the lowest virus titres spanning from 10°'^ to 10 '^^ 
TCIDso/ml (Figure 4.6b), whereas supernatants from mMoDC cultures had the 
highest titres which ranged from 10^° to lO*^ -^  TCIDso/ml (Figure 4.6c). The 
differences in titres observed between EAV strains were significant. The 
Velogenic strain had the highest titres in all cell types, while the Attenuated and 
UKl strains displayed similar titres. These data confirmed the production of 
infectious virions as a result of virus replication. For the UV inactivated virus, 
infectivity titres of 10° ° TCIDso/ml were obtained and highlighted the inability of 
this variant to infect and replicate.
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Figure 4.6. Virai infectivity titres from supernatants of infected Mo and 
MoDC cultures titrated on the susceptible cell line EEL. Monocytes (a ),  
iMoDC (b ) and mMoDC (c) were inoculated at MOI of 5 with different strains of 
live or UV inactivated EAV (section 2.2.7). Virus titrations were performed on 0 
and 16 hpi supernatants (section 2.2.5). The TCIDso/ml at 0 hpi was subtracted 
from the TCIDso/ml at 16 hpi. For all cells the TCIDso/ml was the highest in 
cultures infected with the Velogenic strain. Overall the titres were the highest in 
mMoDC followed by Mo and the least in iMoDC cultures. Results represent the 
TCIDso/ml ± SEM (n=9). A two-tailed paired Student t test was used for single 
comparisons between the 0 and 16 hpi titres (shown in black). A 1 way ANOVA 
with Dunn's multiple comparison test was used for comparisons between strains 
at 16 hpi (shown in red). * and * * *  indicate significant differences between 
sample means where p < 0.05 and 0.0001, respectively.
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4.2.3. The mechanism of cell death In EAV Infected Mo and MoDC
Once it was established that EAV has the ability to infect and replicate 
lytically in Mo and MoDC, apoptosis was examined as a potential mechanism of 
cell killing by this virus. Annexin-V, which has a high affinity for phospholipid 
phosphatidylserine (PS) on the surface of apoptotic cells, was used in 
combination with the live/dead dye 7-Amino- Actinomycin (7-AAD) to allow 
identification of early apoptotic cells from dead cells (section 2.3.2).
The apoptotic process was assessed in infected Mo, iMoDC and mMoDC 16 
hours post infection (Figures 4.7 and 4.8). The basal level of apoptosis varied 
within populations and in the absence of infection, cell populations contained a 
small percentage of apoptotic cells. Again, the mock population was used to 
define the basal level of apoptotic and dead cells. During apoptosis, cells move 
through different stages, that is they are initially viable, gradually becoming 
early apoptotic with the integrity of the membrane still present and finally are 
driven to late stage apoptosis and death. The density plots show that the 
positive percentage expression of Annexin-V-FITC on Mo and mMoDC infected 
with the Velogenic strain significantly increased compared to the mock. 
Attenuated and UKl infected cells (Figures 4.7).
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Figure 4.7. Density piots of the apoptotic effect of EAV on Mo and MoDC.
Monocytes, iMoDC and mMoDC were inoculated at MOI of 5 with different strains 
of live EAV (section 2.2.7). A mock infected control was included. After 16 hpi 
cells were harvested and cell apoptosis assays performed by flow cytometry 
(section 2.3.2). Cells were stained with the apoptotic stain Annexin-V-FITC and 
live-dead stain 7-AAD-PE-Cy5 for 15 minutes at room temperature. Controls 
included unstained cells, cells stained with Annexin-V-FITC alone and cells 
stained with 7-AAD alone. Stained cells of the different treatments were 
analysed by comparing the same number of events (10,000) in the target gate. 
A large percentage Mo and mMoDC infected with the Velogenic strain underwent 
early (Annexin-V^/7-AAD ) or late apoptosis (Annexin-VV7-AAD^). The viral 
apoptotic effect on iMoDC was minimal with most cells maintaining viability 
(Annexin-V"/7-AAD ) compared to Mo and mMoDC. The values highlighted in red
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represent the absolute cell percentages in the each gate. The plots are 
representative of nine independent repeats.
Monocytes and mMoDC infected with the velogenic strain lost their 
viability (Annexin-V'/7-AAD) (Figure 4.8a) and became early apoptotic 
(Annexin-V^/7-AAD') (Figure 4.8b). However, only Mo infected with the 
velogenic strain were driven to late stage apoptosis and death (Annexin-V^/7- 
AAD^) compared to mMoDC, where there were no late stage apoptotic cells 
induced by the virus (Figure 4.8c). I t  must be noted that the virus did not cause 
necrosis (Annexin-V'/7-AAD^) of cells (Figures 4.7 and 4.8d). The Attenuated 
and UKl strains were unable to induce apoptosis of Mo and mMoDC. All virus 
strains, particularly the Velogenic strain, were unable to induce apoptosis of 
iMoDC (Figures 4.7 and 4.8). Apoptosis represented a general mechanism of cell 
death in host cells infected with EAV and is possibly responsible for the 
development of a cytopathic effect during replication.
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Figure 4.8. The percentage cells in the different stages of apoptosis 
induced by EAV on Mo and MoDC. The viable (Annexin-V"/7-AAD ), early 
(Annexin-V^/7-AAD ) and late (Annexin-V^/7-AAD^) apoptotic cells and necrotic 
(Annexin-V'/7-AAD^) cells were identified 16 hpi with the Annexin-V assay as 
described in Figure 4.7. Stained cells of the different treatments were analysed 
by comparing the same number of events (10,000) in the target gate. Mo and 
MoDC infected with the Velogenic strain underwent early apoptotsis, but only Mo 
achieved a late apoptotic stage. There was no apoptosis induced by EAV on 
iMoDC. Overall there were less than 5% necrotic cells in all cultures. The results 
are represented as the percentage positive cells ± SEM (n=9). A 2 way ANOVA 
with Bonferroni post test was used to compare replicate means.
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4.2.4. Phenotypic changes of Mo and MoDC induced by EAV 
infection
There were no previous investigations on the phenotype of EAV infected 
Mo and MoDC. Therefore, in this study changes in the expression of key cell 
surface molecules induced by EAV were assessed by flow cytometry and qPCR. 
Surface molecules can influence or drive the biological function of a cell and any 
alteration in their expression can potentially affect function. For Mo, the 
molecules investigated were CD14 (LPS receptor), CD163 (scavenger receptor) 
and CD172a (signal-regulatory protein-a/SIRP-a). The DC molecules of interest 
for both the immature and mature states were CD206 (mannose receptor), CD83 
(human DC maturation marker), MHC II  (major histocompatibility complex class 
II)  and costimulatory molecules such as CD86, PD-Ll, PD-L2, ICOS-L and B7- 
H3. All investigations were again carried out 16 hours post infection.
4.2 .4 .1 . M odulation o f  key cell surface m olecules on EAV in fected Mo
The Velogenic strain significantly downregulated the expression of CD14 
and CD163 compared to the Attenuated and UKl strains (Figure 4.9). The UV 
inactivated variant had no significant impact on the expression of CD14 and 
CD163 but upreguiated the already high expression of CD172a, as did all EAV 
strains. All treatments increased the percentage cells expressing this molecule 
by approximately 15%, which was not significant against all controls. There were 
no differences in the mean fluorescence intensity (MFI) of CD172a between the 
various treatments (data not shown).
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Figure 4.9. Phenotypic changes induced by EAV on Mo. Monocytes were 
inoculated at MOI of 5 with different strains of live or UV inactivated EAV (section 
2.2.7). Controls were uninfected (media only) and mock infected cells. Cultures 
were incubated at 37°C in 5% CO2 for 16 hours. Cells were stained with the 
live/dead fixable near-IR dead cell kit, followed by staining with CD14-FITC, 
CD163-Vioblue and CD172-PE. The monoclonal antibodies were conjugated via 
the zenon fluorescent dyes and staining controls used were unstained cells and 
isotype controls. All staining were performed and analysed by flow cytometry as 
described in section 2.3.4. Stained cells of the different treatments were 
assessed by comparing the same number of events (10,000) in the target gate. 
The Velogenic strain significantly decreased the expression of CD14 and CD163 
on Mo. There were no significant differences in the expression of CD172a, 
however it was upreguiated by all virus strains and the UV inactivated virus. 
Results were represented as the % surface marker expression ± SEM (n=9). A 2 
way ANOVA with Bonferroni post test was used to compare replicate means. *, 
* *  and * * *  indicate significant differences between sample means where P < 
0.05, P < 0.01 and P < 0.001, respectively.
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4.2.4.2 . Effect o f  EAV in fection on MoDC phenotype
The phenotype of infected iMoDC was assessed using the main DC 
markers. The different EAV strains did not induce any significant changes on the 
surface molecules CD206, CD83, CD86 and MHC II  (Figure 4.10a). This data was 
in line with the low replication of this virus in iMoDC. The UV inactivated variant 
did upregulate the expression of CD86 only but not against all controls.
In contrast to IMoDC, EAV induced significant changes to the expression 
of surface molecules on mMoDC (Figure 4.10b). The Velogenic strain caused 
significant downregulation of CD83. Futhermore, there was an upregulation of 
CD206. There were no significant changes in the CD86 and MHC II expression. 
For the Attenuated and UKl strains, there were no significant changes to the 
overall phenotype of mMoDC. The trends observed with percentage cells 
expressing the respective markers were similar to the MFI data (not shown).
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4.2.4 .3 . M odulation o f  costim u ia to ry  m olecules on EAV in fected Mo and  
MoDC
Costimulatory molecules are crucial to the development of an effective 
immune response and can have both positive and negative modulatory effects 
on T and B cell activation. The costimulatory molecules, PD-L1/CD274, PD- 
L2/CD273, ICOS-L/CD275 and B7-H3/CD276, were investigated for changes in 
their expression levels on Mo and MoDC infected with the Velogenic, Attenuated 
and UKl strains. TaqMan qPCR assays were developed and the relative
quantification method was employed for this study as described in section 2.4.9. 
Samples were normalised to the 18S rRNA gene and calibrated to the mock 
infected cells.
The expression of all four molecules on Mo was equivalent to or slightly 
above baseline levels. Expression was only marginally modulated for the 
Attenuated, Velogenic and UKl strains (Figure 4.11). The expression of PD-Ll 
and PD-L2 changed only slightly on infected iMoDC and increased approximately 
150-fold and 200-fold, respectively on mMoDC infected with the Attenuated 
strain. Infection of mMoDC with the UKl strain also resulted in approximately 
140-fold and 180-fold increases of PD-Ll and PD-L2, respectively. However, 
their expression did not change with the Velogenic strain (Figures 4.11a and b). 
The expression of ICOS-L remained at or slightly below baseline levels on Mo 
and IMoDC upon infection with all strains and was slightly upregulated 1.5/2.0- 
fold on mMoDC infected with all strains (Figure 4.11c). Finally, the UKl strain 
increased the expression of B7-H3 on both iMoDC and mMoDC by 260-fold and 
200-fold, respectively. Similarly, the Attenuated strain increased the expression 
of B7-H3 on iMoDC and mMoDC by 350-fold and 240-fold, respectively whereas 
the Velogenic strain only had a small influence on the expression of infected 
iMoDC (Figure 4 .l id ) .
175
Chapter 4: Interaction of EAV with eqMoDC
(a )
c c — o
il
I :
(c)
200
1 5 0 -
100 -
50 -
0
PD-L1/CD274
Mo ÏÏlo D C mMoDC
ICOS-L/CD275
(b)
c c 200  
8 1  1 5 0
I  I  1001
% iH
u
50
(d)
PD-L2/CD273
Mo iMoDC mMoDC
B7-H3/CD276
.5 §
s’g
II
n
4-1
3-
l i ‘  f f  I I I
= i
s'âIf^ n
n
U . CO
M o iM oDC m M oDC
5 0 0
4 0 0
3 0 0
200
100
0 111
Mo iMoDC mMoDC
IZZI Attenuated Velogenic U K l
Figure 4.11. The expression level of costimulatory molecules on EAV 
infected Mo and MoDC 16 hours post infection. The costimualtory 
molecules, PD-L1/CD274, PD-L2/CD273, ICOS-I7CD275 and B7-H3/CD276, were 
assessed on EAV infected Mo and MoDC 16 hpi using duplex TaqMan qPCR 
assays with 18S rRNA gene as the reference (section 2.4.9). The normalised 
target gene expression was calculated by using the formula using the mock 
infected cells as the comparator (section 2.4.5). (a and b) There were 
significant differences in the expression of PD-L1/CD274 and PD-L2/CD273 on 
infected mMoDC with only the Attenuated and UKl strains resulting in an 
upregulation. (c) The overall expression levels of ICOS-L/CD275 on infected Mo 
and MoDC were low (less than 2 fold differences), (d ) The expression level of 
B7-H3/CD276 on infected iMoDC and mMoDC was significantly different between 
strains. Results were represented as the average fold difference ± SEM (n=3). A 
2 way ANOVA with Bonferroni post test was used to compare replicate means. *, 
* *  and * * *  indicate significant differences between sample means where p < 
0.05, 0.01 and 0.001, respectively.
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4.2.5. Changes induced by EAV infection on the function of Mo and 
MoDC
DC are specialised in presenting antigen to lymphocytes. This interaction 
initiates the adaptive immune response. Hence, DC bridge the gap between the 
innate and adaptive immune response. During infection (inflammation) Mo 
migrate to sites of infection in tissues and differentiate into macrophages (MO) 
and DC to support the immune response. Monocytes also have the ability to 
retain antigen for presentation later in their life cycle (Tacke and Randolph, 
2006). Due to the roles Mo and DC play in the immune system, it was important 
to determine the impact EAV may have on their function. The ability of infected 
Mo and MoDC to uptake antigen was assessed by investigating their endocytic 
and phagocytic capacity. The allostimulatory capacity of MoDC was investigated 
using in vitro mixed leukocyte reactions (MLR).
4.2.5 .1 . The infiuence o f  EAV on the endocytic capacity o f  Mo and MoDC
OVA fluorescently labelled to the APC dye was used to assess the 
endocytic capacity of infected Mo and MoDC (section 2.3.5). The data showed 
that the Velogenic strain significantly reduced the ability of Mo and mMoDC to 
endocytose OVA (Figures 4.12a and c). However, there was no significant 
change in the endocytic capacity of infected iMoDC (Figure 4.12b). The 
Attenuated and UKl strains provided very similar results but not significantly 
different to mock. Interestingly, the UV inactivated variant significantly 
decreased the ability of Mo to endocytose OVA.
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Figure 4.12. The capacity of EAV infected equine Mo and MoDC to  
endocytose antigen. Mo, iMoDC and mMoDC were inoculated at MOI of 5 with 
different strains of live or UV inactivated EAV. Controls were uninfected (media 
only) and mock infected cells. Cultures were incubated at 37°C in 5% CO2 for 16 
hours after which cells were harvested and incubated with 20 pg/ml of OVA-APC* 
at 4°C and 37°C for one hour (section 2.3.5). Cells were stained with the 
live/dead fixable vioblue dead cell stain and analysed by flow cytometry. Cells of 
the different treatments were assessed by comparing the same number of 
events (10,000) in the target gate. The percentage cells expressing OVA-APC* 
represented the difference in values obtained between the 37°C and 4°C 
(control). There were significant differences in the endocytic capacity of Mo and 
mMoDC infected with the Velogenic strain (a and c). (b ) There were no 
significant differences in the endocytic capacity of iMoDC infected with different 
EAV strains. The UV inactivated virus significantly reduced the uptake of OVA- 
APC* by Mo. Results are represented as the percentage positive cells ± SEM 
(n=6). A 1 way ANOVA with Dunn's post test was used to compare replicate 
means. * and * * *  indicate significant differences between sample means where 
p < 0.05 and 0.0001, respectively.
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4.2.5 .2 . The influence o f  EAV on the phagocytic capacity o f  Mo and MoDC
Phagocytosis is the vesicular internalisation of solid particles, such as 
viruses, by the cell membrane. FITC labelled microspheres at 1.0 pm in size 
were used to assess the phagocytic capacity of infected Mo and MoDC. The data 
reflect that of the endocytic assays, in that the Velogenic strain significantly 
decreased the phagocytic capacity of Mo and mMoDC, while the capacity of 
iMoDC was not affected (Figures 4.13a and c). The UV inactivated virus cell 
populations were also not significant although for both Mo and mMoDC a trend 
could be observed (Figure 4.13b).
4.2.5 .3 . The ab ility  o f  in fected MoDC to s tim u la te  T cells
The allostimulatory capacity of infected iMoDC and mMoDC was 
investigated by In vitro MLR assays as described in section 2.3.6. Therefore, the 
ability of CFSE labelled CD5+ T cells to proliferate was measured after exposure 
to infected MoDC. The differences observed in the CD5+ T cells numbers exposed 
to IMoDC infected with various virus strains were not significant (Figure 4.14a). 
However, the velogenic strain completely abolished the allostimulatory capacity 
of mMoDC (Figure 4.14b). Immature MoDC are inferior to mMoDC in their ability 
to stimulate T cell proliferation as shown by the proliferating T cell number scale 
(Figure 4.14; section 3.2.4.2).
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Figure 4.13. The capacity of EAV infected equine Mo and MoDC to  
phagocytose antigen. Mo, iMoDC and mMoDC were inoculated at MOI of 5 with 
different strains of live or UV inactivated EAV. Controls were uninfected (media 
only) and mock infected cells. Cultures were incubated at 37°C in 5% CO2 for 16 
hours after which cells were harvested and incubated at 4°C and 37°C for 4 hours 
with a FITC-conjugated microsphere, 1.0 pm in size, in a 5:1 (beads/cell) ratio 
(section 2.3.5). Cells were stained with the live/dead fixable vioblue dead cell 
stain. Cells of the different treatments were analysed using flow cytometry by 
comparing the same number of events (10,000) in the target gate. The 
percentage cells expressing FITC-microspheres represented the difference in 
values obtained between the 37°C and 4°C (control). There were significant 
differences in the phagocytic capacity of Mo and mMoDC infected with the 
Velogenic strains (a and c). (b ) There were no significant differences in the 
phagocytic capacity of iMoDC infected with different EAV strains. The percentage 
positive cells represent the average mean of six independent experiments ± 
SEM. Results are represented as the percentage positive cells ± SEM (n=6). A 1
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way ANOVA with Dunn's post test was used to compare replicate means. * *  
indicate significant differences between sample means where p < 0.001, 
respectively.
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Figure 4.14. The ability of EAV infected equine MoDC to stimulate T cells 
in in  v itro  mixed leukocyte reactions (MLR). Immature MoDC and mMoDC 
were inoculated at MOI o f 5 with different strains of live or UV inactivated EAV. 
Cultures were incubated at 37°C in 5% COz for 2 hours prior to the addition of 
CFSE (FITC) labelled allogeneic T cells and further incubated at 37°C for 3 days 
(section 2.3.6). Cells were harvested and stained with the fixable violet dead cell 
stain and CDS conjugated to the zenon PE dye to gate T cells. Cells of the 
different treatments were analysed using flow cytometry by comparing the same 
number of events (10,000) in the target gate, (a ) There were no significant 
differences in the allostimulatory capacity of iMoDC infected with different EAV 
strains, although there was a trend in reduction, (b ) There was a significant 
difference in the allostimulatory capacity of mMoDC infected with the Velogenic 
strain. Results were represented as Proliferating T cell numbers ± SEM (n=4). A 
1 way ANOVA with Dunn's post test was used to compare replicate means. * *  
indicate significant differences between sample means where p < 0.001, 
respectively.
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4.2.6. The impact of EAV infection on differentiation and 
activation
Once it was established that EAV inhibited some of the key functions of 
MoDC, the effect of the virus on the differentiation and activation was analysed. 
This was conducted by evaluating the capacity of infected cells to achieve an 
immature and mature MoDC phenotype. The expression of the main DC markers 
namely CD206, CD86, CD83 and MHC II was measured by flow cytometry.
4.2 .6 .1 . D iffe ren tia tion  o f  EAV in fected Mo to iMoDC
To assess the effect on differentiation. Mo were inoculated and incubated 
with the virus prior to the addition of cytokines GM-CSF and IL-4. This approach 
ensured that Mo were infected before stimulation and allowed for the phenotype 
to be assessed during differentiation. It  was clearly shown that the Velogenic 
strain significantly reduced the expression of surface molecules CD206, CD86, 
CD83 and MHC II  compared to the mock. Attenuated and UKl infected cells 
(Figure 4.15). Therefore, the virulent strain inhibited the ability of Mo to 
differentiate into iMoDC. I t  must be noted that the UV inactivated virus 
significantly reduced the expression of CD206 during differentiation.
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Figure 4.15. Effect of EAV infection on MoDC differentiation. Monocytes 
were inoculated at MOI of 5 with different strains of live and UV inactivated 
virus. Cells were washed and Incubated at 37°C in 5% CO2 for 2 hours after 
infection prior to the addition of 1000 U/ml of GM-CSF and 500 U/ml of IL-4. 
Cultures were incubated further at 37°C in 5% CO2 for 16 hours, after which cells 
were harvested and stained to assess phenotype by flow cytometry (section 
2.3.4). Cells were stained with the live/dead fixable vioblue dead cell kit, 
followed by staining with CD206-PE, CD83-PECy5, CD86-PECy5 and MHC II  
conjugated to the zenon APC* dye. For the different treatments, the same 
number of events (10,000) were analysed in the target gate. There were 
significant differences during differentiation in the phenotype of MoDC infected 
with the Velogenic strain. Results were represented as the percentage surface 
marker expression ± SEM (n=6). A 2 way ANOVA with Bonferroni post test was 
used to compare replicate means. * and * * *  indicate significant differences 
between sample means where p < 0.05 and 0.001, respectively.
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4.2.6 .2 . A ctiva tion o f  EAV in fected iMoDC to mMoDC
The effect on activation was assessed by inoculating and incubating 
iMoDC with virus prior to the addition of the maturation cocktail. As described for 
the differentiation, this approach ensured that iMoDC were infected before 
activation followed by phenotypic assessment of cells. This data revealed that 
upon activation there were no significant changes in the phenotype of infected 
mMoDC (Figure 4.16). Therefore, the virus had no effect on the ability of iMoDC 
to be activated to the mature state.
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Figure 4.16. Effect of EAV infection on MoDC activation. Immature MoDC 
were inoculated at MOI of 5 with different strains of live and UV inactivated EAV. 
Cells were washed and incubated at 37°C in 5% CO2 for 2 hours prior to the 
addition of the maturation cocktail (section 2.1.5). Cultures were incubated 
further at 37°C in 5% CO2 for 16 hours, after which cells were harvested and 
stained to assess phenotype by flow cytometry. Cells were stained with the 
live/dead fixable vioblue dead cell kit, followed by staining with CD206-PE, 
CD83-PECy5, CD86-PECy5 and MHC II  conjugated to the zenon APC* dye. For 
the different treatments, the same number of events (10,000) were analysed in 
the target gate. Upon activation, there were no significant differences in the 
phenotype of MoDC infected with different EAV strains. Results were represented
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as the percentage surface marker expression ±  SEM (n=6). A 2 way ANOVA with 
Bonferroni post test was used to compare replicate means.
4.2.7. Modulation of cytokine expression in infected Mo and MoDC
Cytokines are products of immune cells that act as important mediators 
or regulators of immune processes. The effect of viral infection in vivo is 
systemic and not isolated to infected cells. Therefore, it was considered suitable 
to determine if EAV infection triggered the release of cytokines such as IL-10 and 
IL-29. IL-10 is predominantly an inhibitory cytokine, known to block the 
transformation of iDC to immunogenic mDC, whereas IL-29 is a positive 
regulator of the immune response, including antiviral activity. The expression 
profiles of these two cytokines were investigated in infected Mo and MoDC. The 
duplex assays were developed as described in section 2.4.9.
The expression profile of IL-10 was such that it was significantly 
upregulated in Mo and iMoDC infected with the US velogenic strain (by 
approximately 15-fold and 21-fold respectively) compared to the US attenuated 
and UKl strains (Figure 17a). Overall, the expression of IL-10 was the highest in 
iMoDC for all strains. The expression in mMoDC was slightly above baseline 
levels for all strains.
The expression of IL-29 in infected Mo mirrored that of IL-10, in that the 
US velogenic strain significantly upregulated its expression (Figure 17b). 
However, there was no significant upregulation in iMoDC, thus dramatically 
shifting the balance of cytokines post infection. In contrast, the expression of IL- 
29 was significantly upregulated in mMoDC infected with the attenuated and UKl 
strains only, which thereby exhibits a strong pro-inflammatory bias in mMoDC.
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Figure 4.17. Cytokine expression leveis in infected Mo and MoDC. The
cytokines IL-10 and IL-29 were assessed in EAV infected Mo and MoDC 16 hpi 
using duplex TaqMan qPCR assays with 18S rRNA gene as the reference (section 
2.4.9). The normalised target gene expression was calculated by using the 2'^^^ 
formula using the mock infected cells as the comparator (section 2.4.5). (a ) IL- 
10 was significantly upregulated in Mo and iMoDC infected with the Velogenic 
strain. The expression in mMoDC was slightly above baseline levels for all 
strains, (b ) The expression of IL-29 in Mo infected with the Velogenic strain was 
significantly upregulated, while in mMoDC its expression was increased but by 
only a 5-fold difference. There was no significant upregulation in iMoDC induced 
by the Velogenic strain. Results were represented as the average fold difference 
± SEM (n=3). A 2 way ANOVA with Bonferroni post test was used to compare 
replicate means. * and * * *  indicate significant differences between sample 
means where p < 0.05 and 0.001, respectively.
86
Chapter 4: Interaction of EAV with eqMoDC
4.3. Discussion
EAV infections are systemic and the clinical picture ranges from 
asymptomatic infection to severe disease and death. The outcome of the 
infection is dependent on the virus strain and immune status of the horse. Little 
is known about the cell-mediated immune response to EAV such as its role in the 
clearance of virus infection. It  is known that EAV replicates in macrophages (M4>) 
and endothelial cells in vivo (Moore et al., 2002 and 2003) but for dendritic cells, 
which are responsible for initiating an anti-viral immune response and would 
serve as an ideal target for viruses seeking to evade or delay the immune 
response, nothing is known of their interaction with EAV.
The method employed to model the immunological function of DC and 
study the DC-EAV interactions in horses was the highly reproducible and robust 
in vitro equine MoDC system established and characterised in chapter 3. Briefly, 
CD14+ Mo from horse peripheral blood were differentiated into iMoDC after 5 
days in culture with equine GM-CSF and IL-4. Immature MoDC were then 
activated to mMoDC using a cocktail of inflammatory stimuli, which included 
PGEz and equine cytokines such as TNF-a, IL-6, IL-1(3 and IFN-y. I t  has been 
established in the previous chapter that the three cells of this system differ in 
phenotype and function. Transcriptomic studies have clearly shown differences in 
the expression profiles of these cells. Therefore, it has been observed that these 
cells resulted in distinct EAV replication and possibly transmission abilities.
4.3.1. EAV infects and replicates iyticaiiy in Mo and MoDC
All viruses used in this study were concentrated and dialysed to remove 
any impurities that may have influenced the biological changes observed. The 
EAV infectivity data was comparable for both the TCID50 and TaqMan qPCR 
assays (section 4.2.2). I t  has been clearly demonstrated here that the avirulent 
US Bucyrus attenuated strain (Wescott, 2000), the highly virulent US Bucyrus
187
Chapter 4: Interaction of EAV with eqMoDC
velogenic strain (McCollum and Timoney, 1999) and the low pathogenic UKl 
strain (Wood et al., 1995) have the ability to infect and replicate in Mo, iMoDC 
and mMoDC. However, the degree of replication varied between cell types with 
the highest degree of replication in mMoDC 16 hours post infection followed by 
Mo and the lowest level of replication in iMoDC for all strains. In all cell types, 
the Velogenic strain showed the highest degree of replication compared to the 
Attenuated and the UKl strains, which corresponded to the pathogencity of 
these viral strains. The latter two strains replicated to similar degrees in Mo and 
MoDC. This data supports a previous study, which demonstrated the increased 
ability of a virulent Bucyrus strain and the reduced ability of a less pathogenic 
strain to infect CD14+ Mo (Go et al., 2010).
The morphology of infected cells investigated by light microscopy 
revealed the shrinkage and disappearance of cells due to lysis compared to the 
mock infected cells (section 4.2.1.1). Time kinetic viability data confirmed the 
drastic reduction in cell numbers which pertained particularly to the Velogenic 
strain in Mo and mMoDC (section 4.2.1.2). Since the virus replication appeared 
to be slower in iMoDC, the morphological changes described were not visible 16 
hours post infection. Therefore, EAV has demonstrated a higher tropism for 
mMoDC and Mo in vitro, as they best supported productive replication of this 
virus. It is possible that IMoDC do not possess the EAV entry receptor(s), but this 
hypothesis maybe less likely due to EAV's ability to infect a number of different 
cell types from different organisms and the fact that the Velogenic strain showed 
a 50-fold increase in the ORFl gene expression coupled with an increase in virus 
in the supernatant, although these titres were low compared to Mo and mMoDC. 
I t  is possible that the immature DC state has the ability either to lim it the virus 
replication or for this virus to induce a tolerogenic state of iMoDC. Interestingly, 
Mo infected with the Attenuated strain seemed to display a DC-like morphology
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48 hours post infection. However, this theory would have to be tested further by 
conducting both phenotypic and functional studies on these DC-like cells.
The EAV receptor for entry has not been studied. The related Arterivirus, 
PRRSV, has a restricted tropism for porcine MO in vivo and the receptors 
sialoadhesin and CD163 have been identified as the entry receptors (Van Gorp et 
al., 2008). Sialoadhesin mediates virus attachment followed by internalization 
via receptor-mediated endocytosis (Nauwynck et al., 1999; Vanderheijden et al., 
2003). The membrane protein (M)/major glycoprotein (GP5) complex of PRRSV 
was identified as a ligand for sialoadhesin (Van Breedam et al., 2010) whereas 
the minor proteins GP2 and GP4 have been proposed to interact with CD163 (Das 
et al., 2010). Potentially, sialoadhesin and CD163 receptors maybe implicated in 
EAV cell entry. Less than half of equine Mo expressed CD163 and as a result 
other receptors are possibly involved In virus entry. The ability of EAV to infect 
CD14^ Mo was attributed to the intricate interactions among its envelope 
proteins, GP2, GP4, GP5 and M, which affected binding of the virus to different cell 
receptors on Mo (Go et al., 2010). MoDC do not express or show extremely low 
levels of CD163 (data not shown; Sulahian et al., 2000; Maniecki et al., 2006). 
Therefore, other receptors yet to be identified have to be involved in virus entry 
of MoDC. I t  is also possible that host cell receptors may vary between the 
different viruses. Contrast to PRRSV, EAV has a broad in vitro cell tropism which 
has been attributed to the interaction of the minor envelope proteins which play 
a crucial role in viral attachment (Tian et al., 2012). It is possible that EAV has 
the ability to change the combination of interacting envelope proteins depending 
on the target cell. The elements of interacting envelope proteins and immune 
cells surface receptors seem to contribute to the susceptibility of host cells to 
this virus. Further studies should be conducted to identify the EAV entry 
receptors on both Mo and DC. Clarifying the nature of these receptors may aid in
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understanding cell/tissue tropism and virus pathogenicity (Schneider-Schaulies, 
2000; Backovic and Rey, 2012).
The UV inactivated virus was included to assess the effect viral proteins 
may have on these immune cells. The lack of detection of the ORFl viral gene in 
cells inoculated this virus indicates that it was not taken up by cells or degraded. 
The undetectable infectivity titres in supernatants from both the EEL cell line and 
immune cells confirm the inability of this inactivated virus to replicate.
4.3.2. EAV infection induces apoptosis in equine primary Mo and 
DC
Programmed cell death is an essential regulatory process in the 
immunological system. Apoptosis is a controlled process of cell death caused by 
a cascade of biochemical events leading to morphological changes and 
eventually cell death (Bruchhaus et al., 2007). I t  can be seen as either a 
mechanism of the virus to destroy host cells allowing the dissemination of viral 
progeny or an early defence mechanism of host cells to prevent the spread of 
infection. There is ample evidence that the induction of apoptosis is influenced 
by the pathogenesis of viruses such as influenza viruses, chicken anemia virus, 
feline leukaemia virus, feline immunodeficiency virus and human 
immunodeficiency virus type 1 (Jeurissen et al., 1992; Rojko et al., 1992; 
Gougeon and Montagnier, 1993; Levine et al., 1993; Ohno et al., 1993 and 
Hinshaw et al., 1994).
To investigate whether apoptosis played a role during EAV infection of Mo 
and MoDC, the recombinant phosphatidylserine-binding protein, Annexin V, was 
used. This protein allowed for quantification of early and late apoptosis post 
infection. In this study, it was shown that apoptosis of host cells. Mo and MoDC, 
was induced upon infection with the virulent strain (section 4.2.3). Some viruses 
have evolved anti-apoptotic strategies early in infection and/or pro-apoptotic
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strategies late in infection. A study investigating the modulation of apoptosis 
during replication of PRRSV in alveolar MO has shown the stimulation of anti- 
apoptotic pathways early in infection and death of MO by apoptosis late in 
infection (Costers et al., 2008). In this study, EAV infected Mo and mMoDC were 
shown to be in an early and/or late apoptotic state with no necrosis 16 hours 
post infection. However, time kinetic apoptotic assays must be conducted to 
address whether anti and/or pro-apoptotic strategies are induced early or late 
during EAV replication of Mo and MoDC.
EAV infections via the respiratory route spread rapidly within the lung and 
bronchial lymph nodes, followed by dissemination throughout the horse's 
circulatory system (McCollum and Timoney, 1984). Mature DC, naturally located 
in lymph nodes, were shown here to best support the production of EAV 
progeny. Since blood monocytes were also shown to support virus replication, 
they may also play a key role in viral dissemination. Immature MoDC are not as 
efficient as Mo and mMoDC in supporting EAV replication. However, it is possible 
that their role may be one of transporting the virus in blood prior to activation 
and migration to the lymph nodes, as it was shown in this study that infected 
iMoDC still have the ability to undergo maturation (section 4.2.6.2). For future 
studies, further time course experiments need to be performed to identify the 
apoptotic status of iMoDC at later times post infection and upon conversion to 
mMoDC. This will aid in identifying the role IMoDC play in pathogenesis.
Apoptosis induced by EAV infection may possibly lead to dissemination of 
viral progenies to neighbouring cells through phagocytised apoptotic bodies. 
Here, apoptosis would act as a pathogenic mechanism of viral escape such as 
proposed for Dengue virus infection of human monocytes and macrophages 
(Torrentes-Carvalho et al., 2009). The alternative hypothesis is that apoptosis 
may be used as the host's immune mechanism to lim it viral progenies. For the 
Velogenic EAV strain this may be less likely due to the large fold differences in
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the viral genome and high infectivity titres obtained from infected Mo and 
mMoDC cultures in a short time frame of 16 hours (section 4.2.2). This indicated 
that the virus was replicating quickly and possibly promoting apoptosis to 
disseminate progeny. The Attenuated strain and low pathogenic UKl strain were 
less able replicate in these immune cells and did not induce apoptosis. Therefore, 
the viral pathogenicity and replicative competency influenced the ability of 
equine immune cells to undergo apoptosis, which is more likely to be a viral 
pathogenic mechanism.
To further define the apoptotic pathways involved in EAV replication, 
additional studies are required. Apoptosis can be triggered by the binding of the 
death receptors, such as TNF-RI, TRAIL (TNF-related apoptosis-inducing ligang)- 
R I/II and Fas (CD95/APO-1 (apoptosis antigen 1)), to the ligands TNF-a, TRAIL 
and FasL, respectively. The receptor/ligand interaction triggers an enzymatic 
cascade which leads to the activation of caspases and then degradation (Feig 
and Peter, 2007). Of the TNF family receptors involved in apoptosis, the Fas 
receptor has been linked to the pathogenesis of viral infections such as Measles 
and Hepatitis B (Servet-Del prat et al., 2000; Wang et al., 2004). Fas was shown 
to be upregulated on DC infected with Measles. Likewise, the induction of 
apoptosis on human HepG2 (hepatocellular carcinoma) cells infected with 
Dengue virus is Fas-dependent (Limjindaporn et al., 2007). HIV also induced 
apoptosis on human MoDC in response to FasL and TRAIL, resulting in increased 
levels of pro-apoptotic molecules, Bax (Bcl-2-associated X protein) and Bak (Bcl- 
2 homologous antagonist killer) and decreased levels of anti-apoptotic proteins, 
M cl-l (induced myeloid leukaemia cell differentiation protein) and FLIP (FLICE- 
like inhibitory protein) (Laforge et al., 2011). However, there are also multiple 
intracellular proteins, activation of which can trigger apoptosis. These non­
receptor mediated stimuli are mitochondrial initiated events and produce 
intracellular signals that act directly on targets (Elmore, 2007).
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To better understand the apoptosis of equine Mo and mMoDC induced by 
EAV, it is important to identify the molecules involved in this process and to 
determine their regulation. This will give some insight into the pathogenesis of 
EAV and can be carried out using transcriptomic technologies such as 
microarrays.
4.3.3. Immunomodulation of DC by EAV infection
I t  has been clearly demonstrated that mMoDC are highly permissive to 
infection by the Velogenic strain while IMoDC are less susceptible to this virus. 
Monocytes are more susceptible than IMoDC but less than mMoDC. To further 
analyse the consequences of infection for Mo and MoDC, both phenotype and 
function were assessed.
The phenotype displayed by infected Mo and MoDC, particularly with the 
Velogenic strain, reflects the efficiency of the virus replication in these cells. 
There were no changes in the surface marker expression on IMoDC, whereas 
there were significant changes in the modulation of cell surface markers on Mo 
and mMoDC induced by EAV, which influenced the function of these cells. The 
downregulation of the monocytic lineage markers CD14 and CD163 on Mo 
induced by EAV (section 4.2.4.1) possibly reduces their cellular responses. The 
increase in the expression of CD172a, by all virus strains and the UV inactivated 
variant, was not due to the virus pathogenicity but possibly to the signal 
regulatory nature of this molecule which allowed it to respond to both live and 
inactivated virus as the stimulus. On the other hand, this effect is still 
questionable since in relation to all controls the increase in expression was not 
significant.
DC play a central role in priming T cell responses (Banchereau and 
Steinman, 1998; Banchereau et al., 2000) to generate effective cell-mediated 
immunity against viruses (Palucka and Banchereau, 2002). Activation of T cells
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requires two signals, one which is antigen specific and involves the interaction of 
MHC II  on antigen presenting cells with T cell receptors and the second is a 
costimulatory signal which is antigen non-specific (Janeway et al., 2005). To 
assess the impact of infection on the function of immune cells, assays such as 
endocytic, phagocytic and MLR were performed. The replication of the Velogenic 
strain significantly reduced the endocytic and phagocytic capacity of Mo and 
mMoDC within 16 hours, while that of IMoDC was unaffected (sections 4.2.5.1 
and 4.2.5.2). This strain also inhibited the ability of mMoDC to stimulate 
alloreactive T cell responses (section 4.2.5.3). For iMoDC, the differences in the 
allostimulatory capacity were not significant, although a slight reduction could be 
observed which indicates a clear effect of replication.
The expression of CD83 has been associated with the ability of DC to 
stimulate T cell proliferation (Kruse et al., 2000b; Lechmann et al., 2001). The 
downregulation of this maker (section 4.2.4.2) and the lack of modulation of the 
costimulatory markers, namely PD-Ll, PD-L2 and B7-H3, on mMoDC (section
4.2.4.3) infected with the Velogenic strain can potentially be linked to the 
inability of these cells to prime T cells. Therefore, EAV disrupts the adaptive 
immune response. It  is highly possible that the antigen presenting ability of 
mMoDC will also be affected. In most cases it was observed that the UV 
treatment of the virus did not affect phenotype and function of Mo and MoDC. 
However, it did induce few phenotypic changes, including the upregulation of the 
costimulatory molecule CD86 on MoDC. This molecule plays a key role in T cell 
activation and MoDC in the presence of inactivated virus were still able to induce 
activation of T cells (section 4.2.5.3). Therefore, the significance of this effect is 
unknown.
In the presence of the Attenuated strain, PD-Ll, PD-L2 and B7-H3 were 
upregulated and ICOS-L remained at baseline levels on mMoDC (section
4.2.4.3). In chapter 3, it was proposed that the downregulation of PD-Ll and
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PD-L2 on uninfected mMoDC implied an inhibitory role in the equine immune 
response. The upregulation of these molecules in the presence of low pathogenic 
strains may accordingly mean that EAV also adopts other mechanisms to reduce 
an immune response.
B7-H3 was proposed to have a stimulatory role, as discussed in chapter 3, 
which was supported by its expression on mMoDC in the presence of the 
Attenuated strain. ICOS-L has maintained its low expression in the presence of 
both the Attenuated and Velogenic strains (section 4.2.4.3), which may imply 
that it sustained it stimulatory role during infection. This stimulatory signal may 
not be enough to overcome the inhibitory signals from the other costimulatory 
molecules. The downregulation of costimulatory molecules was also observed in 
bovine DC infected with cytopathic bovine viral diarrhoea (BVD), which also 
inhibited their ability to stimulate allogeneic T cells (Glew et al., 2003).
PD-Ll, PD-L2 and ICOS-L were shown to be expressed (chapter 3) on 
IMoDC, but during infection with the Attenuated and Velogenic strains these 
molecules did not change their expression as shown by the baseline level 
expression compared to the mock (section 4.2.4.3). ICOS-L did go slightly below 
baseline levels by 1-fold in the presence of the Velogenic strain, but was still 
expressed. Therefore, the virus had minimal influence on the expression of 
markers and contributed to the ability of these infected cells to stimulate 
alloreactive T cells. The expression of B7-H3 was upregulated in the presence of 
both strains compared to the mock, but its expression was roughly 300-fold 
higher in the presence of the Attenuated strain compared to the Velogenic strain. 
This molecule potentially has a stimulatory role in iMoDC and as with the other 
molecules contributed to the T cell stimulatory capacity of these cells.
Since the expression of MHC II  was not affected on infected mMoDC, it is 
possible that these cells were still able to present antigen that is maintain the 
antigen specific signal of T cell activation. However, due to the effect on the
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costimulatory molecules the T cell activation was possibly incomplete. Therefore, 
the initiation of an adaptive immune response would also be inhibited. I t  must be 
noted that a previous study has demonstrated the ability of EAV to infect CD3+ T 
cells (Go et al., 2010). I t  is possible that equine DC may have the ability to 
transmit the virus to T cells. The transmission of virus from DC to T cells has 
been shown in SIV (Simian Immunodeficiency Virus) infections (Ignatius et al., 
1998) and other lentiviral infection. The ability of both the immature and mature 
DC states to transmit the virus to T cells will need to be investigated. Further 
analysis will be required to assess which equine T cells subsets may be infected 
in this system. I f  T cells are in fact infected this may also contribute to the 
reduced T cells proliferative responses seen.
Mature MoDC infected with the low pathogenic strains are phenotypically 
and functionally largely unaffected and will contribute to the development of an 
immune response. The reduced viability and CPE of mMoDC infected with these 
low pathogenic strains maintained their T cell stimulatory capacity. Immature 
MoDC are also phenotypically unaffected and still functionally active in the 
presence of different EAV strains. It  is documented that CD8+ cytotoxic T 
lymphocytes (CTL) play a key role in the clearance of viral infections as shown 
with equine viruses such as equine herpesvirus (EHV-1), equine infectious 
anemia virus (EIAV) and equine influenza (Allen et al., 1995; Hammond et al., 
1998). A previous study has also implicated CD8+ T cells for the lysis of EAV- 
infected target cells (Castillo-Olivares et al., 2003). Indeed, IMoDC and mMoDC 
infected with less pathogenic strains may still have the ability to stimulate CD8+ 
T cells leading to clearance of these infected cells.
Endocytosis in human DC has been linked to the receptor CD206 
(Wollenberg et al 2002). The upregulation of CD206 on mMoDC infected the 
Velogenic strain and the decreased capacity to endocytose antigen may suggest 
that this uptake may not be CD206 mediated. Endocytosis of macrophages has
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been shown to be mediated by the scavenger receptor CD163 (Kristiansen et a!., 
2001; Schaer et a!., 2006) and the CD14-dependent endocytosis pathway has 
been reported for both Mo and DC (Kitchens et a!., 1998; Zanoni et a!., 2011). 
CD163 was not expressed on MoDC but on Mo and was shown to be 
dowregulated upon infection with the Velogenic strain along with the expression 
of CD14. The endocytic capacity of Mo infected with the Velogenic strain was 
also reduced. This reduction in the endocytic capacity was also exhibited by 
Human cytomegalovirus (HCMV) infected human Mo (Gredmark and Soderberg- 
Nauclér, 2003). I t  is possible that EAV inhibited the CD14 and CD163-mediated 
endocytosis of equine Mo. Alternatively, since the UV inactivated virus decreased 
the endocytic capacity of Mo and iMoDC, the reduction observed with the 
Velogenic strain may not only be due to replication. Further investigations are 
required to better understand the antigen uptake pathways in equine Mo and 
MoDC.
IL-10 and IL-29 belong to the same cytokine family known as the IL-10- 
IFN family. IL-29 was identified recently with limited amino acid similarity to IL- 
10 but due to the structural and functional properties IL-29 fits between the IL- 
10 family and type I interferons (Kotenko et al., 2003; Sheppard et al., 2003; 
Wolk et al 2008). IL-10 is a known immunosuppressor and when blocked may 
potentially restore antiviral T cell responses, as described in LCMV (Lymphocytic 
Choriomeningitis) infection (Brooks et al., 2010). On the other hand, it has been 
suggested that IL-29 amplifies the anti-viral response against viruses (Osterlund 
et al., 2005; Melchjorsen et al., 2006). EAV infection of equine immune cells has 
shown that the overall expression of IL-10 in Mo and iMoDC was higher than that 
of IL-29 (section 4.2.7). In mMoDC, the overall expression of IL-29 was higher 
than that of IL-10. Therefore, the functional descriptions of these cytokines do 
not fit with what has been described above for EAV. Based on the data presented 
for EAV replication, apoptosis and function of MoDC, it was expected that
197
Chapter 4: Interaction of EAV with eqMoDC
mMoDC would have had a higher expression of IL-10 and lower IL-29 
expression. It must be concluded that there are elements of this infection 
system, particularly related to cytokine expression, not yet understood and a 
conclusive statement cannot be made on the limited cytokines assessed. A more 
comprehensive cytokine expression profile is required for these infected immune 
cells.
4.3.4. EAV in monocytic cells suppressed their differentiation into 
DC
It is clear that the immature and mature MoDC states dramatically differ 
in their susceptibility to EAV. It  was thus necessary to determine the impact of 
this virus on the differentiation and activation of MoDC. Not interestingly, the 
Velogenic strain inhibited the ability of Mo to differentiate towards iMoDC 
(section 4.2.6.1). All the main DC surface molecules, namely CD206, CD83, 
CD86 and MHC II, were significantly downregulated on infected cells upon 
stimulation. Similarly, HCMV infected Mo were unable to differentiate into DC 
(Gredmark and Sôderberg-Nauclér, 2003). However, it is clear that different 
viruses have varying influences on Mo differentiation. VSV, VV and influenza A 
viruses induced the rapid differentiation of Mo (Hou et al., 2012). Equine Mo 
infected with the Attenuated and UKl strains still had the ability to differentiate 
into iMoDC. However, further studies beyond 16 hours would determine if the 
less pathogenic strains eventually inhibit differentiation.
In contrast, infected equine iMoDC in the presence of the maturation 
cocktail had the capacity to obtain a mature phenotype as EAV did not hinder the 
activation of infected iMoDC (section 4.2.6.2). Dengue virus stimulation of 
human DC also induced maturation of cells (Ho et al., 2001), while other viruses 
such as HCMV and Japanese encephalitis virus (JEV) suppressed maturation of 
human and mouse DC (Moutaftsi et al., 2002; Cao et al., 2011). The induction of
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maturation may contribute to the ability of the horse to establish a cell-mediated 
immune response and to overcome or clear the infection of low pathogenic 
strains. However, it may also be a virus transport mechanism to aid further 
infection.
To further examine whether active EAV replication was required to block 
DC differentiation. Mo were inoculated with a UV inactivated virus. The 
inactivated virus only reduced the expression of CD206, which does not to 
correlate with equine DC differentiation (Chapter 3). This expression possibly 
influenced the reduction in receptor-mediated endocytosis of iMoDC. The reason 
behind this effect is unknown. Thus, in contrast to other functional elements, 
such as T cell activation, differentiation was not inhibited by the UV inactivated 
virus, which required active replication of EAV. A specific cellular and humoral 
immunity can be induced by inactivated viruses as described in rhesus monkeys 
injected with inactivated SIV DC (Lu et al., 2003).
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5.1. Introduction
Recently, the emergence of novel orbivirus strains in Europe, North 
America, Asia and Australia (MacLachlan and Guthrie, 2010) has been of great 
concern to the worldwide livestock industry. The similarity of Equine 
encephalosis virus (EEV) to African horse sickness virus (AHSV), one of the most 
devastating pathogens of equids, authorised further investigations on the effect 
of EEV on its host immune cells by determining if crucial myeloid cells such as 
dendritic cells (DC) are replication targets for EEV. These in vitro virus-cell 
interactions may provide meaningful explanations for the pathogenesis of EEV 
infection in horses, as well as dissemination and immunity within the infected 
host. Since no previous work has been reported on the interaction of EEV with 
the in vitro DC system, monocyte-derived DC (MoDC), it was first determined 
whether EEV has the ability to infect and replicate ih monocytes and MoDC. 
Comparisons were made to determine the phenotypic and functional changes 
induced on MoDC as a result of virus infection. As with EAV, further 
investigations were performed to assess the impact infection has on the 
differentiation and activation states of eqMoDC.
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5.2. Results
5.2.1. Effect of EEV on Mo and MoDC morphology and viability
5.2.1.1 . The m orphologica l effects o f  EEV on Mo and MoDC
The morphological changes induced by EEV on Mo and MoDC have not 
been previously investigated. As carried out on EAV supernatants (sections 2.2.4 
and 4.2.1.1), EEV supernatants and mock controls (supernatants from Vero 
cells) were concentrated and dialysed to remove any impurities that may have 
influenced the biological changes observed. Similar to EAV, the data from all 
downstream assays showed no influence of the mock on myeloid cells, which 
confirmed the observed effects were due to the virus. The mock infected Mo 
maintained their round and adherent appearance (Figure 5.1a), while EEV 
infected Mo formed dense clusters 24 hours post infection (Figure 5.1b). These 
clusters were maintained 48 hours post infection (Figure 5.1c) and the presence 
of finger-like projections increased over time until 72 hours post infection (Figure 
5.Id ). This DC morphology was induced in the absence of the differentiation 
cytokines, GM-CSF and IL-4. The formation of cell clusters along with the 
presence of dendrites may indicate that the virus induced some differentiation or 
activation of Mo.
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Figure 5.1. Morphology of equine monocytes during culture with EEV. Mo
were inoculated with the mock control or at a MOI of 5 with the Israel strain. 
Cells were incubated at 4°C for 90 minutes, then washed thoroughly 3 times with 
cold RPMI-1640 media (section 2.2.7) and incubated at 37°C in 5% CO2 for 24- 
72 hours, (a ) Mock infected Mo maintained their round and adherent 
appearance, (b ) 24 hours post infection (hpi) they showed at first clustering of 
cells, which increased over time, (c) Mo 48 hpi. (d ) Mo 72 hpi. Photographs 
were captured at a magnification of x 20 and x 40 (72 hpi).
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EEV infected iMoDC maintained the classic appearance of DC clusters with 
finger-like projections until 72 hours post infection (Figure 5.2), thus no 
observable morphological changes were induced in iMoDC.
(a ) Mock % (b) EEV 24 h.p.i.
(c j EEV 48 h.p.i. (d ) EEV 72 h.p.i.
Figure 5.2. Morphology of equine IMoDC during culture with EEV.
Immature MoDC were inoculated with the mock control and at a MOI of 5 with 
the Israel strain. Cells were infected as described in Figure 5.1. (a ) Mock 
infected iMoDC maintained their less adherent clusters with the presence of 
dendrites and elongated cells, (b, c and d) Virus infected iMoDC similarly 
maintained the classical DC clusters with finger-like projections from 24 to 72 
hpi. Photographs were captured at a magnification of x 40.
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Similarly to iMoDC, mMoDC maintained their morphology in the presence of virus 
up to 72 hours post infection (Figure 5.3). Compared to EAV, little or no 
morphological differences were observed in MoDC cultures infected with EEV.
(b ) EEV 24 # p %  I(a ) Mock
I
(c) EEV 4 8 li.p .i. (d ) EEV 72 h.p.i.
/  % î ' i " A 7 X ' X .
A
W - \
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Figure 5.3. Morphology of equine mMoDC during culture with EEV. Mature 
MoDC were inoculated with the mock control and at a MOI of 5 with the Israel 
strain. Cells were infected as described in Figure 5.1 and incubated at 37°C in 
5% CO2 for 24-72 hours, (a ) Mock infected mMoDC and (b, c and d) Virus 
infected mMoDC maintained their large, dense and loosely adherent clusters with 
the presence of protrusions. Photographs were captured at a magnification of x 
20 (mock and 72 hpi) and x 40.
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5.2.1.2 . The e ffect o f  EEV on equine Mo and MoDC v iab ility
To determine the effect of EEV on cell viability over time, viability assays 
were performed with the violet live/dead stain kit (Figure 5.4). A significant 
difference in the viability of EEV infected Mo was observed only 72 hours post 
infection. This is in contrast to EAV where a significant change in cell viability 
was observed already at 8 hours. For EEV infected iMoDC there were no 
significant changes in the cell viability even 72 hours post infection. Similarly, for 
EAV infected iMoDC there were no significant changes observed 24 hours post 
infection (section 4.2.1.2). Interestingly, there were no significant changes in the 
viability of EEV infected mMoDC. Any effects observed after 48 hours may be 
influenced not by the virus but by the limited number of cells left in culture, due 
to the short life span of activated DC. This quantitative data supports the 
qualitative data of no observable changes observed in the morphology of Mo and 
MoDC (Figures 5.1, 5.2 and 5.3). I t  became evident that the effect by EEV on 
these immune cells by EEV was slower and without the devastating effect on 
morphology and viability compared to EAV.
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Figure 5.4. Time kinetics on the viability of EEV infected Mo and MoDC.
Mo, iMoDC and mMoDC were seeded at a density of 1 x 10® cells and infected at 
MOI of 5 with the live and UV inactivated virus as described in Figure 5.1. 
Controls included uninfected cultures (media only) and mock infected cultures. 
After the respective hours post infection (hpi), cells were stained with the 
live/dead violet dead cell stain and analysed as described in section 2.3.2. For 
the different treatments, the same number of events (10,000) were analysed in 
the target gate. Data are represented as the mean percentage viable cells 
expressing ± SEM (n=4). A 2 way ANOVA with Bonferroni post test was used to 
compare replicate means of the different treatments and mock. * *  indicate 
significant differences between sample means where p < 0.01.
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5.2.2. Detection of EEV in equine Mo and MoDC
To identify the ability of EEV to infect and replicate in equine immune 
cells, both the real-time quantitative SYBR Green PCR and TCID50 assays were 
used. The SYBR Green qPCR assay aided in the identification of the most suitable 
time point for subsequently assessing phenotypic and other alterations in the 
myeloid cells. The TCID50 assay detected the quantity of infectious virus released 
into the cell culture supernatants.
The SYBR Green qPCR assay detected EEV NS3 gene expression in Mo 
and both the immature and mature MoDC cells. The 0 hour post infection, which 
represented virus attachment, was used as the calibrator sample in the relative 
quantification data analysis for each cell type. For the UV inactivated control, the 
level of NS3 gene detected equalled the baseline levels after attachment of the 
virus (data not shown) which demonstrated both that the virus was able to bind 
to the cells and the appropriate inactivation. The NS3 expression increased in all 
cells over time (Figure 5.5), however, reaching almost a plateau after 48 hours 
particularly in MoDC. The increase in NS3 expression was most rapid in mMoDC 
followed by Mo and then iMoDC. Hence, EEV seemed to replicate most effectively 
in mMoDC whereas iMoDC produced the least EEV gene product. The biggest fold 
change in NS3 expression occurred at 24 hours post infection which indicated a 
first complete replication cycle.
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Figure 5.5. Time kinetic of EEV gene expression in equine Mo and MoDC.
Horse Mo, IMoDC and mMoDC were Inoculated at MOI of 5 with the Israel strain. 
Infections were performed as described In Figure 5.1 and cells harvested directly 
after washing (0 hour) or after 8, 16, 24, 48 and 72 hpi. Total RNA extractions 
from cells and reverse transcription were performed. The NS3 SYBR Green qPCR 
was performed In parallel with the 18S TaqMan rRNA qPCR. As described for EAV 
(sections 2.4.7. and 4.2.2), the normalized fold difference ratio was calculated 
using the formula with the 0 hpi as the comparator. Results are 
represented as the mean fold difference ± SEM (n=9).
The TCIDso time kinetics showed the accumulation of new virions In the 
cell culture supernatant. The data represented the difference In the viral 
Infectlvlty titres between the 0 hour and the testing time points. The overall 
titres were very low In these supernatants (Figure 5.6), however the differences 
In the titres between the test and 0 hour post Infection were significant 24 hours 
post Infection and onwards. Titres Increased over the first 24 hours post 
Infection, but remained almost stable thereafter up to 72 hours post Infection. 
Thus, while the qPCR data demonstrated a strong NS3 gene expression, only 
very limited amounts of virus were de-novo produced.
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Figure 5.6. Viral titres measured in the supernatants of infected Mo and 
MoDC cultures titrated on the susceptible cell line Vero. Monocytes, IMoDC 
and mMoDC were Infected as described In Figure 5.1. Cells were also Inoculated 
with the UV Inactivated preparation of EEV. Cultures were Incubated at 37°C In 
5% CO2 and cell supernatants were collected at various time points. TCID50 
assays were performed on cell supernatants and the titres calculated using the 
Karber formula (section 2.2.5). The TCIDso/ml of the 0 hour time point was 
subtracted from the TCIDso/ml of the various time points. At 8  hours no 
Indication for a de-novo production of virions could be detected. Subsequently, 
however, there was always more virus retrieved than detectable at 0 or 8  hpi. 
This Indicates that the replication remains very restricted. Results represented 
the TCIDso/ml ± SEM (n=9). For single comparisons between the test and 0 hpi, 
a two-tailed paired Student t test was used with Bonferroni post test. * *  and * * *  
Indicate significant differences between sample means where p < 0.005 and 
0 .0 0 0 1 , respectively.
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5.2.3. Apoptosis is not induced by EEV infection of Mo and MoDC
Some viruses Induce apoptosis In their target host cells as shown for EAV 
(section 4.2.3). Although EEV appeared not to replicate lytlcally, apoptotic 
assays with Annexin-V and 7-AAD were performed to assess this further. The 
data confirmed that the percentage of Mo and MoDC positive for AnnexIn-V and 
7-AAD 48 hours post Infection were not significant when compared to the mock
Infected cells (Figure 5.7). The percentage cells that underwent early and late
apoptosis were similar to the mock control. Apoptotic assays performed at 16, 
24 and 72 hours post Infection, also showed no significant differences between 
the mock and virus Infected cells (data not shown). Therefore, as a result. It can 
be ruled out that EEV Induced apoptosis of Mo and MoDC.
5.2.4. Phenotypic changes induced by EEV infection
In this part, the expression of key cell surface molecules was assessed on 
Infected Mo and MoDC by flow cytometry. I t  was described In chapter 4 that the 
altered expression of the cell surface molecules by EAV paralleled the biological 
function of these cells. Hence, It was Important to determine the effect of EEV on 
the phenotype of these Immune cells. The molecules Investigated on Mo were 
CD14, CD163 and CD172a while on MoDC the molecules selected were CD206, 
CD83, CD86 and MHC II.
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Figure 5.7. Apoptotic effect of EEV on Mo and MoDC. Monocytes, iMoDC and 
mMoDC were infected as described In Figure 5.1. Cultures were Incubated at 
37°C In 5% CO2 for 48 hours after which apoptosis assays were performed by 
flow cytometry (section 2.3.2). Mock and Infected cells stained with the apoptotic 
marker AnnexIn-V and live-dead stain 7-AAD for 15 minutes at room 
temperature. Controls Included unstained cells, cells stained with Annexin V-FITC 
alone and 7-AAD-PECy5 alone. Stained cells were analyzed using the 
MACSQuant Analyzer. For the different treatments, the same number of events 
(10,000) were analysed In the target gate. There were no significant differences 
between the mock and EEV Infected cultures In the percentage (a ) cell viability 
(Annexln-V/7-AAD ), (b ) early apoptotic cells (Annexln-V+/7-AAD ), (c) late 
apoptotic cells (Annexln-VV7-AAD+) and (d ) necrotic cells (Annexln-V'/7-AAD+). 
The results are represented as the percentage positive cells ± SEM (n=9). A 2 
way ANOVA with Bonferroni post test was used to compare replicate means of 
the virus and mock.
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5.2 .4 .1 . The expression o f  m onocytic  m arkers on EEV in fected  Mo
The EEV Israel strain had no significant Influence on the expression of 
surface molecules 48 hours post Infection except for CD163 expression which 
was slightly but statistically significantly upregulated In the presence of EEV 
(Figure 5.8). This Indicated the ability of the virus to exert some effects on 
monocytes.
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Figure 5.8. Phenotypic changes induced by EEV on Mo. Monocytes were 
seeded at a density of 1 x 10^ cells and Infected as described In Figure 5.1. 
Cultures were Incubated at 37°C In 5% CO2 for 48 hours after which cells were 
harvested and stained to assess phenotype. Cells were stained with the live/dead 
fixable near-IR dead cell kit, followed by staining with CD14-FITC, CD163- 
Vloblue and CD172-PE. The monoclonal antibodies were conjugated via the 
zenon fluorescent dyes. The controls included were unstained cells and Isotype 
controls. All staining were performed and analysed as described In section 2.3.4. 
For the different treatments, the same number of events (10,000) were analysed 
In the target gate. The EEV strain upregulated the expression of CD163 but had 
no significant effect on the expression of CD14 and CD172a. Results were 
represented as the percentage cells expressing surface markers ± SEM (n=9). A 
2 way ANOVA with Bonferroni post test was used to compare replicate means of 
the different treatments and mock. * * *  Indicate significant differences between 
the mock and EEV sample means where p < 0.001.
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5.2.4.2. The expression o f DC m arkers on EEV Infected Mo
Following the observed morphological changes in infected Mo (section 
5.2.1.1), cells were infected with virus and incubated longer in the absence of 
cytokines before specifically stained for the DC markers CD206, CD86, CD83 and 
MHC II. Strikingly, EEV upregulated all surface molecules assessed in the 
absence of GM-CSF and IL-4 and viral replication was clearly required to drive 
this process since the UV inactivated virus was unable to do so (Figure 5.9). The 
expression of these surface molecules resembles an IMoDC phenotype described 
in section 3.2.3.2.
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Figure 5.9. EEV infected Mo drive DC-like phenotype. Monocytes were 
seeded at a density of 1 x 10^ cells and infected as described in Figure 5.1. 
Cultures were incubated at 37°C in 5% CO2 for 72 hours. Cells were stained with 
the live/dead fixable vioblue dead cell kit, followed by staining with CD206-PE, 
CD83-PECy5, CD86-PECy5 and MHC II conjugated to the zenon APC* dye. Cells 
were stained and analysed as described in section 2.3.4. For the different 
treatments, the same number of events (10,000) were analysed in the target 
gate. There were significant differences in the phenotype of infected Mo, where 
all DC markers were upregulated in the absence of GM-CSF and IL-4. Results are 
represented as the percentage cells expressing surface markers ± SEM (n=3). A 
2 way ANOVA with Bonferroni post test was used to compare replicate means of 
the different treatments and mock. * * *  indicate significant differences between 
the mock and EEV sample means where p < 0.001.
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5.2.4 .3 . E ffect o f  EEV in fection on MoDC phenotype
EEV had no measurable influence on the expression of CD206, CD83 and 
CD86 on iMoDC 24 hours post infection. Only the expression of MHC II was 
slightly but significantly downregulated (Figure 5.10a). Similarly, there were no 
significant differences in the expression of CD206, CD83 and MHC II  on mMoDC 
but the expression of CD86 was slightly but significantly downregulated (Figure 
5.10b).
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Figure 5.10. Phenotype of EEV Infected MoDC. Immature and mature MoDC 
were seeded at a density of 1 x 10® cells and infected as described in Figure 5.1. 
Cultures were incubated at 37°C in 5% CO2 for 48 hours. Cells were stained with 
the live/dead fixable vioblue dead cell kit, followed by staining with CD206-PE, 
CD83-PECy5, CD86-PECy5 and MHC II conjugated to the zenon APC* dye. All 
staining were performed as described in section 2.3.4. For the different 
treatments, the same number of events (10,000) were analysed in the target 
gate, (a ) Only the expression of MHC II was significantly downregulated. (b ) 
The EEV Israel strain significantly decreased the expression of only CD86 on 
mMoDC. Results were represented as the percentage surface marker expression 
± SEM (n=9). A 2 way ANOVA with Bonferroni post test was used to compare 
replicate means of the different treatments and mock. * indicate significant 
differences between sample means where p < 0.05.
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5.2.5. Changes regarding the functional attributes of Mo and 
MoDC induced by EEV
As described in chapters 1, 3 and 4, Mo and DC have important functions 
in the immune system. Therefore, it was crucial to determine the impact EEV 
may have on the function of these immune cells. The ability of infected Mo and 
MoDC to take up antigen was assessed by investigating their endocytic and 
phagocytic capacity. In addition, the ability of MoDC to stimulate T cell 
proliferation in vitro was assessed in MLR.
5.2.5.1. The effect o f EEV on the endocytic and phagocytic capacity o f Mo 
and MoDC
The endocytic and phagocytic capacity of EEV infected Mo and MoDC were 
assessed using OVA fluorescently labelled to the ARC* dye and FITC labelled 
microspheres at 1.0 pm in size, respectively as described in section 3.2.4.1. The 
data showed that this virus did not alter the ability of either of the infected cells 
to endocytose OVA and phagocytose microspheres (Figures 5.11).
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Figure 5.11. The capacity of EEV infected equine Mo and MoDC to 
endocytose ovaibumin and phagocytose microspheres. Mo, iMoDC and 
mMoDC were infected as described in Figure 5.1. Cultures were incubated at 
37°C in 5% CO2 for 48 hours. Subsequently cells were harvested and incubated 
at 4°C and 37°C with (a ) 20 pg/ml of APC^'-conjugated OVA for 1 hour or (b ) 
FITC-conjugated microspheres (1.0 pm in size) in a 5:1 (beads/cell) ratio for 4 
hours as described in section 2.3.5. Cells were stained with the live/dead fixable 
vioblue dead cell stain for 30 minutes at 4°C. Stained cells were analysed by flow 
cytometry. For the different treatments, the same number of events (10,000) 
were analysed in the target gate. All dead and duplex cells were removed from 
analysis. There were no significant differences in the endocytic and phagocytic 
capacity of Mo and mMoDC infected with EEV. (Uninfected=Uninf; 
inactivated=inact). Results are represented as the percentage positive cells ± 
SEM (n=6). A 1 way ANOVA with Dunn's post test was used to compare replicate 
means.
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5.2.5.2 . The ab ility  o f  in fected MoDC to s tim u la te  T cell p ro life ra tion
The allostimulatory capacity of infected iMoDC and mMoDC was 
investigated by in vitro MLR assays as described in section 3.2.4.2. In brief, the 
ability of CFSE labelled CD5+ T cells to proliferate was measured after exposure 
to infected MoDC. The differences observed in the CD5^ T cells numbers exposed 
to EEV infected iMoDC was not significant (Figure 5.12a). I t  needs to be taken 
into account though that these are the less efficient T cell stimulators. In 
contrast, there was a significant decline in T cell numbers in the presence of the 
infected mMoDC, reducing the T cell response approximately by half (Figure 
5.12b). Thus, demonstrating once more that while the replication of EEV might 
have been restricted the virus clearly affected infected cells.
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Figure 5.12. The ability of EEV infected equine MoDC to stimulate T cells 
in in  v itro  mixed leukocyte reactions (MLR). Immature MoDC and mMoDC 
at a density of 1 x 10® cells were infected as described above in Figure 5.3. 
Cultures were further incubated at 37°C in 5% CO2 for 24 hours. MoDC were 
incubated with CFSE (FITC) labelled allogeneic T cells at 37°C for 3 days as 
described in section 2.3.6. The MLR was analysed as described in section 
3.2.4.1. For the different treatments, the same number of events (10,000) were 
analysed in the target gate, (a ) There were no significant differences in the 
allostimulatory capacity of iMoDC infected with EEV. (b ) There were significant 
differences in the allostimulatory capacity of mMoDC infected with the EEV Israel 
strain. Results were represented as CFSE T cell numbers ± SEM (n=4). A 1 way 
ANOVA with Dunn's post test was used to compare repiicate means. * *  indicate 
significant differences between sample means where p < 0.001, respectively.
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5.2.6. The impact of EEV infection on differentiation and 
activation
The ability of EEV infected Mo and iMoDC to differentiate and activate into 
iMoDC and mMoDC, respectively was assessed by measuring the expression 
levels of the main DC markers, namely CD206, CD86, CD83 and MHC II. Mo and 
IMoDC were inoculated and incubated with virus prior to the addition of cytokines 
and the maturation cocktail, respectively.
In the presence of cytokines, there were no significant changes in the 
phenotype of infected iMoDC during differentiation (Figure 5.13a). Therefore, the 
virus did not inhibit the differentiation of Mo to iMoDC. Upon activation, there 
were no significant changes in the expression of most markers tested on infected 
mMoDC. However, the expression of CD83 was not upregulated to the same 
extent as in uninfected or mock infected mMoDC (Figure 5.13b). Although, the 
expression of CD83 is not strictly correlated with DC maturation in the horse 
(sections 3.2.3.2 and 3.2.5.3), its reduced upregulation might be functionally 
important for mature DC, as it is in line with the reduced ability to stimulate T 
cells.
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Figure 5.13. Effect of EEV infection on MoDC differentiation and 
activation. Monocytes and iMoDC were infected as described in Figure 5.1. For 
MoDC differentiation, Mo cultures were incubated at 37°C in 5% CO2 for 2 hours 
followed by the addition of 1000 U/ml of GM-CSF and 500 U/ml of IL-4 and the 
maturation cocktail to iMoDC, as described in Figures 4.15 and 4.16. Cultures 
were incubated at 37°C in 5% CO2 for a further 48 hours after which cells were 
harvested and stained to assess phenotype. Cells were stained with the live/dead 
fixable vioblue dead cell stain, followed by staining with CD206-PE, CD83-PECy5, 
CD86-PECy5 and MHC II  conjugated to the zenon APC* dye. All staining were 
performed and analysed as described in section 2.3.4. For the different 
treatments, the same number of events (10,000) were analysed in the target 
gate, (a ) There were no significant differences in the phenotype of infected 
iMoDC during differentiation in the presence of GM-CSF and IL-4. (c) There was 
only a lack of upregulation of CD83 upon activation of infected iMoDC. Results 
were represented as the percentage surface marker expression ± SEM (n=6). A 
2 way ANOVA with Bonferroni post test was used to compare replicate means of 
the different treatments and mock. * indicate significant differences between 
sample means where p < 0.05.
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5.3. Discussion
5.3.1. Restricted EEV infection of Mo and MoDC
The EEV Israel strain was shown to cause febrile outbreaks in horses 
during 2008-2009. Other clinical signs included lack of appetite, oedema and 
lethargy (Mildenberg et al., 2009; Aharonson-Raz et al., 2011), with no reported 
deaths. Thus overall the clinical picture resembled EAV and in fact was first 
misdiagnosed as such. There have been no prior investigations on the tropism of 
EEV for immune cells such as monocytes and dendritic cells. In orbiviruses, the 
NS3 protein has been shown to influence the release of virus particles from host 
cells (Hyatt et al., 1993; van Niekerk et al., 2001; Huismans et al., 2004). Here, 
the NS3 gene was used as the target to identify the replication of EEV within Mo 
and MoDC. Indeed, the NS3 real-time qPCR assay data demonstrated NS3 
expression from EEV in all infected cells, whereby most NS3 was over time 
expressed within mMoDC followed by Mo and finally IMoDC. The very low 
infectlvlty titres, however, revealed that the production of infectious virions from 
these leukocytes was restricted (section 5.2.2). Altogether, these findings 
showed that Mo and MoDC became infected at an early stage but are not fully 
permissive for EEV. While the data suggest that the release of de novo virus 
requires additional signals, EEV also maintained cell viability (section 5.2.1.2) 
enabling it to hide from the immune system. The lack of apoptosis and no 
obvious CPE (sections 5.2.1.1 and 5.2.3) supported a non-lytic restricted or 
abortive replication of EEV in Mo and MoDC. Therefore, this complex interaction 
may control the acute infection and viral persistence over a longer term and 
influence the severity of the disease.
EEV is related to other orbiviruses such as BTV and AHSV. BTV, a 
prototype orbivirus, has been shown to replicate in monocytes via labelling of 
the non-structural protein NSl and electron microscopy. In that study, the
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budding of virus particles into cytoplasmic vesicles of infected cells was 
demonstrated 48 hours post infection (Brewer and MacLachlan, 1994). The 
persistence of virus particles in the invagination of cell membranes has provided 
an explanation for the prolonged cell-associated viremia observed with BTV 
infections. I t  may be possible that the accumulation of virions within equine 
immune cells and the few virions in the culture supernatants are similarly linked 
to the persistence of virus particles in the cells. To assess this, staining of viral 
proteins with antibodies, which are not readily available, and other techniques 
such as electron microscopy will have to be employed.
As stated above, the NS3 protein mediates the budding and release of 
virus particles from infected cells, but co-expression with the NSl protein has 
been shown to inhibit the association of BTV with the cell cytoskeleton and their 
release from cells (Hyatt et al., 1993). Hence, further studies will be required to 
determine whether NSl is co-expressed with NS3 thereby inhibiting the release 
of EEV from infected Mo and MoDC. Additionally, there may be other viral 
proteins, such as the inner capsid proteins (VP3 and VP7) and not the outer 
capsid proteins (VP2 and VP5), that are otherwise eventually inhibiting budding 
and release as suggested for BTV (Hyatt et al., 1993). I t  is conceivable that 
orbiviruses self-regulate the function of these proteins by selecting those that 
will prevent release from cells, hence favouring persistence.
Several in vitro studies with bovine leukocytes have shown that BTV 
targeted Mo with 10% to 20% producing viral proteins 24 hours post infection 
(Whetter et al., 1989; Barratt-Boyes et al., 1992). Unfortunately, for EEV the 
percentage cells producing viral proteins could not be determined due to the lack 
of available antibodies for flow cytometry. Like in the case of EEV, BTV infection 
of bovine blood Mo in vitro produced low titres of infectious BTV within the first 
24 hours post infection (Whetter et al., 1989; Barratt-Boyes et al., 1992). 
Despite the expression of the NS3 gene in infected cells, the minimal increase in
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the virus titres in infected cultures suggests that Mo and MoDC are not conducive 
to productive replication of EEV. Similarly, bovine monocytes were not conducive 
to the productive replication of BTV even with the production of BTV proteins in 
infected cells (Whetter et al., 1989). Recently, ovine cDC from the lymph were 
shown to support productive BTV replication, due to the increase in infectivity 
titres over time from 50 to 400 TCID50, including the residual amounts of 
infectivity (< 50 TCID50) (Hemati et al., 2009). Previously, it has been shown 
that coculture of y6 (gamma-delta) T cells with skin fibroblasts promoted BTV 
synthesis (Brodie et al., 1998), therefore coculture of equine Mo and MoDC with 
other cells they interact with, such as endothelial cells might promote EEV 
synthesis and increase infectivity titre.
The replication of BTV in cDC did not induce apoptosis (Hemati et al., 
2009), which is in accordance with this study. The induction of apoptosis in BTV 
infected mammalian cell lines has been attributed to the viral outer proteins, VP2 
and VP5, independent of viral replication (Mortola et al., 2004). The cytopathic 
effect induced by EEV on Vero and EEL is observed around 4 days post infection 
only and highlights the time span it may take for the de novo virus synthesis to 
occur and the mechanisms required such as the production of virions only when 
the cell is no longer viable..
The capacity for viral replication without cytopathic effect may involve 
viral budding by association of the viroporin NS3 to the cell's protein sorting 
TsglO l (Tumor susceptibility gene 101) molecule, instead of cell membrane 
permeabilization (Wirblich et al., 2006). The signal transduction cascades 
induced by VP2 and VP5 may vary between different cell types (Hemati et al., 
2009) and inhibitory pathways such as those induced by the inner caspid 
proteins VP3 and VP7 may be involved.
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5.3.2. Viral infection triggered differentiation of equine blood 
monocytes
The infection of monocytes by EEV did not alter the expression of 
monocyte markers at first (section 5.2.4.1). Only the expression of CD163 was 
significantly upregulated and may Indicate that this scavenger receptor might act 
as a Mo entry receptor for EEV. These cells also maintained their endocytic and 
phagocytic capacity in the presence of virus replication (section 5.2.5.1).
Intriguingly, EEV induced phenotypical changes similar to a DC phenotype 
in the absence of GM-CSF and IL-4 (section 5.2.4.2). Key DC rharkers such as 
CD206, CD83, CD8 6  and MHC II  were all significantly upregulated with an 
immature DC phenotype 72 hours post infection. This effect was dependent on a 
replication competent virus, as it was not present at UV inactivated EEV, thus 
not being an effect of receptor interaction or endocytosis aiming to present the 
virus. The positive correlation between viral gene expression in Mo and the DC 
phenotype suggested that a tissue state of myeloid cells was advantageous for 
the virus. Interestingly, IMoDC seemed to support the replication of EEV the 
least, if at all. Thus, the primary effect of this mechanism could be in hiding from 
the immune system and further work will be required to study the function of 
such DC-like cells.
While this finding is seemingly striking, a recent study has proposed 
another theory for virus induction of Mo differentiation (Hou et al., 2012). In that 
study, other viruses such as VSV (Vesicular stomatitis virus), VV (Vaccinia virus) 
and Influenza A viruses (including the circulating swine origin virus) also induce 
DC differentiation or activation. The expression of CD83 was upregulated on 
differentiated cells, along with other DC markers, such as CD141, CLEC9A and 
DC-LAMP, not assessed here. It  was proposed that blood and tissue Mo have 
evolved to be infected by a variety of viruses and rapidly transforming into DC to 
enhance antigen presentation (Hou et al., 2012), which will be an evolutionary
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advantage for the host. In this thesis, EEV did inhibit the T cell stimulatory 
capacity of activated DC (section 5.2.5.2) making that theory less likely. I t  must 
be noted that in both studies no functional assays were carried out on virus 
induced DC, which is required to further elucidate this effect.
5.3.3. MoDC preserved most but not all of their properties
Monocyte differentiation was also assessed during the differentiation and 
activation of MoDC (section 5.2.6). Similar to infected monocytes, infected 
iMoDC and mMoDC maintained their capacity to endocytose and phagocytose 
antigen. Surface molecules were mostly expressed as compared to the mock- 
infected cells. Only the expression of MHC II  was significantly downregulated 
upon infection of iMoDC, but the percentage cells expressing this molecule 
remained relatively high. Similarly, the phenotype of infected mMoDC revealed 
not much alteration upon EEV infection, except for the significant but slightly 
reduced CD8 6  expression. Thus, the infection of differentiated or activated MoDC 
had only a minimal impact on the phenotype and ability to take up antigen, but 
interestingly targeted key molecules for antigen presentation both first and 
second signals.
Dendritic cell activation is crucial to the host immune response since the 
mature cells are more potent T cell activators. Immature MoDC seemingly still 
had the capacity to be activated in the presence of the maturation cocktail and 
only the expression of CD83 (but neither MHCII nor CD8 6 ) was significantly 
reduced. However, the T cell activation capacity was indeed significantly 
impaired, thus demonstrating that EEV infection targets the activation of the 
immune system. The reduced T cell proliferation will delay and reduce the 
primary host defence and provide EEV with additional time. The selective 
advantage for a virus to infect and impair DC function has been demonstrated to 
occur with measles virus by interfering with signalling pathways essential for T
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cell activation (Servet-Del prat et al., 2000; Schneider-Schaulies et al., 2003), 
HSV-1 by inhibition of T cell stimulatory capacity and dramatically reducing 
lymphoid chemokine-mediated migration (Kruse et al., 2000a; Prechtel et al., 
2005), and Lymphocytic choriomeningitis virus (LCMV) by viral persistence in DC 
(Sevilla et al., 2000).
5.3.4 Replication pattern of EEV in myeloid cells is yet to be 
elucidated
Three types of non-lytic replication have been described before and could 
occur here. Firstly an abortive infection, this would require the virus to be 
cleared and the infection not having an effect. This does not seem to be the 
case, given the fact that viral gene expression increased over time and that 
function was impaired at least with mMoDC,.
A persistent infection would be another option as viral persistence 
depends on a virus having a non-lytic strategy of replication and must actively 
curtail the host's anti-viral immune response. In in vitro cultures, persistent BTV 
infection has been suggested in ovine and bovine 78 (gamma-delta) T cells that 
grew continuously with no obvious CPE (Takamatsu et al., 2003). This was also 
demonstrated in some insect cell cultures without host cell DNA or protein 
synthesis shut-off (Jennings and Boorman, 1979; Wechsler et al., 1989; Fu et 
al., 1999). In the case of EEV, the host's immune response is not shut off but 
may be delayed through the impaired T cell activation extending the infection 
time.
Thirdly, a restricted or restricted-persistent infection as discussed for 
herpesviruses and poxviruses in myeloid cells (Linnavuori and Hovi, 1983; Seet 
et al., 2003; Foster-Cuevas et al., 2004; Chahroudi et al., 2005) would be 
possible. Here, replication commences (as indicated by the NS3 gene expression 
level) but then halts at a later stage not resulting in infectious particles. A fully
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restricted infection at least again seems unlikely, since some viral particles were 
produced.
At present, the nature of the replication of EEV in myeloid cells remains to 
be determined. Since no changes in morphology and cytopathogenic effects were 
observed even over a longer period of observation (up to 72 hours), the lytic 
replication seems unlikely taken the abundantly expressed NS3 into account. 
However, given the fact that orbiviruses carry segmented genomes with multiple 
transcription initiation sites, it may be that another viral gene is not readily 
transcribed and lytic replication may follow provided the appropriate stimulation 
of cells. Antibodies will be required to demonstrate the viral proteins and further 
investigations will also need to make use of antibodies or fluorescent probes to 
determine the percentage of infected cells. Through such studies, the nature of 
the replication of EEV in myeloid cells could also be determined.
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6.1. Equine DC Biology
DC play a crucial role as immune regulators in both health and disease. It 
is well established that DC are potent antigen presenting cells (APC) with the 
capacity to prime naïve T cells (Steinman, 1991; Sallusto and Lanzavecchia, 
1994), which has also been demonstrated for eqDC (Chapter 3). Due to their 
scarcity in blood, DC are typically generated in vitro by culturing Mo with GM- 
CSF and IL-4 (Sallusto and Lanzavecchia, 1994; PickI et al., 1996). The in vitro 
MoDC system has been well characterised, particularly in humans and mice. A 
recent study in mice has shown that MoDC resemble inflammatory DC in 
function, including antigen presentation and cross-presentation. In this thesis 
eqMoDC have also shown the ability to cross-present antigen to CD8 + T cells, 
which highlights their similarity to other systems.
Characterisation of equine Mo has shown their heterogeneity and 
identified three Mo subsets in horse peripheral blood based on the expression of 
CD163"^, as shown in pigs, and CD14^‘^ /^'°' ,^ also shown in humans (section 
3.3.1; Figure 1.9). Further studies will be required to assess whether these 
subsets exhibit either pro-inflammatory or anti-inflammatory functions, as 
described in humans, mice and pigs (Sanchez et al., 1999; Geissmann et al., 
2003; Gordon, 2003; Chamorro et al., 2004; Drevets et al., 2004; Mantovani et 
al 2004; Mantovani et al., 2005; Nahrendorf et al., 2007; Biswas et al., 2008; 
Kigerl et al., 2009; Moreno et al., 2010; Robbins and Swirski, 2010). Further 
assessment will be needed to determine if these subsets have an equal ability to 
differentiate into DC or even MO. Here, as in most other studies, all CD14+ cells 
were isolated to generate MoDC.
Previous attempts were made to establish the horse in vitro MoDC system 
(Mauel et al., 2006; Cavatorta et al., 2009) but the results raised questions 
regarding the differentiation status not least as the maturation stimuli used were 
unable to confer the phenotypic and functional characteristics of mature human
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DC. In this study, purified baculovirus-derived cytokines, which eliminated 
impurities from cell culture that may have influenced the differentiation 
previously, and a maturation cocktail, consisting of a range of inflammatory 
mediators, were used to establish and characterise a highly reproducible in vitro 
MoDC system in horses (Chapter 3). This system has addressed the crucial issue 
to obtain activated eqDC in vitro. I t  has been proposed that the maturation 
cocktail with IFN-y, compared to LPS or polyI:C (Mauel et al 2006; section 
3.2.2.3) and inactivated E.coli (Cavatorta et al., 2009), has substantially 
increased the ability of eqMoDC to take up antigen, present and cross-present 
antigen to T cells. This enhanced effect was also observed in the human MoDC 
system activated with the cocktail (Nicolette et al., 2007; Landi et al., 2011). 
Phenotypic, functional and transcriptomic studies have clearly demonstrated that 
eqlMoDC and eqmMoDC are distinct cell populations. Furthermore, comparisons 
between the immature (tolerogenic state) and mature (immunogenic state) DC 
demonstrated that iMoDC are better at antigen uptake while mMoDC are better 
at stimulating T cell proliferation (section 3.2.4). This corresponds to what has 
been described in humans and mice both in vitro and in vivo (sections 1.3.4 and 
1.3.5).
CD83, a maturation marker of human and murine DC, was already highly 
expressed on eqlMoDC and coexpressed with CD206, a marker of immature DC 
(section 3.2.3.1). While there were significant changes between immature and 
mature MoDC, coexpression of these markers was maintained during maturation. 
Hence, neither CD83 nor CD206 are truly correlated with differentiation or 
maturation and cannot solely be used to distinguish stages of eqMoDC. While 
this opposes studies on human MoDC, it complements previous studies on the 
equine system (Mauel et al., 2006, Dietze et al., 2008, Cavatorata et al., 2009) 
and is similar to the situation described in other veterinary species, where these
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markers were not best placed to discriminate immature from mature DC either 
(Guyzlack-Piriou et al., 2006; Ricklin Gutzwiller et al., 2010).
Analysing the expression of costimulatory molecules such as CD80, PD- 
L l, PD-L2, ICSO-L and B7-H3 via gene expression provided further insight into 
the biology of eqDC. The expression of PD-Ll and PD-L2 on mMoDC implied an 
inhibitory role in the equine immune response, while that of ICOS-L and B7-H3 
implied a stimulatory role (section 3.2.5). In comparison to the human system, 
these molecules were shown to be highly upregulated on eqlMoDC, which 
potentially influenced the ability of these cells to stimulate T cell proliferation, 
although not to the extent shown by eqmMoDC. The migratory ability of equine 
MoDC was also delineated from the transcriptomic analysis and revealed that 
some of the most highly regulated genes were the chemokine receptors and 
their ligands (section 3.2.5.3), The differences in expression of 
chemokines/chemokine receptors between the differentiation and activation 
states were either stable or variable and reported in the human and mouse 
systems to be involved in DC migration and T cell interaction.
Since the first generation equine array resembled only part of the equine 
RefSeq database and was poorly annotated, further work is essential to obtain a 
better annotated equine array. This will allow for the use of pathway analysis 
tools that can give great insight into the biological processes and better 
understand how these molecules influence the role of DC in the equine immune 
response. Further work will be necessary to investigate if equine DC are in line 
with the proposed pan-species classification of DC, which suggests a unifying 
model for DC subsets based on phenotype and function (Guilliams et al., 2010).
In summary the data presented suggest that equine MoDC can be used 
both in vitro and potentially in vivo to test not only host-pathogen interactions, 
but also DC based prophylactic and therapeutic approaches or vaccines.
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6.2. Evasion of the horse immunologic surveillance system by 
different equine viruses
There is limited or no information available on the interaction of 
peripheral blood Mo and MoDC with the arterivirus EAV and the orbivirus EEV. 
They both possess viral proteins that influence their cellular tropism, control the 
release of viral progeny from infected cells thereby influencing their natural 
dispersion and contributing to their virulence. Since the entry receptors for these 
viruses are unknown and there are no available antibodies to measure the 
percentage cells infected, a high MOI of 5 was used to infect approximately 99% 
of cells as predicted by the Poisson distribution. Although this may not be 
representative of an in vivo infection, it was necessary in an in vitro system to 
have synchronous infection with virus which ensured the occurrence of only a 
single cycle of infection (Flint et al., 2009).
The host defends itself against invading viruses by activating the innate 
immune response and initiating virus-specific humoral and cellular immunity, 
which target virus replication and clear the infection. However, many viruses 
have adapted to subvert the host's antiviral responses to ensure their survival 
(lannello et al., 2006). For EAV, comparisons were made between strains from 
the American genogroup, which include the highly pathogenic Velogenic strain 
and the avirulent Attenuated strain, and the European genogroup, which include 
the low pathogenic UKl strain. The high and low pathogenic strains, which 
belong to the same genogroup, caused extreme differences in Mo and MoDC 
morphology, phenotype and function. On the other hand. Mo and MoDC infected 
with the two low pathogenic strains belonging to different genogroups displayed 
similarities in biology. Therefore, the effect on the immune cells was due to the 
virus virulence and not as a result of the associated genogroup or geographical 
location. For EEV, only the Israel strain was available for investigation. The
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clinical signs and zero mortality rate induced by this stain suggested it is of 
moderate pathogenicity.
EAV was shown to infect Mo and MoDC and productively replicate leading 
to lysis of cells (Table 6.1, sections 4.2.1 and 4.2.2). The replication was most 
efficient in mMoDC and the least in iMoDC, with the highly virulent strain having 
the most severe effects. In contrast, EEV was shown to infect but not replicate 
productively in Mo and MoDC (sections 5.2.1 and 5.2.2). The longer Infection 
times without cell lysis and low titres in cell supernatants implied persistence of 
EEV in Mo and DC. Hence, a possible restricted or restricted-persistent 
replication was proposed for EEV (Table 6.1), although further studies will be 
required to fully explore the nature of replication in myeloid cells. The 
susceptibility of the different MoDC states to EEV correlated with that observed 
for EAV. EAV infection induced an apoptosis-mediated cell death in equine blood 
Mo and MoDC (section 4.2.3) but there was no induction of apoptosis or killing of 
cells with EEV infection (Table 6.1, section 5.2.3). The virulent EAV strain may 
have modulated apoptosis of immune cells to its own advantage by promoting 
progeny dissemination after completion of viral replication. EEV potentially 
maintains cell survival so that it may persists in its host, thus escaping host 
immunity.
EAV in monocytic cells suppressed the differentiation into iMoDC (Table 
6.1) while infected iMoDC were still activated to mMoDC (sections 4.2.6 and 
4.3.4). DC are important in the immune recognition of antigen by presenting 
virus derived antigenic peptides in association with MHC class I / I I  to T cells. The 
inhibition of Mo differentiation to DC by EAV is a mechanism used by the virus to 
possibly escape immune recognition. On the other hand, EEV infection triggered 
differentiation of equine blood Mo even in the absence of GM-CSF and IL-4 
(Table 6.1, section 5.2.4.2). EEV infected iMoDC were still activated, but with a 
slight reduction in the expression of CD83 (section 5.2.6). I t  would be possible
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that EEV induced a tolerogenic DC state so that its antigen will be rendered 
harmless to its host and thereby goes undetected. Thus, different mechanisms 
may be used by viruses to achieve the goal of escaping immune recognition. In 
this context infected iMoDC preserved their functional properties upon infection 
having encountered 'danger signals'. Hence, it is possible that the lack of 
changes observed for IMoDC demonstrates the ability of the immature state to 
withstand a lytic and possibly a restricted-persistent replication, but equally to 
induce an immune response. Further investigations such as transcriptomic 
analysis on infected cells compared to uninfected or mock infected cells will be 
required to determine why these cells are less susceptible to infection and/or 
replication. It is possible that these studies will identify mechanisms that the 
immature DC state is using to lim it viral replication or of viruses to embark on 
the tolerogenic nature of iMoDC.
Table 6.1. Comparison of the effects of EAV and EEV on MoDC.
Viruses EAV (velogenic) EEV
Replication
qPCR
infectivity titres 
cell viability 
cell apoptosis
productive and lytic 
increased expression of 
ORFl gene
high in cell supernatants
not viable
yes
persistent and restrictive 
increased expression of NS3 
gene
low in cell supernatants 
remained viable 
no
Differentiation
(Mo^iMoDC)
inhibited stimulated; induction of 
tolerogenic DC state
DC function inhibited T cell activation inhibited T cell activation
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The interaction of mature DC and T cells is crucial for antigen 
presentation and the induction of an effective antiviral cellular immunity. EAV 
impaired the function of mMoDC, which will subsequently lead to the inability of 
the host immune system to eliminate the virus. The velogenic strain impaired 
the endocytic and phagocytic capacity of the mature state as well as inhibited 
the ability of these cells to stimulate T cells proliferation by inhibiting the 
expression of costimulatory molecules (Table 6.1, section 4.2.5), which hindered 
their interaction with ligands on T cells. Similar to EAV, mMoDC Infected with 
EEV were unable to activate T cells (Table 6.1, section 5.2.5.2). Although the 
overall effects on the phenotype and function of Mo and MoDC were minimal, the 
reduced allostimulatory capacity indicated that EEV can have a detrimental effect 
on the main DC function. Both viruses suppressed T cell activation of mature 
MoDC thereby initiation of an anti-viral immune response will be inhibited.
The possible persistence of EEV, particularly in immune competent hosts, 
may support the potential ability of the virus to direct innate immune evasion. 
Hence, the virus is able to avoid the immediate host defences designed to detect 
and clear pathogens from infected cells. The evasion tactics of both these viruses 
may target both the innate and adaptive host immune responses. To better 
elucidate these viral evasion mechanisms, a systems biology approach will give 
insight into the key biological processes and genes, including cytokine profiles, 
affected by these viruses. It will possibly identify the viral entry receptors on 
myeloid cells which may be different for the three cell types studied in this 
thesis. Once the target genes are identified, reverse genetics can be used to 
discover the function of these genes. This will uncover new targets for the 
rational design of therapeutic intervention strategies, such as vaccine and 
adjuvant development, aimed at protecting against infection by these viruses.
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6.3. In  vitro eqMoDC system as a model to study horse-virus 
interactions
As sentinels of the immune system, DC are crucial for the generation of 
protective antiviral immunity. The MoDC system has been used to study many 
species specific or zoonotic viruses (Werling et al., 2002; Glew et al., 2003; 
Tavakoli et al 2004; Silva et al., 2007; Marsac et al., 2011; Fairman and Angel, 
2012; Zhang et al., 2012).
A better understanding of the horse-virus interaction is of central 
importance in improving and developing therapies to fight viral diseases. The 
licensed EAV vaccine in the UK can only be used in horses and ponies over 9 
months of age with boosters every 6 months. The efficacy of this vaccine is not 
yet fully known and seropositive horses due to vaccination cannot be 
distinguished from true infections (Department for Environment, Food and Rural 
Affairs, 2012). On the other hand, there is no vaccine for EEV and no recognised 
control measures. Here MoDC can be used to improve vaccine design and testing 
as demonstrated with feline MoDC against Feline Immunodeficiency Virus (FIV) 
(Freer et al., 2008) and human MoDC in cancer vaccination therapy (Saha et al., 
2003; Gyôngyôsi and Nagy, 2008).
The general approach of this in vitro cell culture model can also be 
applied to other myeloid cells such as monocyte-derived macrophages (MoMO) 
and to other viruses, such as the lentivirus Equine Infectious Anaemia Virus 
(EIAV), which is similar to the Human Immunodeficiency Virus (HIV) in humans.
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Appendix II
The presence of EAV after UV inactivation was confirmed using the EAV 
O RFl TaqMan assay.
Z
2
6 0 0 0
50 0 0
4 0 0 0
3 0 0 0
2000
1000
0 10 20 30 4 0
Cycles
Appendix I I .  Identification of EAV after UV inactivation. The US Bucyrus 
reference strain was exposed to 254 nm of short UV wavelengths for 1 hour in a 
class II biological safety cabinet as described in section 2.2.2. The ORFl TaqMan 
qPCR assay was used to detect virus after inactivation. The amplification plot of 
fluorescence versus cycle threshold values confirmed the presence of virus; 
(Chapter 2, section 2.2.2). The presence of EEV was also confirmed with the NS3 
SYBR Green assay (data not shown).
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Appendix I II
Optimisation of a real-time TaqMan qPCR assay for relative detection of 
the EAV ORFl gene.
HTJ
3IL
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1 6 0 0 -
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8 0 0
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No RT 
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1
 1  —  1---
70 80
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90
Specificity of the ORFl primers for EAV strains investigated. A SYBR 
Green assay was performed as described in section 2.4.8. cDNA was used as the 
template in the SYBR Green assay and a No RT control was included. The 
melting curve analysis of the negative first derivative of the change in 
fluorescence intensity as a function of temperature shows one specific product 
for all EAV strains at a Tm of 88°C. Each curve represents the average of 3 
technical repeats; Chapter 2, section 2.4.7.
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Appendix IV
Optimisation of a real-tim e SYBR Green qPCR assay for relative  
detection of the EEV NS3 gene.
800
I-"O
600
g 400 
c
8W
O 200
O3
EEV
No RT 
control
60 70 80
Temperature (°C)
90
Appendix IV . EEV NS3 real-tim e SYBR Green assay. RNA isolated from 
culture supernatant of Vero cells infected with the Israel strain was reverse 
transcribed into cDNA (section 2.4.4). The cDNA was used as the template in the 
SYBR Green assay and a No RT control was included. A melting curve analysis 
with the negative first derivative of the change in fluorescence intensity as a 
function of temperature was plotted. The presence of one specific product for the 
EEV strain at a Tm of 81°C showed the specificity of this assay and corresponds 
to the band in the gel insert which represented the gel analysis of the qPCR 
products; lane 1, molecular weight marker 100-1500 base pair (bp) in 100 bp 
increments; lane 2, EEV and lane 3, No RT control. The qPCR product was at 130 
bp in size. The melting curve represented the average of 3 technical repeats, 
(n=4); (Chapter 2, section 2.4.8).
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Appendix V
Optimisation of real-time TaqMan qPCR assays for relative expression of 
the costimulatory genes.
PD-L2/CD273PD-L1/CD2741200
1000
800 No RT 
control
NoRT
controlH"O 600
400
3
IL
■D
I
200
IC06 L/CD275■ . --- B7-H3/CD2761200
8
§
£
1000
800
No RT 
control
NoRT  
co n tro l■600o3
IL 400
200
908070 90 60 7060 80
Temperature (°C)
Appendix V. The specificity of the costimuiatory assays. The primers of the 
costimulatory molecules, PD-L1/CD274, PD-L2/CD273, ICOS-L/CD275 and B7- 
H3/CD276, were first optimised using the SYBR Green dye (section 2.4.8). 
Assays were developed and optimised using RNA isolated from activated PBMC 
stimulated with ConA for 24 hours. No reverse transcriptase (No RT) controls 
were included. The melting curves represent the change in fluorescence intensity 
plotted as a function of temperature. The presence of one specific product, at the 
Tm of 82°C (PD-Ll), 85°C (PD-L2 and ICOS-L) and 88°C, showed the specificity of 
these assays; (Chapter 2, section 2.4.9).
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Appendix VI
Optimisation of real-tim e TaqMan qPCR assays for relative expression of 
the IL -10  and IL -29  genes.
(a ) IL -10 (b ) IL -29
k  1200
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Appendix IV . Specificity of the cytokine assays. The primers used in IL-10 
and IL-29 duplex TaqMan qPCR assays, were first optimised using the SYBR 
Green dye (section 2.4.8). Assays were developed and optimised using RNA 
isolated from activated PBMC stimulated with ConA for 24 hours. No reverse 
transcriptase (No RT) controls were included. The melting curves represent the 
change in fluorescence intensity plotted as a function of temperature. The 
presence of one specific product at 84°C and 87°C Tm for IL-10 and IL-29, 
respectively showed the specificity of these assays; (Chapter 2, section 2.4.9).
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